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ABSTRACT
CHAPTER 1: PART A: A UNIQUE APPROACH OF PREPARING 3,3‐DISUBSTITUTED
OXINDOLES FROM ACYCLIC TETRASUBSTITUTED ALDEHYDES: TOTAL SYNTHESIS
OF (‐)‐COERULESCINE AND (‐)‐COIXSPIROLACTAM A
by
Md Shahnawaz Ali
The University of Wisconsin‐Milwaukee, 2021
Under the Supervision of Professor M. Mahmun Hossain

(‐)‐Coerulescine and (‐)‐coixspirolactam A, two naturally occurring compounds
characterized with an all‐carbon quaternary center containing a spirooxindole,
have been synthesized asymmetrically. The key feature of their total synthesis
involves

a novel rational construction of the chiral 3,3‐disubstituted oxindole core from the
acyclic chiral tetrasubstituted aldehyde. The later scaffold was prepared in high
enantioselectivity (up to 86%) from the ethyl 3‐hydroxy‐2‐(2‐nitrophenyl)acrylate
1 by exploring both intermolecular and intramolecular Pd‐mediated asymmetric

ii

allylic allylations (Pd‐AAA). A through optimization of these approaches is described
in this thesis.
CHAPTER 1: PART B: SYNTHETIC SCOPE OF BRØNSTED ACID CATALYZED
REACTIONS OF CARBONYL COMPOUNDS AND ETHYL DIAZOACETATE

The comprehensive study of the reactions of carbonyl compounds and ethyl
diazoacetate in the presence of a Brønsted acid catalyst is described. In this, a broad
range of 3‐oxo esters were synthesized from a variety of ketones, specifically
benzophenones and aliphatic ketones. For the diaryl ketones, we have
characterized two inseparable products of migration by two‐dimensional nuclear
magnetic resonance spectroscopy (2D‐NMR) and calculated the ratio of their
relative migratory tendencies. However, the symmetric and nonsymmetrical
aliphatic ketones provided the higher migration for relatively longer alkyl chains
length. In case of the aliphatic aldehydes, we got exclusively the expected β‐keto
ester by a 1,2‐ hydride shift.
CHAPTER 2: INVESTIGATION OF THE C2‐ALKYLATION OF 1‐(1H‐INDOL‐3‐YL)‐N,N‐
DIMETHYLMETHANAMINE

Indole derivatives can be conveniently alkylated at the C2 position by choosing
appropriate N‐protecting group and appropriate base. However, 1‐(1H‐indol‐3‐yl)‐

iii

N,N‐dimethylmethanamine (commercially named as gramine) is also limited to that
restricted choice of a protecting group for such alkylation. Herein we explore a the
lithiation of gramine with different protecting groups (such as Ms, Ts, Me, TIPS etc.)
on the N‐heteroatom and investigate the alkylation at the C‐2 position by trapping
the C‐2 lithio species with a variety of electrophiles such as methyl iodide, benzyl
bromide, prenyl bromide, allyl bromide, etc.
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1.1 Introduction
1.1.1 Importance of 3,3-disubstituted oxindoles and their asymmetric synthesis
The Chiral 3,3-disubstituted-2-oxindole frameworks carrying a tetrasubstituted carbon
stereocenter at the 3-position are present in several alkaloid natural products. This privileged
heterocyclic motif makes up the core of a large family of bioactive natural products and a series
of pharmaceutically active compounds (Figure 1). [1,2] One specific molecular architecture of
this class of compounds encompasses the spiro[pyrrolidine-3,3’-oxindole] ring system that exists
Figure 1 Privileged heterocyclic motifs contain oxindole core
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in a number of spirooxindole alkaloids such as 1–5. Such oxindoles were first isolated from the
family of plants termed the Apocynaceae and Rubiacae and characterized by a spirofusion to a
pyrrolidine ring at the 3-position of the oxindole core. Another significantly explored family of 3substituted 3-hydroxyoxindole units covers a large variety of alkaloids and natural products
exemplified by 6-9 (Figure 1). Moreover, 3-substituted 3- amino oxindoles are very useful because
of the presence of this structure in pharmaceutical candidates, [3a, 3b] such as the potent
gastrin/CCK-B receptor antagonist AG-041R 12 and the vasopressin VIb receptor antagonist SSR149415. The existence of sulfur-containing tetrasubstituted carbon stereocenter was first
discovered in Spirobrassinin 14 oxindole.
An extension of the importance added with the previous discussion of spiropyrolidine moiety is
the γ-lactone scaffold. A recent isolation of natural product like Coixspirolactam (A/B/C), 10-12
from the traditional Chinese medicine adlay bran exhibit potent anti-proliferative effects on human
lung cancer cells (A549), human colorectal carcinoma cells (HT-29 and COLO205), and human
breast cancer cell lines (MCF-7, T-47D and MDA-MB-231).[4] Out of many other scopes of
obtaining 3,3-disubstituted oxindole a couple of them has been added to the Figure 1 numbered
from 13-18.

2

1.1.2 Useful synthesis of natural and bioactive compounds containing the 3,3-disubsituted
oxindole
Based on the broad natural availability of such oxindoles, it is evident that the 3,3-disubstituted
oxindole framework can be utilized to synthesize pyrrolidinoindolines bearing a carbon substituent
at C-3a of the hexahydropyrrolo-[2,3-b]indole ring system, which exists in a number of natural
products such as 1-6 with strong bioactivity (Figure 2). [5] Some other agents with this pivotal
Figure 2 Examples of some natural and nonnatural moieties synthesized from 3,3disubstituted oxindoles
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core has already been explored for the synthesis of unnatural drug candidates shown in Figure 2,
compounds 7-14. Owing to its importance and versatility in the synthesis of these natural products,
drugs and related analogues, much effort has naturally gone into the asymmetric synthesis of the
3,3-disubstituted oxindole framework. The aim is to facilitate the synthesis of sufficient quantities
of the desired natural, unnatural products and related analogues for biological evaluation and
studies on structure-activity relationships. The overreaching goal is the development of new
therapeutic agents or important biological tools.

4

2.1 Strategies for the catalytic asymmetric synthesis of 3,3-disubstituted
oxindoles
Although the development of the strategies for chiral 3,3-disubstituted oxindole core is quite recent
but the importance of its impact attracted a lot of chemists to develop dozens of catalytic
asymmetric reactions. These reactions could be categorized into the following categories based on
the substrates employed for the reaction design: 1) intramolecular coupling reactions 2) direct
functionalization of 3-substituted oxindoles 3) nucleophilic additions to Isatins and 4) others
(Figure 3). Intriguingly, to realize the impact of each and individual component of a reaction a
detail study of use of chiral metal catalysts or organocatalyst are both reported in some cases..
Most of the approaches avoided the formation of oxindole ring by using commercially available
oxindoles because the ring formation is the critical step to optimize. But the problem is there are
only very limited number of substituted oxindole and thus somehow limited the expansion of the
scope for putting different substituent on the aromatic ring. Idea of putting different substituent on
the benzene ring oxindole selectively is still an elusive challenge. It should be mentioned that there
is no single example of inducing chirality before the for the formation of oxindole so far observed
from the literature survey. In the following sections, we summarize these exciting results in each
category, and briefly discuss the scope, advantages, and limitations of each method.
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Figure 3 Strategies for the synthesis of 3,3-disubstituted oxindoles
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2.1.1 Intramolecular Heck Coupling/modified coupling
The palladium-catalyzed asymmetric synthesis of 3,3-disubstituted oxindoles by intramolecular
amide α-arylation has received much attention. The first practical catalytic asymmetric method for
the enantioselective synthesis of chiral oxindoles was developed in the past decade of the past
century by Overman and coworkers in the context of the total syntheses of the alkaloids (-)physostigmine and (-)-physovenine. [6] A couple of other methods reported the formation of
disubstituted oxindole by modified Heck coupling strategies such as intramolecular amide αarylation and cyanomidation reaction. [7] Overman’s approach relied on the intramolecular Heck
reaction of the (Z)-(2-methyl)-2-butenanilide, which was catalyzed by a palladium (0) complex
formed in situ from commercially available (S)-BINAP and Pd2(dba)3 to afford the 3,3disubstituted oxindole 2 with excellent enantioselectivity (Scheme 1). Subsequently, Overman’s
group found that this approach could also be applied to the enantioselective synthesis of 3-alkyl3-aryloxindoles (Scheme 2 for a representative example). [8]
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Following the seminal work of Hartwig and coworkers, which discovered that by using chiral NHC
ligands they could perform this reaction at room temperature with moderate enantioselectivities
(40–76% ee) [9], subsequent research focused on modifying the structure of the NHC ligand L1*
in order to upgrade the stereoselectivity of the process (Scheme 3a). [10] In 2007, Ku¨ndig and
coworkers modified the NHC ligand using a strategy that (i) instead of using alkyl system an
aromatic ring can be introduced and (ii) ortho position of the ligand can be made more sterically
hindered by putting methyl/methoxy substituent. They were able to achieve high
enantioselectivities (up to 95% ee) in the cyclization of o-bromo(α-aryl)propanilides by means of
the sterically hindered NHC ligand L2* (Scheme 3b). [11]
Scheme 3 Intramolecular coupling using NHC and modified NHC ligand-Pd catalyst pair
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Moreover, the use of palladium has also proven to be a very useful [12] for intramolecular
asymmetric arylation of α-keto amides introduced by Shibasaki et al during the optimization study
of 3-hydroxy-3-alkyl oxindole synthesis. The catalyst [Pd(CH3CN)4](BF4)2/(R)-difluorPhos (5
mol%/6 mol% - chiral ligand L*)(Scheme 4) could generate chiral 3-hydroxy-2-oxindole
derivatives in moderate to good yields and excellent stereoselectivity (up to 95% ee). [13]
Scheme 4 Palladium catalyzed asymmetric intramolecular arylation of α-keto amides

Additionally, Yamamoto's group used Iridium catalyst to prepare 3-hydroxy-3-substitutedoxindole derivatives. They promoted an asymmetric intramolecular direct hydroarylation of αketoamides using cationic iridium ([Ir(cod)2](BaRF 4)) and chiral ligand L* to afford the desired
products in high to excellent yields and enantioselectivities (Scheme 5). [14] Further studies
indicated that the turnover-limiting step in the catalytic cycle was the carbonyl insertion step into
the aryl-iridium bond. [15]
Scheme 5: Iridium-catalyzed asymmetric intramolecular direct hydroarylation of α-keto
amide
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2.1.2. Direct functionalization
In 1991, Wong group reported the first known example of asymmetric C-H functionalization of a
3-prochiral oxindole to generate the C-3 quaternary stereocenter via phase-transfer catalysis
(Scheme 6). [16] The catalytic asymmetric alkylation of a 3-substituted oxindole was achieved by
means of phase-transfer catalysis (PTC), in the context of a formal total synthesis of (-)esermethol. The alkylation of the 3-Me-oxindole with chloroacetonitrile was performed under PTC
conditions with the aid of the quinidine-derived quaternary ammonium salt catalyst, C and
furnished the 3,3-disubstituted oxindole with excellent yield 83% and moderate enantioselectivity
of 77%.
Scheme 6 First Asymmetric PTC mediated alkylation of a 3-substituted oxindole

Remarkably, one more example of the application of PTC catalysis to the asymmetric alkylation
of oxindoles by alkyl halides has been reported up to now. In 2010, Ooi and coworkers synthesized
and tested the chiral triazolium salt. Under PTC conditions, this compound catalyzed the
asymmetric alkylation of a series of 3-substituted N-Boc oxindoles with reactive alkyl bromides
with excellent yield up to 99% and enantioselectivity up to 98% (Scheme 7). [17]
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Scheme 7 Chiral triazolium salt catalyzed asymmetric alkylation of oxindoles

Additionally, some other protocols have also been established based on acid induced catalysis,
direct fluorination / hydroxylation, asymmetric Michael addition, asymmetric Mannich reaction
and aldol reaction that would be described briefly in the following discussion. [18]
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2.1.2.1 Organocatalytic functionalization of C3-H
In 2009 three independent research groups reported, almost at the same time, the organocatalytic
enantioselective electrophilic α-amination reaction involving 3-substituted oxindoles as
nucleophile. All three-group used azodicarboxylates as a source of nitrogen and a cinchona
alkaloid as an organocatalyst. Chronologically, the group of Liu and Chen reported high yields
and enantioselectivities ranging from good to high when the amination of unprotected oxindoles
Scheme 8 Organocatalytic Amination of oxindole with DIAD
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was performed using dimeric dihydroquinidine-derived (DHQD)2PHAL as an organocatalyst and
diisopropyl azodicarboxylate (DIAD) as amination reagent. [19] The results obtained by the group
has presented in Scheme 8 (condition A). Moreover, performing a fine tuning of reaction variables
(solvent, temperature etc.) and more sterically hindered C3 substituent, Zhou and co-workers
obtained slightly better yield and enantiobenefit (Scheme 8, condition B). Thus, in this case
dimeric quinidine derived (QD)2PYR and CH2Cl2 were the preferred organocatalyst and solvent,
respectively (Scheme 8). [20]
Shortly after, Barbas and co-workers reported the asymmetric C3- amination of N-benzyl protected
oxindoles, using dimeric cinchona-derived organo-catalyst 1 and diethyl azodicarboxylate
(DEAD) as electrophilic aminating reagent (Scheme 8. Condition C). The protection of the
nitrogen allowed broadening the scope of oxindoles used, obtaining slightly better results than
when the unprotected analogues were employed. [21] However, using nitrosobenzene and
unprotected oxindoles, Liu and Chen could obtain the corresponding hydroxyamination products
with high yields and good enantioselectivities by employing cinchona organocatalyst O1 (Scheme
9). [22]
Scheme 9 Hydroamination of oxindoles with nitrosobenzene
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2.1.2.2 Halogenation:
The exchange of the 3-hydrogen of oxindoles by halogens is a challenging practice of improving
the biological activity of these molecules for drug discovery. Benefit in bioavailability, metabolic
stability and increasing protein-ligand interactions are the three main reason for the popularity of
fluorinated drugs nowadays compare to the nonfluorinated parents. [23] Thus 3-substituted 3fluorooxindoles can be referred as an interesting medicinally potential target. [24]
2.1.2.2.a Fluorination:
At the beginning of this century, a pioneering work by Shibata and co-workers described a new
method for the asymmetric enantioselective C3-fluorination of oxindoles. The main problem
associated with fluorine is the stable source of obtaining that, unstable sources of fluorine lead to
multistep procedures. [25] Initially in 2001, Shibata’s group used a stoichiometric combination of
various cinchona alkaloid derivatives and Selectfluor® in their procedure using indanones and
tetralones as model substrate. However, in 2008 when they established a successful procedure
Scheme 10 Organocatalyzed fluorination of oxindoles
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for the organocatalytic enantioselective C3-fluorination of oxindoles, by using a catalytic amount
of bis-cinchona-derived alkaloid (DHQD)2AQN, C and N-fluorobenzenesulfonimide (NFSI) as a
source of electrophilic fluorine (Scheme 10). [26]
Some years later, another work was reported by Zhang et al in which (DHQD)2PHAL (1) was used
as an organocatalyst instead of (DHQD)2AQN and added a tertiary butyl substituent on the para
position of NFSI’s phenyl ring. The authors reported slight increase of ee from 86-88% the
Scheme 11 Proposed catalytic cycle for the catalytic asymmetric organocatalyzed
fluorination of oxindoles
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previous reported enantioselectivities. [27] In both articles, a similar catalytic cycle for this
reaction was proposed (Scheme 11). The researchers hypothesized that the NFSI analogues react
with the quinuclidine ring of the cinchona derived organo-catalyst to afford intermediate A. This
species moves the inorganic base to the organic phase by acting as phase-transfer catalyst,
affording intermediate B, which then promotes the enolization of the oxindole to form enolate C
and intermediate D. Then either intermediates A or B or NFSI, can fluorinate the enolate
generating the final product.
2.1.2.2.b Chlorination
The organocatalytic asymmetric chlorination of oxindoles is a rare reaction. [28] There are very
few examples, mainly based on the use of Brønsted bases as organocatalysts. One example is the
enantioselective C3-chlorination of 3-aryloxindoles using the cinchona alkaloid derivative as an
Scheme 12 Organocatalytic chlorination of oxindoles using N-chlorosuccinimide (NCS)
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organocatalyst (condition 1) and N-chlorosuccinimide (NCS) as the chlorine source (Scheme 12).
[29]
The procedure gave rise to the corresponding 3-aryl-3-chlorooxindoles in high yields and moderate
to high enantioselectivities under mild reaction conditions. However, the use of 3-alkyl and 3benzyl-substituted oxindoles rendered the chlorination product in low optical purity. In addition,
a similar chlorination procedure by using an iminophosphorane base organocatalysts has been
proven to be more advantageous (Scheme 12, condition B). [30] Higher conversions and
enantioselectivities were achieved even with lower catalyst loadings and short reaction time at
room temperature. Furthermore, alkyl and benzyl substituents at C3 were well tolerated and
excellent results were also achieved. Finally, it is worth mentioning that the catalyst could be
recycled up to six times after chromatographic purification with almost no decrease in efficiency.
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2.1.2.3 Sulfenylation:
The presence of a trifluoromethylthio (SCF3) functionality in the structure of bioactive compounds
gives rise to some important properties, such as a reduced hydrophilicity and higher electronwithdrawing ability, which helps to enhance their transmembrane permeation bioavailability. [31]
Therefore, the addition of SCF3 to oxindoles may lead to interesting developments for
pharmacological applications. The trifluoromethylthiolation of oxindoles can be carried out by
using Brønsted base catalysts, particularly cinchona alkaloid-derived organocatalysts (Scheme
13).
Scheme 13 Sulfenylation (trifluoromethylthiolation) of 3-substituted oxindole using
Bronsted base Catalysis

A precedence of such activation was first established in 2014 by Tan’s group. They have executed
that the asymmetric trifluoromethylthiolation of 3-arylated oxindoles could be achieved via in situ
generation of an active electrophilic triofluoromethylthio species from AgSCF3 and
trichloroisocyanuric acid (TCCA) in presence of dimeric cinchona alkaloid organocatalysts such
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as (DHQD)2PYR (CPD-01) (Scheme 13, Condition A). [32] The scope of this reaction is broad
as both electron-donating and electron-withdrawing substituents on the oxindole can afford high
yields and enantioselectivities of the final products. The main advantage of this procedure is the
fact that the starting materials are cheap and there is no need for the isolation of the SCF3 reagent,
saving time and money. Moreover, Chin et al initiated the asymmetric trifluoromethylthiolation of
oxindoles using trifluoromethyl-substituted thioperoxide as the electrophilic reagent and quinine
as organocatalysts, affording 3-substituted-3-SCF3 oxindoles (Scheme 13, Condition B). [33]
When exploring the scope of this reaction, an exchange of the N-protecting group from Boc to less
hindered groups, caused any noticeable change in the enantioselectivity. It was also observed that
the 3-trifluoromethylthiolated reaction products from 3-arylated oxindoles had lower optical purity
than those from 3-alkylated ones. In addition, the same organocatalyst can be used for the
enantioselective

synthesis

of

3-aryl-3-SCF3-substituted

oxindoles

(trifluoromethylthio)phthalimide with good results (Scheme 13, Condition C). [34]
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using

N-

2.1.2.4 Hydroxylation
Itoh et al developed a convenient protocol of hydroxylation for 3-substituted oxindoles in presence
of molecular oxygen, using cinchonidine derived phase-transfer catalyst CPD-02. (Scheme 14,
Condition A). [35] However, reduction using 4 equivalents of (EtO)3P turned out to be vital for
achieving high yields and ee when N-p-methoxybenzyl (PMB)- protected oxindoles were employScheme 14 Asymmetric hydroxylation of oxindole using various phase-transfer catalyst

ed. In subsequent studies, pentanidium-based phase-transfer catalyst CPD-03 was employed in
presence of molecular oxygen, they achieved slightly better enantiobenefit than in the previous
case (Scheme 14, Condition B). [36] What is significant about this procedure is that there is no
need for an additional reducing agent. According to the authors, this reaction proceeds via a kinetic
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resolution of the hydroperoxyl oxindole intermediate by means of its reduction by the in situ
generated enolate of the 3-substituted oxindole. Finally, it is worth mentioning that, only phasetransfer catalysis has been used to achieve the asymmetric electrophilic hydroxylation of
oxindoles.
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2.1.3 Nucleophilic addition to Isatin moiety
A direct but challenging approach of introducing various functionality in the prochiral moiety
using metal catalyst is asymmetric allylation. The idea is to put the allyl group at first and leter
convert it to the require functionality by additional steps. Such a commercially available oxindole
moiety is known as Isatin. Qiao and coworkers published the asymmetric allylation of Isatin
analogues with allylic alcohols using the catalyst [Pd(OAc)2] / La* (5 mol% / 10 mol%) (Scheme
15a). During screening different ligands of chiral spiro phosphoramidite family La* proved to be
the best to access tertiary homoallylic alcohols 3-allyl-3-hydroxy-oxindole derivatives. Although
the process resulted in very high yields with moderate enantioselectivities (up to 71% ee). [37]
Scheme 15 Pd Catalyzed asymmetric allylation for the synthesis of 3-hydroxy oxindole
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Moreover, Aikawa et al., also focused on the synthesis of tertiary alcohol, studied ene reactions of
N-protected Isatins along with isopropenyloxy(triisopropyl)-silane (Scheme 15b) and aldol
reaction using isopropenyloxy(tert-butyldimethyl)-silane trimethylsilyl ketene thioacetal (Scheme
15c). In both the cases they have used [Pd(SbF6)2] and the chiral ligand Lb* in 10 mol% as an
optimized quantity. The chiral 3-hydroxy-3-substituted-oxindole derivatives were isolated in high
yields and with remarkable ee in some cases (>99% ee). [38]
Use of arylboronic acids to the N-substituted Isatins for nucleophilic addition allowed the
formation of 3-aryl-3-hydroxyoxindole derivatives with moderate to good yields and
enantioselectivities. A pair of C2-symmetric cationic N-heterocyclic carbene-Pd2þ-diaqua
complex, prepared from the chiral ligand Lc* was incorporated as a catalyst (Scheme 16). [39]
Scheme 16 Catalytic asymmetric allylation of isatin derivatives with arylboronic acid

Lanthanides have also been described for their potential application in asymmetric catalysis. [4042] Among them, ytterbium was applied in the enantioselective decarboxylative addition of βketoacids to Isatins. The author mentioned that the use of N-substituted Isatins is crucial for the
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reaction yield and enantioselectivity, in the presence of the catalytic system Yb(OTf)3/Ld*. As a
result, chiral 1-benzyl-3-hydroxy-3-substituted-oxindole derivatives were obtained in very good
yields (88-95%) and moderate to excellent enantioselectivities (65-98% ee) (Scheme 17). [43]
Scheme 17 Decarboxylative addition of β-ketoacids to isatin derivatives catalyzed by
ytterbium

Iridium is a transition-metal from period 6 of the periodic table that presents a wide range of
Scheme 18 Allylation, crotylation and reverse prenylation of Isatin derivatives using Ir
catalyst
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applications in synthesis. [44] Itoh et al. reported the first asymmetric allylations (Scheme 18a),
crotylations (Scheme 18b) and prenylations (Scheme 18c). N-benzyl-isatin derivatives, using an
isopropanol mediated transfer hydrogenation, in the presence of the catalyst [Ir(cod)Cl]2 (2.5
mol%) and the ligand (R)-p-phos Le* ((R)-(þ)-2,2,6,6-tetramethoxy-4,4-bis(diphenylphosphino)3,30 -bipyridine - 5 mol%), achieving moderate to good yields and good to excellent
enantioselectivities (up to 96% ee). [45]
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2.1.4 Other approaches:
2.1.4.1. 1,4-Michael addition:
Mechler and Peters developed a polyfunctional, readily available novel NiII-bis(phenoxyimine)
type catalyst which can overwrite the inherent diastereoselectivity in direct 1,4-additions of
oxindoles to nitroolefins to give rise to the epimeric product series (Scheme 19). Crucial for the
switch in diastereoselectivity is the interplay of a Lewis acid, free hydroxy groups, and an axially
chiral bisimidazolium linker in combination with the appropriate arrangement of the different
chirality elements. The axially chiral bisimidazolium determines the configuration of the
stereocenter generated at the nitroolefin, while the constitution as well as the relative.
Scheme 19 Diastereoconvergence for difference substrates of N-protected oxindoles

and absolute configuration of the iminoalcohol side arms mainly control the stereocenter generated
at the oxindole. [46] The group has reported a novel polyfunctional catalyst type in which a NiII-

26

bis(phenoxyimine) unit, free hydroxy groups, and an axially chiral bisimidazolium entity
participate in the stereocontrol of the direct 1,4-addition of oxindoles to nitroolefins. Both epimers
of the 1,4-adduct are accessible in excess on demand by changes to the ligand constitution and
configuration.
The observed diastereodivergency might be explained by a mechanism in which the Ni centers,
OH group, and the bisimidazolium moieties cooperate (Figure 4). A control experiment with an
N-methyloxindole resulted in no 1,4- adduct. We thus suggest a scenario in which oxindole
enolization is triggered by bidentate coordination of the carbonyl group to Ni(II). As shown above,
changes within the iminoalcohol side arms have an influence on the preferred configuration of the
stereocenter at the oxindole. The orientation of the oxindole in the C-C bond-forming transition
state might thus be dictated by the iminoalcohol moieties. Whereas. the preferred configuration
Figure 4 Simplified working model of Ni-catalyst with oxindole framework
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of the generated stereocenter in the nitroalkane chain is always identical when using the Ra configured bisimidazolium linker. For that reason, we suggest that the nitroolefin is activated by
hydrogen bonds/electrostatic interactions with the bisimidazolium groups, whereas the free
hydroxy groups might be important to control the reactive conformation of the oxindole-Ni(II)
adduct (Figure 4). It should be noted that the iminoalcohol side chains can be symmetrically
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inequivalent after substrate coordination. The flexibility of an axially chiral bisimidazolium linker
might be beneficial to readily adopt the optimal positions of both reacting centers

2.1.4.2 Enantioselective Michael Addition Cascade: Metal carbenoid assisted
C-C bond formation
The first practically highly enantioselective synthesis of indolyl-indanes through a combination of
either ruthenium (II) or Rhodium(II) complexes and quinine-derived squaramide enables 3diazooxindoles, indoles, and nitroalkenes to undergo highly efficient asymmetric three-component
reactions, thus affording optically active 3,3’-bis(indole)s through a consecutive C-C bondforming sequence, (Scheme 20). It should be noted that an early attempt by Enders group
Scheme 20 Three component cascade reaction for the enantioselective synthesis of 3,3disubstituted oxindole
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back on 2013 reported the formation of 3-methyloxindole (R=Me) with only 39% yield and 33%
ee and oxindole (R=H) gave 44% yield and 73% ee although the same group later in 2015 reported
a one pot scalable triple domino asymmetric synthesis of fully substituted cyclopentane-oxindoles
through an organocatalytic triple Michael domino reaction. [47-48] In fact, N-benzyl-3diazooxindoles, N-methylindoles and nitroalkenes reacted under [RuCl2(p-cymene)]2 and quininebased squaramide catalysis.
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2.1.4.3 Asymmetric Strecker reaction:
Zhou et al first applied safe cyanide source, trimethylsilyl cyanide (TMSCN) in the Strecker
reaction [49] of N-aryl Isatin ketimines (Scheme 21). At that time, the bifunctional tertiary-amine
catalyzed Strecker reaction was undeveloped. [50] Although Deng had reported a highly
enantioselective chiral tertiary-amine mediated ketone cyanosilylation, [51] the breakthrough was
achieved by a newly developed phosphoramide derived from the Cinchona alkaloid.
Scheme 21 Preliminary study of the Strecker reaction for N-aryl isatin ketimines

Preliminary studies indicated that 10 mol % phosphinamide catalyst C1 afforded oxindole based
aminonitrile with moderate ee. [52] However, the best results of enantioselectivity were obtained
whenever they used phosphinamide catalyst with amide or thiourea as the H-bond donor (Scheme
21). These results encouraged the Chouhan group to examine their potency in other reactions and
triggered subsequent research on catalytic enantioselective addition of nucleophiles to Isatin
ketimines for the synthesis of chiral 3-substituted 3-aminooxindoles. [53] The same group
furnished an asymmetric synthesis with thiourea driven cinchona alkaloid and ended up with
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excellent results (Scheme 22a). The catalyst Ca they developed was proved useful later for Zhou
et al who perused another approach using Isatin a starting material with same catalyst and found
an excellent outcome as well (Scheme 22b)
Scheme 22 Direct cyanidation using thiourea driven Cinchona alkaloid
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2.1.4.4 Desymmetrization of diyne:
The Cu-catalyzed alkyne-azide cycloaddition (CuAAC) reaction has been applied in many areas
of research; however, applying this strategy to the asymmetric synthesis remain still undeveloped.
[54] Zhou group reported a strategy to develop enantioselective CuAAC, namely,
desymmetrization of prochiral diynes (Scheme 23). [55] The key idea was to develop a highly
enantioselective desymmetric CuAAC of oxindole-based 1,6- heptadiynes, furnishing quaternary
oxindoles (Scheme 23) bearing a 1,2,3-triazole-containing moiety with 84−98% ee. This research
also revealed that suppressing achiral diazole formation while achieving excellent
enantioselectivity was very difficult, although they were fortunate to identify 2,6-hexadione as a
solvent that could solve this problem in this case.
Scheme 23 Asymmetric CuAAC reactions for the preparation of 3,3-disubstituted oxindole
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3.1 Introduction:
Part: II Palladium Catalyzed Asymmetric Allylic Alkylation
Palladium-catalyzed asymmetric allylic alkylation (Pd-AAA) stands as a unique reaction due to
the high number of stereocenters that can be created by this process. [56] Arguably, few transitionmetal-catalyzed reactions offer the synthetic chemist the ability to form C–C, C–N, C–O, C–F,
and C–S bonds by such a variety of mechanisms for asymmetric induction (Scheme 24). The
development of Pd-AAA has been reviewed extensively; however, a specific aspect of Pd-AAA
has not significantly matured over the past 20 years, namely the synthesis of acyclic quaternary
stereocenters. [57] Unfortunately, the term “quaternary center” is a confusing terminology,
because it is also used to mean “quaternary-substituted carbon”, that includes tri-carbonsubstituted carbon such as occurs in tertiary alcohols. The term “all-carbon quaternary centers” is
also found in the literature. Thus the ‘Quaternary substituted carbons’ and ‘quaternary carbons’ in
the full sense must be distinguished carefully. Thus, in this chapter we are using the term
“quaternary carbon” to designate those carbon centers that are substituted with four carbon
substituents.
Pd-AAA has been shown to be successful for inducing asymmetry on both electrophilic and
nucleophilic partners. Consequently, the discussion can be divided mainly into these two classes
of reactions, with an emphasis on vinyl epoxides as electrophiles and enolates as prochiral
nucleophiles. Possibility of using cyclic pronucleophiles that are readily converted into acyclic
tetrasubstituted stereocenters after the alkylation reaction is also less explored as well.
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Scheme 24 Formation of stereocenters by Pd-AAA

Asymmetric induction can be done by two different methods either by stereo control of the
prochiral electrophile or the prochiral nucleophile. The process proceeds with different type of
mechanism and can be described by considering different examples introduced by different group
of researchers. A details discussion on the asymmetric induction for the synthesis of cyclic
tetrasubstituted stereocenter is more common practice. [58] But the formation of acyclic
quaternary stereocenter is still limited due to their conformation mobility. [59] Our focus in this
part of chapter is to elaborate the idea of exploring the less accessible acyclic quaternary molecules
using asymmetric allylic alkylation.
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3.1.1 General mechanism of regio and stereospecific Pd-catalyzed asymmetric
allylation
In the case of Pd-allylic alkylation, the most common mechanism operative involves an initial
coordination of a chiral Pd(0) catalyst with an olefin bearing a leaving group at the allylic position
(Scheme 25). Ionization occurs with inversion, where the η2-π-allyl–Pd(II) complex is situated on
the opposite face to the leaving group. Alkylation of the η3- π-allyl–Pd(II) complex occurs with
inversion of the stereochemistry about Pd(II), with simultaneous regeneration of the chiral Pd(0)
catalyst. Because both the ionization and nucleophilic addition occur with inversion, the
nucleophilic substitution occurs with net retention of the stereochemistry of the leaving group. An
outer-sphere attack of a nucleophile is the most common pathway for soft nucleophiles (pKa <
Scheme 25 Mechanism of regio and stereospecific Pd-catalyzed asymmetric allylation
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25). For hard nucleophiles, the nucleophile attacks the metal directly and undergoes an innersphere reductive elimination with retention of stereochemistry about Pd(II), and overall net
inversion of stereochemistry.
Nucleophiles such as ketone enolates alkylate at the α- carbon, producing a stereocenter on the
nucleophile. In this case, asymmetric induction can be difficult to achieve since the C–C bond
forming event most commonly occurs via an outer-sphere mechanism and the nucleophile remains
distal to the chiral information about the metal–ligand environment. Alkylation of allyl
electrophiles bearing substituents, although typically much easier substrates for obtaining
asymmetric induction, operate via more complicated mechanisms involving π–σ–π equilibration
of the π-allyl intermediate (Scheme 26d). Additionally, the enantio-determining step of the
reaction may occur during any step of the catalytic cycle, save for dissociation of the alkylation
product. In Pd-AAA, only two mechanisms are likely to be operative in the synthesis of acyclic
Scheme 26 Modes of asymmetric induction by electrophile
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tetrasubstituted stereocenters on the electrophile, namely differentiation of enantio-topic olefin
faces (Scheme 26b) and π–σ–π equilibration (Scheme 26d). In most cases, the chiral ligands
employed in Pd-AAA are phosphines, and a variety of scaffolds have arisen from the many creative
approaches toward acyclic stereocontrol in allylic alkylation (Figure 5). [60]
Figure 5 Examples of the variety of ligands widely used in Pd -AAA

Ferrocenyl phosphine
Ferrocenyl PHOX

Ferrocenyl crown ether

Biaryl Phosphino
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Aryl sulphonamide

A feature that is unique to transition-metal catalyzed asymmetric allylic alkylation reaction is the
ability to convert different types of starting materials such as chiral racemic, meso and achiral to
enantiomerically pure compound. Therefore, several factors are primarily considered during the
optimization study of the reaction conditions.
3.1.2 General consideration for optimizing reaction procedure for Pd-AAA
i.

Choice of appropriate solvent system that effect the formation of stable catalyst-ligand
complex with solvent cage sometimes ion pair interaction

ii.

Choice of appropriate source of metal to reduce the interaction of the leaving ligand in
the reaction system. Such as a leaving ligand can act as a base and influence the reaction
rate of the incoming electrophile/nucleophile and a bulky substituent attach to the
catalyst stable complex may act on formation of desire geometry of the Catalyst-Ligand
complex. Some of the commonly used Pd(0) source widely used in Pd-AAA or PdDAAA have shown in Figure 6.

Figure 6 Examples of some commercially source of Pd(0) as a catalyst
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iii.

Choice of ligand that hinder one site of the electrophile (during inner sphere reaction
mechanism) and exposed another site for the nucleophilic

iv.

attack selectively. For the outer sphere mechanism, the metal directly interacts with the
substrate. The types of ligands to effect the site selective transformation have followed
three general concepts in design: (1) creating chiral space with an array of groups whose
conformational bias originates from primary stereogenic centers [61] (2)
desymmetrization of electron density on the donor atoms of the ligand where different
bond lengths on each side of the chiral space promote differential reactivity at each
terminus [62] (3) attaching a tethering agent to the main skeletal symmetry which can
coordinate with the incoming nucleophile. [63] Figure 5 lists those ligands which are
most prevalent in AAA-driven natural product total synthesis.

v.

Tuning the reaction temperature controls the kinetics of the reaction and thus influence
the preferential formation of thermodynamic and kinetic products.

vi.

Addition order of the reactant may control the availability of the substrate to the
catalyst-ligand system.

vii.

Choice of proper electrophile based on the lability of the leaving group and steric
hindrance of the attacking site by the catalyst-ligand complex or toward the nucleophile

viii.

Controlling the concentration of the substrate on selected solvent system increases the
interaction of the reactant molecules and thus control the rate of reaction

ix.

Use of different additives participate in some way such as formation of H-bonding,
works as a linker, increase the availability of the rapid molecular interactions may
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affect the reaction outcomes. [64]
x.

Consistency of the required reaction environment such as inert atmosphere, controlled
increase or decrease of temperature and pressure.

Therefore, a fine tuning of all the different factors mentioned earlier can introduce an excellent
outcome of getting one optically pure compound. Some other techniques of getting one selective
isomer such as kinetic resolution, dynamic kinetic resolution, chiral derivatization is limited due
to the additional step or the reduced yield because of the separation. Therefore, the significance of
an enantiomer selectively is utmost goal for the organic chemist.
3.1.3 Approaches involved in stereocontrol interactions of Pd-AAA
Herein our discussion of the asymmetric induction will be based on two different approach:
1. Stereocontrol of the prochiral electrophile and
2. Stereocontrol of the prochiral nucleophile
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3.1.3.1 Stereocontrol on prochiral electrophiles
An ideal example of the Pd-AAA of prochiral electrophile was introduced by the Trost group using
isoprene monoepoxide back in 1998. The success of this novel approach was due to the alkylation
at the branched position for carbon, [65] oxygen [66] and nitrogen [67] nucleophiles to afford
acyclic tetrasubstituted building blocks (Scheme 27).

Their approach was basically a dynamic kinetic asymmetric transformation (DYKAT), whereby
they choose the racemic isoprene monoepoxide which is ionized by a palladium catalyst, with the
initially formed π-allyl species bearing an opposite sense of chirality or opposite syn/anti
configuration (Scheme 28). Since π-allyl contains two hydrogen substituents on the unbranched
terminus, the η1-σ-Pd(II) complex allows for rotation from one stereoisomer to the other without
syn/anti isomerization (Scheme 28a). They have considered the π-allyl complex that places the
higher priority group cis to the central hydrogen as the syn isomer. But the π-allyl stereochemistry
and the syn/anti configuration have isomerized at the branched carbon because of the π–σ–π
equilibration (Scheme 28b). An important structural consideration for this reaction can be
represented by flap and wall model involving the equilibrium between syn and anti-isomers
(Scheme 29).
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A pair of diastereomeric π-allyl complexes are formed due to the ionization of butadiene
monoepoxide (2). The presence of more sterically hindered hydroxymethylene substituent
compared to the hydrogen substituent favors complex 2a due to the least amount of steric clash
with the ligand (flap-wall) environment. The regioselectivity of such nucleophilic addition shows
Scheme 29 Cartoon model for wall and flap concept inducing regio and stereoselective AAA

42

an opposite idea of typically observed for Pd-AAA, where the branched isomer is formed in high
selectivity mostly. Therefore, ‘wall and flap model’ becomes an attractive design to represent the
approximate chiral environment about each terminus of the electrophile based on chelation of a
C2-symmetric ligand bearing diarylphosphines (i.e., Trost ligand, BINAP). In fact, if we compare
the case of isoprene monoepoxide (1a as shown in Scheme 27), the methyl and hydroxymethylene
substituents they are sterically very similar but the presence of an alkoxide from the epoxide
opening improvise the electronically dissimilarity (Scheme 30a). As a result, we can dictate three
factors for the alkylation at the branched terminus, namely: 1. The alkoxide group present in the
molecule behaves more like a leaving group often acts as a base for the pronucleophile 2. They are
also engaged in hydrogen bond directed alkylation of the nucleophile. 3. Ligand and additive
effects can alter the most favorable trajectory of the incoming nucleophile toward the branched
Scheme 30 Mechanistic pathways for Pd-AAA of isoprene monoepoxide
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product. [68] The outer-sphere nucleophilic attack occurs with inversion of the stereochemistry of
the π-allyl, and each enantiomer of product can be obtained from two of the stereoisomeric
complexes (Scheme 30b).
Later in 2004, it was observed by the same group that, primary alcohol can be alkylated at the
branched carbon with high enantioselectivity in the Pd-AAA of isoprene monoepoxide (Scheme
31). [65] The reaction introduced the useful interaction of the alkyl boron substance during
exploring the scope of several primary alcohols 3 as competent nucleophilic partners in this
Scheme 31 Synthesis of tertiary ether through the Pd-AAA of prochiral electrophile isoprene
monoepoxide
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reaction. For substrates with low enantioselectivity using triethylborane as catalyst, it was reasoned
that etherification was occurring faster than the required π-allyl equilibration. Use of the relatively
bulky tri-sec-butylborane proved useful for solving this problem (4b and 4d). With a hampered
rate of etherification, the products were formed with higher enantioselectivity. Spontaneous
cyclization to a hemiketal (4d) or lactone (4b) occurred when the nucleophilic alcohol contained
a pendant ketone or methyl ester respectively. The etherification product due to the addition of 4methoxybenzyl alcohol is a particularly useful synthetic precursor due to the ubiquity of PMBprotected alcohols in synthetic sequences.
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3.1.3.2 Stereocontrol on prochiral nucleophiles in Pd-AAA reaction
Achieving high enantiocontrol on nucleophiles remains fundamentally more difficult than getting
enantiocontrol on the electrophilic partner, due to the change of mechanism from inner sphere to
outer sphere mechanism for nucleophilic addition. For this type of approach, the chiral
environment created by the metal catalyst-ligand is distal from the isolated nucleophile. Therefore,
the nucleophilic attack of specific site selective face is challenging. This problem is combined by
the presence of enantioconvergent and enantiodivergent allylation pathways (Scheme 32).
Scheme 32 Catalytic recognition of prochiral nucleophile (enolates)

In the case of enantioconvergent allylation (Scheme 32a), the chiral catalyst recognizes the
substituents at the site of reaction. Although the restriction of controlling the enolate geometry has
been removed, R1 and R2 are limited to sterically differentiable substituents (i.e., alkyl vs. aryl).
When an enantiodivergent pathway is operative (Scheme 32b), the catalyst recognizes the
substituents vicinal to the site of reaction. This pathway is desirable if R1 and R2 are of limited
steric differentiation; however, the enolate geometry must be strictly controlled to observe high
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enantioselectivity. The enantiodivergent pathway has an important advantage over the
enantioconvergent pathway since the identity of X can be exploited as an achiral auxiliary and a
tunable parameter for reaction optimization. As will be seen, both the α-substituents and the
enolate geometry are commonly recognized by the catalyst in the allylation event. In this case, the
presence of match-mismatch effects will be apparent when both enolate isomers can be synthesized
in geometrically pure form. The stereo fidelity of the enolate is assumed to remain intact during
enantio-divergent allylations; however, oxygen-to-carbon migration may provide a mechanism for
erosion of the enolate geometry if palladium enolates are formed as intermediates (Scheme 33). A
potential example was summarized by the isomerization of palladium enolates which has been
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exploited for the Pd-AAA DYKAT of butenolide electrophiles with phenolic nucleophiles
(Scheme 34). [69] In this scenario, the palladium enolate is formed on the butenolide electrophile
and the mechanism for isomerization of the π-allyl species involves carbon-to oxygen migration.
Another complicacy of inducing asymmetry has been so far explored quite a bit based on the
accomplishing control of enolate geometry. In situ formation of enolate using external
base/additives or the intentional synthesis of O-allyl/O-carboxy allyl in control E/Z geometry (of
course sometimes racemic) using control equivalence of base are two most popular approach. As
a result, there are two different approach namely intermolecular asymmetric allylation and
intramolecular asymmetric allylation has been introduced so far.
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3.1.3.2.1 Intermolecular alkylation of prochiral nucleophiles
Many of the first syntheses of acyclic tetrasubstituted stereocenters by reactions of prochiral
nucleophiles were discovered by the Ito group. In 1992, Ito et al reported the allylation of an
acyclic 1,3-diketone 5 (Scheme 35a) in modest enantioselectivity by employing Ferrocenyl ligand
(point and planar chiral) scaffold bearing an aza-crown ether. [70] Later in 1996, the same group
established allylation of a challenging aliphatic α-nitro ester 7 by utilizing the similar strategy
mentioned earlier (Scheme 35b). [71] In order to enhance enantioselectivity upon nucleophilic
attack of a π-allyl Palladium (II) complex, it was envisioned that linking a crown ether to chiral
phosphine ligands would allow for recognition of the nucleophile counterion. In this case, the
chiral information of the catalyst could be relayed distal the site of the reaction, thus solving the
problem of poor selectivity when using prochiral nucleophiles in Pd-AAA. In both cases,
significant optimization of the crown ether and counterion was required to obtain the
enantioselectivity.

3
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An early report on asymmetric induction utilizing acyclic prochiral nucleophiles was provided [72]
on α-acetamido-β-keto esters 9 using Pd(0)/BINAP-catalyzed Pd-AAA (Scheme 36). High levels
of enantioselectivity were reported when using potassium tert-butoxide as base. Additionally, high
geometric control of the resulting olefinic products 10 was reported, even for commonly difficult
allylic acetates as an electrophile such 10g and 10h. The highest enantioselectivities were observed
for cinnamylation reactions mostly for electron stabilized cinnamyl acetate (10c, 10d and 10f),
simple allylations proceeded in good enantioselectivity as well.
Scheme 36 Pd/BINAP-catalyzed allylation of α-acetamido-β-keto ester
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Other work by the Ito group demonstrated acyclic control in the cinnamylation of 1,3-diketones
(Scheme 37). [73] They have demonstrated the cinnamylation of acyclic 1,3- diketones in good
enantioselectivity. Cryogenic temperatures were required for high enantiocontrol in this reaction,
however, in conjunction with their work on α-acetamido-β-keto esters and α-acetamido-βketophosphonates, these reactions serve as some of the earliest examples of Pd-AAA with
stereocontrol on acyclic nucleophiles under simple catalyst conditions.
Scheme 37 Pd-Catalyzed asymmetric allylation of β-keto ester

In 2011, List and Jiang were able to demonstrate the asymmetric α-allylation of α-arylpropanals,
15 under three-way catalysis using chiral acid, enamine, and palladium (Scheme 38). [74]
Surprisingly, they optimized the reaction using an achiral source of palladium, Palladium tetrakis,
by achiral amine catalyst, 14 in the presence of (S)-TRIP phosphoric acid L*. In addition to allyl
alcohol, more substituted alcohols 16 were effective in the reaction. The limitation of this protocol
is that elongation of the aliphatic aldehyde side chains of α-arylpropanals diminishes the
enantioselectivity albeit with reduced yield 17f even though the reaction showed impressive
display of control for asymmetric quaternary carbon synthesis.
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Scheme 38 Direct α-arylation of α-arylpropanals with allylic alcohols

In the discussion they stated that the geometry was highly controlled firstly due to the in situ
transiently formed chiral enamine due to their steric elements (Scheme 39a), and then the chiral
information is transferred by hydrogen bonding by the enamine to the chiral phosphate (Scheme
39b). The chiral phosphoric acid also acts as a ligand to the π-allyl-Pd(II) species .The resulted
complex is counterion-paired with the cationic π-allylpalladium(II) species, asymmetric induction
can be realized in the alkylation event. Interestingly, under the reaction conditions, allyl alcohols
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can be used directly, due to the activation of the hydroxyl leaving group by the phosphoric acid
(Scheme 39c).
Scheme 39 Typical features related to the triple catalytic activation

A dual-catalytic approach was showed by Ooi’s group for the α-cinnamylation of α-nitro esters
shown in (Scheme 40). [75] They have also employed the achiral phosphine like system developed
by List and Jiang. A Pd/ligand ratio of 1:2 was used, as it was believed that a C2- symmetric
palladium complex would form upon cis-complexation of the phosphine ligands. An interesting
finding about this synthesis is the use of a linked cationic ammonium functionality with the chiral
BINOL counterion. Excellent yields and enantioselectivities were observed for the reaction when
using cinnamyl carbonate electrophiles (Scheme 40) although no enantioselectivity was observed
for the simple allyl system (19d).
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Scheme 40 Chiral counterion strategy for the cinnamylation of α-nitro esters
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In 2015, Hossain et al published the first unprecedented example of the Intermolecular PalladiumCatalyzed Asymmetric Allylic Alkylation of 3-hydroxy aryl acrylates for the synthesis of allcarbon α-aryl quaternary aldehydes. [76] The formation of servocontrolled enol/ protection of enol
with bulky protecting group are the common practices but the use of unprotected enol as a
nucleophilic counterpart with a thorough optimization ligands, solvents, temperatures was not
established before, the group published an excellent enantiocontrol by a fine tuning of variables
and resulted ee up to 94% with quantitative yield. Both the electron donating and electron
withdrawing substituents resulted from good to excellent enantio-discriminations as shown in
Scheme 41.
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Scheme 41 Enantiocontrol synthesis of acyclic quaternary carbon from unprotected enol and
its synthetic scope
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3.1.3.2.2 Intramolecular Pd-mediated asymmetric allylic alkylation
A. Pd-Catalyzed Decarboxylative Asymmetric Allylic Alkylation (Pd-DAAA)
The intention of inserting allylic groups into the α-position of carbonyl-containing compounds was
first reported by Carroll in 1940. [77] In this version of the Carroll rearrangement, Pd(OAc)2 in
the presence of triphenylphosphine, was employed as the catalyst (Scheme 42). However, the
reaction only found limited scope in organic synthesis due to the harsh conditions required to
induce the [3,3]-sigmatropic rearrangement. The limitation was overcome by Tsuji-Trost reaction
through the development of mild synthetic route to the formation of allylic compounds via π-allyl
palladium complexes. [78] The unique idea involves the reaction of activated nucleophiles such as
enolates, amines and phenols with allylic compounds such as allyl acetates and allyl halides, allyl
carbonates and allyl mesylate/tosylates. In 1980 Tsuji and Saegusa independently reported the
decarboxylative allylation of β-keto allyl esters (Scheme 42). [79] Here the electrophile and
nucleophile are generated in situ eliminating the requirement to prepare preformed enolate
equivalents.
Scheme 42 Pd-catalyzed Carroll rearrangement by Tsuji

During the 1980s other groups extended the substrate scope to allyl enol carbonates, silyl enol
ethers and enol acetates. [80] Although regioselectivity was excellent for the above transformation,
it was a further 20 years before the reaction was performed enantioselectivity. Several methods to
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address their synthesis have been developed, particularly in cyclic systems. [81] In acyclic
systems, however, the synthesis of this motif is less explored. [82] This is in part due to additional
problems that often arise in acyclic systems such as reduced rigidity of substrates leading to lower
levels of selectivity. Additionally, selectively controlling the formation of fully substituted
olefins/enolates is required for high selectivity in many catalytic processes. In the case of
electrophilic functionalization of fully substituted enolates, the general and selective formation of
such enolates as pure geometric isomers is highly challenging and has slowed progress. Although
selective enolizations have been reported, these typically require highly specialized substrates,
often incorporating chiral auxiliaries to impart selectivity in the enolate formation step. [83]
Recently a practical approach of Pd-DAAA for the formation of acyclic quaternary carbon was
introduced by Marek et al in 2004 involving the use of achiral acyclic amide enolates in
combination with enantioselective palladium-catalyzed decarboxylative allylic alkylation
technology (Scheme 43). They have synthesized the carboxy allyl enolate species in two steps.
Scheme 43 Palladium-catalyzed enantioselective decarboxylative asymmetric allylic
alkylation of stereo defined acyclic enolates (by Marek)

[84] A copper-promoted carbomagnesiation reaction using Normant-type reagent (RMgBr/CuI in
a 2:1 ratio) provided highly regioselective formation of compound 21 in diethyl ether as solvent.
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Scheme 44 Synthesis of stereocontrolled carboxy allyl enolate

Then the resulting vinyl magnesium species with molecular iodine leads to the formation of fully
substituted vinyl iodide 21 in excellent yields as a single constitutional isomer (Scheme 44). The
vinyl iodide is then directly converted to the corresponding vinyl lithium species by iodine–lithium
exchange, Finally the oxidation with an externally prepared oxenoid (t-BuOOLi) retained the
stereoselectivity. The resulting stereodefined fully substituted enolate is then reacted with AllocCl
to deliver well-diversified products 22 in excellent yields as single isomers as shown in Scheme
44.
Later they reported an excellent outcome of the asymmetric induction using chiral Trost ligand by
a thorough optimization of ligands, solvents, catalyst loading. During the study they realized the
enolate geometry plays the vital roles for the conservation of enantioselectivity and therefore the
syn position of small substituent to the allyoxycarbonyl group concluded as a favorable enolate
structure for getting high optical purity of the desired compound. [85] Gratifyingly, the scope of
the reaction process appears to be fairly broad with respect to the R3 substituent on the carbamate
group (COOR3 where R3 = Me, Et, t-Bu and Bn; 23a-c, respectively) and produced reaction
products 24a–c of uniformly high enantiomeric excess.
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Scheme 45 Synthetic scope of the stereoconfined Pd-DAAA
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Recently, Stoltz group has become interested in preparing fully substituted acyclic enolates and
applying them toward the synthesis of acyclic quaternary stereocenters, particularly via transitionmetal catalyzed allylic alkylation (Scheme 46). [86] While palladium-catalyzed allylic alkylation
has been employed in the synthesis of acyclic tertiary stereocenters, the formation of all-carbon
quaternary stereocenters has proven more challenging. Using the allylating agent consistently they
found a huge impact of solvent especially non-polar solvents such as 3:1 mixture of hexane/
toluene for providing highest and most reproducible yields. In this solvent system, using ligand
L1* gave the desired product obtained in 98% isolated yield and 90% ee. They have also reduced
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Scheme 46 Pd-DAAA for carboxyallyl substrate (with selective scopes) by Brian Stoltz
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the catalyst loading from 1.0 mol% to 0.5 mol % and found similar yield and selectivity without
significantly increasing reaction time. Some of the selective substrate scope of the reaction has
been presented in the Scheme 46.
After optimizing the reaction conditions, they tried to examine the importance of enolate geometry
on the transformation (Scheme 47). Whenever they used ligand L1*, for E/Z ratio of enolates from
>98:2 and 25:75 they have isolated the desired product in excellent ee of 91 and 90% respectively.
Surprisingly, the 25:75 E/Z ratio of enolates provides the product in a diminished 64% yield and
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50% ee (compared to 89% yield and 86% ee) whenever using ligand L2*.
Scheme 47 Effect of enolate geometry on the asymmetric inductions during Pd-DAAA

They mentioned that a dynamic kinetic resolution of the two enolate geometries and different facial
selectivity between the two enolates occurs in the reaction when L2 is used as the ligand, possibly
due to facile equilibration between O-bound and C-bound palladium enolates. Therefore, the
enolate geometry along with right kind of ligand is a major tunable area along with other general
parameters of these type of reactions. In fact, an analogous phenomenon regarding different
enolate geometries was observed by the Trost lab when forming acyclic tertiary stereocenters via
palladium-catalyzed allylic alkylation. [87]
In 2014 Hossain’s group reported a synthesis of chiral aldehydes bearing all carbon quaternary
stereocenters via the decarboxylative asymmetric allylic alkylation (DAAA) (Scheme 48). [88] At
first, they were able to develop a stereoselective synthesis for the formation of both E- and Z-allyl
carbonate by optimizing the choice of base and screening temperature along with solvent. Then a
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fine tuning of solvent with number of different ligands resulted the formation of desired quaternary
aldehyde up to 73% enantioselectivity and 96% conversion. A general trend of getting better
enantiobenefit for electron donating group was observed compared to the electron withdrawing
groups.
Scheme 48 Pd-DAAA of carboxy-allyl enol using Trost ligand
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A recent approach of the first enantioselective palladium-catalyzed decarboxylative allylic
alkylation of fully substituted N-acyl indole-derived enol carbonates forming acyclic all-carbon
quaternary stereocenters is reported by Stoltz group in 2019 (Scheme 49). [89] Use of a novel
electron deficient phosphinoxazoline (PHOX) ligand namely (S)-Ty-PHOX yielded up to 99% and
ee up to 98%.
After getting an optimized ratio of E/Z for the enolate they have agreed that the control of substrate
enolate geometry is crucial for high selectivity. They have examined the scope of the
transformation for accessing various acyclic all-carbon quaternary stereocenters (Scheme 49). The
presence of electron-rich aryl groups resulted in a slight increase in selectivity, with both p-Me
(28e) and p-OMe (28f) substrates yielding the desired products in 98% ee each, and the bis-OMe
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Scheme 49 Pd-DAAA of N-acyl indole derived enol carbonate by using Ty-PHOX ligand
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substrate (2g) in 95% ee. Notably, both methoxy containing substrates 28f and 28g required longer
reaction times to reach full conversion (i.e., 24h). An examination of electron-poor aryl groups
demonstrated that, while p-Cl (28h), p-Br (28i), and p-F (28j) groups were well tolerated (94–96%
ee), a p-CF3 (28k) containing substrate provided the product in a diminished 72% ee, believed to
result from increased stabilization of the resultant enolate.

63

B. Asymmetric Claisen rearrangement as a route to quaternary stereocenter
To make chiral Claisen rearrangement products using an asymmetric route there are several
possibilities. If no external asymmetric induction is applied, the enantiomers can be separated via
resolution, but this method suffers from the disadvantage of losing half of the unwanted
enantiomer, which is highly undesirable. The first option is to transfer chirality from either the
allylic or vinylic fragment of the allyl enol ether to the chiral carbon through a complete [1,3]chirality transfer (remote stereocontrol), although other positions in the allyl enol ether substrate
have also be used to transfer the chirality. Alternatively, more than one chiral center can be used
to transfer the stereochemical information. The chiral allylic fragment can be obtained by such
well known processes like the Sharpless asymmetric epoxidation, [90] enantioselective reduction
of carbonyl compounds6and enzymatic processes. [91] In the diastereoselective reaction
proceeding through remote stereocontrol the chiral center is usually present to position one and six
(Scheme 50).
Scheme 50 Remote stereo-control of the diastereoselective reaction
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Overman et al. reported the first examples of a truly catalytic reaction of the conversion of allyl
amidates into the corresponding carbamates employing chiral palladium catalysts. [92] A series of
chiral oxazoline substituted ligands were tested by Uozumi and Hayashi in the palladium (II)-
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catalyzed rearrangement of a N-(4- (trifluoromethyl) phenyl) substituted allyl imidate (Scheme
51).
Scheme 51 First catalytic conversion of allyl amidates to carbamates

The most conventional approach of using Palladium usually being used for the primary Oallylation and the 1,2-Claisen type rearrangement is usually conveyed out by using other rare
metals like Europium, Holmium etc. Some of the examples has shown in the Scheme 52. [93]
Beside the use of rare metal with Pd catalyst, the use of achiral Al (III) Lewis acids are able to
accelerate the aliphatic Claisen rearrangement as well. However, their applicability as catalysts is
mainly prevented by product inhibition. [94] Al (III), B (III), and Mg (II) chiral Lewis acid
complexes have been efficient for the asymmetric reaction but have not found applicability for a
catalytic version of the reaction. However, the Lewis acid catalysts are substrate specific, (Scheme
53) if one metal Lewis acid is found to catalyze the Claisen rearrangement of a specific allyl enol
ether substrate, this does not make it suitable as a catalyst for a varied range of allyl enol ether
substrates.
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Scheme 52 Rare metal induced O-allylation and their further rearrangement

The following example shows some of the metal induced O-allyl rearrangement where the catalyst
used in stoichiometric or more amount of the aluminum and boron catalyst.
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Scheme 53 Aluminum and Boron catalyzed O-allyl rearrangement for acyclic quaternary
carbon formation

But the use of Pd-L* for the rearrangement is quite rare and little complicated because of the
reaction condition. A representative study has been shown by Hossain et al. [95] They have shown
the first Palladium (0)-catalyzed asymmetric allylic alkylation (AAA) of O-allyl enol ether
rearrangement of via π-allylpalladium intermediate using Trost chiral diphosphine (Scheme 54).
This unprecedented reaction produced very rare a-aryl quaternary aldehydes with multi-functional
groups. The main novelty in the chemistry demonstrates the formation of enol, 30 from the
unprotected enol 29 using nBu4NI as a phase transfer catalyst (PTC) in presence of KOH base.
Therefore, they have used the ethers as a precursor for p-allylpalladium intermediates, to the best
of the knowledge, perhaps without prior precedent. Chiral ligand (R,R)-L* was found to be optimal
in this Pd-AAA reaction and provided good to excellent yield (80–95%) and enantioselectivity
(70–90%) with a range of analogs.
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Scheme 54 Pd catalyzed rearrangement of O-allyl ether 30 using DACH-naphthyl Trost
ligand

In fact A small number of catalytic achiral metal catalysts that speed up the Claisen rearrangement
have been reported, for example Pd(II) complexes, lanthanide (III) complexes and TiCl4. [96-98]
In both metal promoted and metal catalyzed Claisen rearrangement reaction, substituents on allyl
enol ether have a dramatic effect on the rate of rearrangement briefly.
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3.1.4 Some Other recent approaches for the synthesis of achiral quaternary
center
Additionally, the Evans lab has reported the use of rhodium-catalyzed allylic alkylation to furnish
acyclic α-quaternary nitriles and aldehydes (Scheme 55a). [99] In the later work, they showed that
both enolate geometries (E/Z) result similar enantiomeric excess of the product, which they have
predicted as a consequence of substrate selectivity and not the result of an enolate equilibration
event. In contrast, a dynamic equilibration of tributyltin enolates has been invoked by the Jacobsen
group to directly alkylate fully substituted acyclic enolates with alkyl halides catalyzed by a
[Cr(salen)] complex, affording α-quaternary ketones in high enantioselectivity starting with
mixtures of enolates (Scheme 55b). [100a] Recently, Shimizu and Kanai demonstrated the
preparation of acyclic α-quaternary carboxylic acids via allylic alkylation utilizing a hybrid boronpalladium catalytic system (Scheme 55c). [100b]
Scheme 55 Recent approaches for asymmetric induction using Rh, Cr and B
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Part 3: Introduction
Introduction to Spirooxindole pyrolidine
Phalaris coerulescens, a lesser-known species of Phalaris, is a winter growing perennial with rapid
germination, vigorous seedling growth and high production in its seedling year. Trials in Australia
in the late 1950s and the 1960s produced conflicting reports on persistence and productivity. [101]
The introduced strains were not commercialized but it has become volunteer species in higher
rainfall areas, particularly in the state of Victoria, where it has also been circumstantially associated
with horsy fatalities.
P. coerulescens has recently reintroduced to Australia to provide a more persistent and productive
grass, other than the traditional perennial veldt grass (Ehrharta calycina), for low water-holding,
acid soils. Trials of P. coerulescens accessions were established in the south east of South Australia
already. Because of the known potential toxicity of Phalaris and of a suspected association of P.
coerulescens with horse fatalities on a farming property in Victoria in the late 1980s, it was
considered necessary to investigate the accessions for alkaloid content before further agronomic
development was pursued. [102] In the process of evaluating the alkaloid content of the various P.
coerulescens accessions by TLC, HPLC and GC-mass spectrometry methods a new alkaloid was
identified and isolated.
Thereafter a detail phytochemical study of various accessions of Phalaris coerulescens for the
presence of toxic phenylethylamines, indoloamines and tetrahydro-β-carbolines revealed the
presence of oxindoles previously not reported to occur in Phalaris species. One of the oxindoles,
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the structure of which was elucidated by spectroscopic methods (in fact a spirooxindole), has not
been reported to occur naturally and has been given the trivial name coerulescine.
Figure 7 Examples for the structure of spirooxindole containing natural products
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A spirooxindole is a key structure of coerulescine, horsfiline, elacomine, spirotryprostatin B, and
strychnofoline can exhibit various biological activities. [103-104] Among the spirooxindole
alkaloids, the relatively simple structure of coerulescine has become attractive to many medicinal
chemists as a new pharmaceutical skeleton (Figure 7). It was first isolated in 1998 from Pharalis
coerulescens by Colegate et al. [102]. The construction of the quaternary stereogenic center of (–
)-coerulescine has been quite challenging, and until now, only four synthetic methods have been
reported for the synthesis of enantiomerically enriched coerulescine.
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4.1.1 Synthesis of (-)-Coerulescine: (by Denishefsky et al)
The first reported synthesis of natural product (-)-coerulescine was introduced during the
investigation on the oxidative diastereoselective rearrangement of chiral tetrahydro-β-carboline
precursors, for the targeted synthesis of Phalarine which is a natural product isolated from Phalaris
Coerulescine (blue canary grass) by Danishefsky group in 2010. [105] They have reported the
synthesis of (s)-coerulescine with excellent enantioselectivity (94%) but not as a final product
rather a metabolic intermediate. The synthesis of the intermediate has shown in Scheme 56. Ltryptophan has used as the starting material and 4 step functional modification of the substrate
produced compound 32 after recrystallization (Scheme 56), Then the subsequent rearrangement
of the six (6) member ring and decarboxylation resulted the coerulescine as an intermediate.
Scheme 56 Danishefsky synthesis of (S)-(-)-coerulescine
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4.1.2 Synthesis of (-)-Coerulescine: (by Hayashi et al)
Later in 2014, Hayashi et al report the three one-pot sequential synthesis of (-)-coerulescine by
employing two key reactions, namely 1) the synthesis of a 2-oxoindoline-3-ylidene acetaldehyde
from acetaldehyde and an Isatin derivative and 2) the organocatalyzed Michael addition of
nitromethane to the 2-oxoindoline-3-ylidene acetaldehyde to construct the all-carbon quaternary
stereogenic centers with excellent enantioselectivity (Scheme 57). [106] Furthermore, they also
synthesized (-)-coerulescine according to the route of Danishefsky and co-workers to verify the
small optical rotation of coerulescine and to define the solvent for optical rotation comparison.
[105] In this way they concluded the absolute configuration of (-)-coerulescine to be R which is
not analogous to the experimental outcome earlier done by Danishefsky’s group.
Scheme 57 Hayashi synthesis of (R)-(-)-Coerulescine
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The aldol addition of Isatin derivatives 35 with acetaldehyde generated the β-hydroxyaldehyde
and dehydration under acidic conditions provided 36 directly as a mixture of E/Z isomers (Scheme
57). The interesting outcome is the one pot formation of the enals 36 from Isatins 35 in excellent
yield. This method was found to be higher yielding and more convenient than reported methods;
for example, enal 36 has been produced in 27% over 3 steps by the reduction of the 3-position on
35 to form an alcohol, alkylation with bromoacetaldehyde diethyl ether, and acetal deprotection to
afford 36. Therefore, the approach was to start with an aldol reaction of the commercially available
isatin derivatives 35 with acetaldehyde, followed by dehydratiounder acidic conditions to give 2oxoindoline-3-ylidene acetaldehydes 36 as E/Z mixtures in excellent yields. The enantioselective
conjugate addition of nitromethane to 36 generated aldehydes 37 with excellent enantioselectivity
in the construction of the all-carbon quaternary stereogenic centers. Zn, AcOH, and water were
added to the same reaction vessel to reduce the nitro group into an amine. At the same time, an
intramolecular reductive amination proceeded to form the pyrrolidino spirocycle. Formaldehyde
was then added to the reaction mixture sequentially to install the N-methyl group by an
intermolecular reductive amination. The four reactions from aldehydes 36 were performed in the
same reaction vessel and afforded 38 in 69% yield over 4 steps. Removal of the benzyl group
under Birch conditions furnished (R)-horsfiline (1) and (R)-coerulescine in good yields. They
understood that the spirooxyindole may tends to racemize under acidic conditions; [107-108]
therefore, the optical purity was checked by HPLC analysis over a chiral phase. This showed the
ee values of the prepared coerulescine was 94%, which indicated that racemization did not occur
during their synthesis. Hence, the three one-pot sequential syntheses of (R)-coerulescine were
developed in good total yield.
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4.1.3 Synthesis of (-)-Coerulescine: (by Basai et al)
In 2015, Basai et al. also constructed the quaternary stereogenic center of coerulescine via an αhydroxymethylation of α-(aminoalkyl)oxindole using cinchona-derived thiourea bifunctional
organocatalysts as shown in the Scheme 58 starting from compound 39 as a potential starting
material.[109]
Scheme 58: Basai total synthesis of (+)-Coerulescine
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Compound 39 was potentially attached to a primary alcohol on the C3 position to form 40 with
very good yield and enantioselectivity. Compound 40 was then treated with trifluoroacetic acid to
get oxindole which was further reacted with methanesulfonyl chloride to afford mesylate 41 in
83% yield over 2 steps (Scheme 58). The latter was then converted to naturally occurring (+)-
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coerulescine in 85% yield when subjected to catalytic Pd−C in ethanol (1 atm of H2). This protocol
is a newer approach, but the overall yield and the number of steps is not comparable to the other
established protocol especially the formation of the starting material add 4 more steps to the overall
consideration of the synthetic feasibility.
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4.1.4 Synthesis of (-)-Coerulescine: (by Park et al)
Recently a practical enantioselective synthetic method for preparing (S)-(+)-coerulescine is
reported through the use of diphenylmethyl tert-butyl α-(2-nitrophenyl)malonate (16% overall
yield, 7 steps) by Park et al. [110] Allylation is the key step under phase-transfer catalytic
conditions (82% ee).Then the compound was recrystallized and the enantiobenefit was raised up
to >99% (Scheme 59).
Scheme 59: Park total synthesis of (s)(+)-Coerulescine using PTC
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For the first step, the enantioselective allylation of 42 was performed under the reported PTC
conditions with allyl bromide (10.0 equiv.), 50 mol% KOH (s) and (R, R)-L* at 0 ◦C in toluene to
produce the allylated product (S)-43 (yield 83%, ee: 82%). A reduction using sodium borohydride,
afforded lactone 45 (95%) via the oxidative cleavage of the terminal allylic double bond was done
ozonolysis which resulted compound 44. Without purifying 45, the treatment of additional sodium
borohydride with cerium (III) trichloride heptahydrate and tetrahydrofuran as a co-solvent at 0 ◦C
selectively reduced 45 to the corresponding diols 46 (52% from 44) in situ. Diol 46 was purified
as a single stereoisomer (>99% ee) with a 45% yield by recrystallizing (86% ee) using ethyl acetate
and hexane (1:5). Dimesylation of 47 (94%) followed by N-alkylation in the presence of excess
methylamine successfully produced N-methylpyrrolidines 48 retaining the enantiobenefit. The
reduction of the nitro group on 48 by a catalytic hydrogenation under Pd/C and atmospheric H2
afforded amine 49. Finally, the prepared amine 49 was directly cyclized to (+)- coerulescine
{observed [α] 20 D = 3.08 (c=1, MeOH); literature [α] 20 D = 1.0 (c=2.4, MeOH) (Mukaiyama et
al., 2014)} by stirring with silica gel (SiO2) in CH2Cl2 with no racemization (90% from 49, >99%
ee).
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Part 4: Introduction
4.2.1 Introduction to spirooxindole lactone
A 2-oxindole spirofused with either a lactone or lactam moiety is a privileged three-dimensional
framework existing across a large family of alkaloid natural products with diverse biological
profiles. [1] For example, coixspirolactam A–C, isolated from the traditional Chinese medicine
adlay bran, [5] exhibit potent anti-proliferative effects on human lung cancer cells A549, human
colorectal carcinoma cells HT-29, and COLO 205 (Figure 8). [4] Although their optical rotations
were reported, the absolute configuration of the spiro-carbon center was not elucidated. Another
oxindone containing moiety namely, Trigolutes A–C are extracted from the twigs of
trigonostemonlutescens and show promising activity in the treatment of hemorrhagic fever with
renal syndrome. [111] Lactam derivatives such as compound 50 of spirooxindole are antagonists
on the mouse CRTH2 receptor and may directly mediate the recruitment of inflammatory cells
Figure 8 Representative natural products and bioactive molecules containing the
spirooxindole lactone and lactams
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in allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis. [112] The S enantiomer,
which is separated by preparative chiral-phase HPLC is about 52 times more active than the R
isomer. Therefore, highly enantioselective assembly of these spirooxindole lactones/lactams is of
great interest in medicinal chemistry. [113] Although stereoselective construction of the
spirooxindole has been well established, asymmetric synthesis of allcarbon spirooxindoles
containing either a lactone or lactam moiety has had limited success. [114-115]
4.2.2 Different approaches for the synthesis of spirooxindole lactone
In 2014, Liang and Xu developed a novel approach to chiral spirooxindole δ-lactones through
bifunctional thiourea catalyzed [5+1] annulation of oxindoles with ester-linked bisenones (Scheme
60a). [115a] An enantioselective synthesis of spirooxindole alkylidene-ϒ -lactones was
successfully developed by Quintavalla and co-workers through organocatalytic aldol reaction of
C3-alkylated oxindoles with aldehydes (Scheme 60b).[115b] The first asymmetric synthesis of
spirooxindole ϒ-lactams was accessed by an oxoindolin-3-ylidene involving a four-component
reaction promoted by a recyclable fluorous bifunctional cinchona alkaloid/thiourea organocatalyst
(Scheme 60c).[115c] Each of these reactions must start from either oxindoles or their derivatives
to deliver a specific skeleton after a long reaction time (up to 8 days). Therefore, a general and
highly enantioselective approach, applicable to all spirooxindole ϒ- and δ-lactones/lactams,
starting from non-oxindole-based materials, under mild reaction conditions is highly desirable.
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Scheme 60 Different successful approaches for preparing lactone derivatives

Out of many known and unknown natural spiro lactone one very recent study on the extract of
Adlay (Chinese pearl barley, soft-shelled Job’s tears, Coixlachryma-jobi L. var. ma-yuen Stapf)
grass crop that has long been described by Kuo et al in 2008 is our focus of discussion. [116-117]
The adlay seeds are used in traditional Chinese medicine and as a ‘nourishing’ food. It is mainly
planted in Taiwan, China, and Japan, where it is considered a health food supplement. According
to the ancient Chinese medical book Pen-Tsao-Kang-Mu, Li (1596), the seed of adlay was used in
China for the treatment of warts, chapped skin, rheumatism, and neuralgia, and as an antiinflammatory or anti-helminthic agent. Numerous recent reports have indicated that the
consumption of adlay seed is beneficial to the human body. [118-119]
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Takahashi et al. (1986) reported that coixans A, B, and C isolated from adlay seeds have
hypoglycemic activity in rats. [120] Coixenolide was isolated from adlay seeds, and it exhibited
anti-tumor activity towards Ehrlich ascites sarcoma in mice. [121] The anti-tumor constituents of
adlay include a-monolinolein, and free fatty acids such as palmitic, stearic, oleic, and linoleic acids.
[122-123] In addition, recent studies indicate that adlay has antitumor effects. Chiang et al found
that adlay inhibited sarcoma-180 tumor in mice. [118] Kuo et al. indicated that a methanolic extract
of adlay hull has antiproliferative activity against human histolytic lymphoma U937 monocytic
cells via apoptosis. Chang et al reported that a methanolic extract of adlay has an anti-proliferative
effect on A549 lung cancer cells by inducing cell cycle arrest and apoptosis. [116] Feeding mice a
diet containing adlay reduced the number of surface lung tumors in mice. Shih et al showed that
dehulled adlay suppressed early events in colon carcinogenesis and it also reduced COX-2 protein
expression. [117]
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4.2.3 Previous synthesis Coixspirolactam A
Recently the natural product coixspirolactam A was conveniently synthesized asymmetrically and
absolute configuration was elucidated for the first time by Zhu et al. The key achievement of this
finding is an efficient one-pot assembly of all-carbon spiro-oxindole compounds from nonoxindole-based materials through a palladium-catalyzed asymmetric Heck/carbonylative
lactonization and lactamization sequence. [124] They have also reported the formation of
diversified spirooxindole ϒ-and δ-lactones/lactams in high yields with good to excellent
enantioselectivities (up to 99% ee) under mild reaction conditions.
The N-(2-iodophenyl)-N-methylacrylamide derivative 1, bearing a branched homoallylic alcohol,
was investigated in Pd-catalyzed carbonylation (Scheme 58). When PPh3 was used as a ligand in
Scheme 61 Synthesis of coixspirolactam A and the elucidation of its absolute configuration

the presence of balloon pressure of CO, intramolecular carbopalladation followed by carbonylative
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lactonization occurred to give a racemic spirooxindole δ-lactone in excellent yield. Encouraged by
this result, several chiral bidentate phosphine ligands were then screened and ligand (R)- L*
delivered the product with good enantioselectivity (91% ee) with excellent chemical yield 92%.
The optimized result was obtained using PivOH was used as an additive and K2CO3 as a base.
To elucidate the absolute stereochemistry of coixspirolactam A, both enantiomers R and S were
synthesized conveniently through a two-step sequence with 99% and 97% ee, respectively
(Scheme 58). By comparing their optical rotations with the reported value, (c = 0.70, MeOH at 27
o

C), the structure of coixspirolactam A was confirmed as R. [125]
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1.2 Results and Discussion
1.2.1 Optimization study of Pd -AAA of prochiral 2-nitro-3-hydroxy phenyl acrylate
The formation of all carbon quaternary stereocenter [126] by catalytic enantioselective manner has
proven to be a challenge for the organic chemist since they are working on developing concise and
facile synthetic route for drug designing and development of new synthetic route for the targets
with proven potency. From the synthetic point of view a considerable number of such bioactive
compounds contains a moiety namely 3,3-disubstituted oxindole. Therefore, we envisioned a
retrosynthetic route as a primary goal which is achievable through the formation of all carbon
quaternary center shown in retrosynthetic plan 1.
Retrosynthetic Plan 1:

Out of many different metal (such as Rh, Pt, Ni. Cr and Ru etc.) catalyzed approach, Pd-AAA that
has played a key role in creating such stereocenter and allowed researchers to synthesize numerous
biologically potent natural products. [127-129] However, synthetic methodologies to access
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acyclic quaternary carbon center is still rare due to the conformational mobility of the structures.
The existence of such aryl quaternary stereocenters in a growing number of biologically active
natural products and pharmaceutical agents [130] demands a pressing need for the ability to
construct this important motif enantioselectivity. Our group has first reported the synthesis of 3hydroxy aryl acrylate with an outstanding scope of the reaction in 1998 which was then modified
to a facile reaction protocol in 2004 by introducing a BrØnsted acid HBF4.OEt2 in place of Iron
Lewis acid catalyst. [131,132] But the scope was somehow limited to the electron withdrawing onitro group due to the complexity of work up procedure. We have recently sorted out a convenient
work
Scheme: 62 Retention of structural information during asymmetric induction
Aryl bound tertiary

All-carbon α-aryl quaternary

Prochiral α-carbon

center

up protocol for 2-nitro-3-hydroxy phenyl acrylate and isolated the desired compound with 78%
yield. Due to the presence of aryl bound tertiary α-prochiral carbon centers in 3-hydroxyaryl
acrylates, these compounds should allow us to synthesize chiral all-carbon α-aryl quaternary
stereocenters (Scheme 62). The necessity of having nitro group is the potential planning of forming
an oxindole ring after preparing the o-nitro containing quaternary aldehyde 2. One of the most
convenient practice is Pd- AAA that can introduce an alkyl group by nucleophilic attack. To prove
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this hypothesis, we first attempted allylation (as alkyl group) of a nitro containing substrate 1 which
in fact demands a thorough investigation to prepare the challenging unprecedented formation of
the quaternary chiral aldehyde, (ethyl 2-formyl-2-(2-NO2-phenyl)pent-4-enoate 2. The screening
has initiated based on our previous success with Pd-AAA using a chiral Trost modular ligand
mediated enantioselective synthesis. [133] To our disappointment, the attempt failed to result
better enantiomeric excess (ee) may be because of the steric hindrance of the α-prochiral center
due to the presence of nitro group at ortho-position (Scheme 63).
Scheme 63 Screening the previously optimized reaction condition

Even though the results were dissatisfactory, it might be only because of the optimized condition,
which is not good enough for ortho-substituted analogs specially the electron withdrawing group
like nitro and fluoro. We must optimize the reaction variables and find out a different condition
for this class of analogs. Therefore we started with screening the solvent along with temperature
at first by keeping the exact same ligand and Pd2(dba)3.CHCl3 as a source of Pd(0).
Initially, we have studied variable polarity solvents of both protic and aprotic classes, namely
DCM, DME, ether, toluene, MeOH, EtOH, iPA, tBuOH, Acetonitrile, DMF, HMPA, and THF.
Surprisingly, we did not observe any O-allylation with any of these single solvents or the mixture
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Table 1 Solvent optimization studies for the Pd-AAA of 3-hydroxy-2-nitro phenyl acrylate 1

Entry[a]

Solvents

Temp, [oC]

Conv. [%][b]

ee [%][c]

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

DCM
DME
MeOH
i
PA
Acetonitrile
THF
THF
t-Butanol
toluene
toluene
DMF
HMPA
CF3CH2OH
1,4-dioaxane
Cyclohexane
Cyclohexane : toluene (3:1)
Cyclohexane : THF (3:1)
THF: t-BuOH (1:1)
THF : toluene (1:1)
THF : 1,4-dioxane (1:1)
THF: 1,4-dioxane (1:1)
THF: t-BuOH (1:1)
THF: toluene (1:1)
Tol : Hex : tBuOH (1 : 1 :1)
Tol : Hex : THF (1 : 1 :1)
Amyl alcohol

rt
-10
-10
-10
rt
rt
-10
rt
rt
-10
rt
rt
-10
rt
rt
rt
rt
rt
rt
rt
10
-10
-10
rt
-10
rt

90
47
100
100
85
99
92
80
95
70
82
100
20
47
40
38
20
90
75
100
75
47
99
99
33
65

5
11
10
24
20
38
46
42
11
33
20
31
n.d.
27
53[d]
53
10
21
33
30
racemic
11
21
30
25
11

[a] Reaction conditions 1 (0.105-0.210 mmol), THF (2-5 mL). [b] Conversions were calculated from NMR. [c]
Enantiomeric excess determined by chiral HPLC analysis. [d] Inversion of configuration.
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of solvents. Conversion is good at room temperature in most of the cases (Table 1, entry 1, 5, 6,
8, 9, 11, 12, 18, 20 and 24) except 1,4-dioxane and cyclohexane (entry 14 and 15) and even at low
temperature in some cases (entry 3, 4, and 7) for the single solvent system. However, for some
cases at low temperature, the conversion was low (entry 2, 11, 14 and 27). We did not find a
patterned correlation of enantioselectivity with the change in polarity of solvents. For example,
toluene (nonpolar)provided 11% ee (entry 9) and increasing the polarity seemed like decreasing
ee as with DCM (entry 1) but the most polar protic alcohols relatively increased the ee value (entry
8). The order of increasing ee obtained from primary to tertiary alcohol (entry 3, 4, and 8) at
different temperature especially t-BuOH provided a promising ee but we could not go further
lowering the temperature due to high freezing point of the solvent. However, polar aprotic solvent
THF and HMPA proved to be relatively better class of solvent, as among acetonitrile, DMF,
nitromethane, HMPA and THF (entry 5, 6, 11 and 12), HMPA provided 31% (entry 13) and THF
provided maximum 38% ee at rt (entry 6). On the other hand, temperature does have an effect on
ee in some cases (entry 7 vs 6; entry 9 vs 10). Surprisingly the solvent cyclohexane provided the
best result of enantioselectivity, but the conversion was too low (entry 15) and we saw an inversion
of configuration which was confirmed by chiral HPLC analysis. We have therefore planned to
explore this solvent later so that we can make both enantiomer of our targeted compounds. From
the screening of different solvents, we found best conditions (ee 46%) with THF at −10 ˚C (entry
7). It seems like the reaction goes to completion without any base in THF at as low as −10 ˚C
without affecting %conversion or % ee. The use of binary or ternary solvent system provided no
interesting result to explore furthermore (entry 16 to 25).
Whenever we achieved an enantiomeric excess from 6% to 46% by tuning the solvents, we then
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turned our investigation of different ligands on enantiodiscrimination. We have selected five C2symmetric ligands namely Trost modular (diphenylphosphino)benzoic acid (DPPBA), 2,2′bis(diphenylphosphino)-1,1′-binaphthyl

(BINAP)

and

bioxazoline

(BOX)

ligand;

two

nonsymmetrical
Figure 9 Selected ligands for Pd-AAA of prochiral 2-nitro-3-hydroxy phenyl acrylate, 1
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ligands such as a mixed P/N-type phosphinooxazoline (PHOX); ferrocenyl oxazoline and
phosphoramidite for the investigation (Figure 9). For this optimization, we kept the solvent
constant to THF that provided maximum ee of 46% and studied the effect of ligands. It should be
mentioned that such a diverse selection of ligands may lead the formation of both C-alkylation and
O-alkylation products at the same time. It has been observed that the DPPBA ligand class,
including L1, L5, L7, L10 and nonsymmetrical PHOX ligand L4 showed better enantioselectivity
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Table 2 Optimization of ligands for intermolecular Pd-AAA of compound 1 (Method A)

Entry[a]

Ligand

Temp [oC]

Conv.[%][b], 2

Conv.[%][b], 9

ee[%][c]

1
2

L1
L1

rt
0

99
95

0
0

38
42

3

L1

-10

92

0

46

4
5

L1
L2

-20
-10

nr
99

0

11

6
7

L3
L4

-10
-10

60
80

0
20

16
34

8

L5

-10

100

0

30

9
10

L6
L7

-10
-10

99
30

0
70

10
36

11

L8

-10

nr

nr

n.d.

12
13

L9
L10

-10
-10

29
90

71
0

n.d.
41[d]

[a] Reaction conditions 1 (0.105-0.210 mmol), THF (2-5 mL). [b] Conversions were calculated from NMR. [c]
Enantiomeric excess determined by chiral HPLC analysis [d] Inversion of conversion.

(Table 2). But ligands L4 and L7 formed C-allylated product 2 along with O-allylated product
ethyl 3-(allyloxy)-2-(2-nitrophenyl)acrylate 9. Although both ligands L1 (46% ee) and L5 (30%
ee) regio-selectively provided the C-allylated product 2, we selected ligand L1 to explore further
for its promising optical selectivity. The Ferrocenyl ligands L9 has also been employed, which
ensued the O-allylated product 9 with very poor yield of desired compound 2 (entry 12). One BOX
ligand L6 has been tried as well without much success (entry 7). The (S,S)-L10 was used which
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gave the product similar to the results obtained from (R,R)-L1 (entry 13 vs entry 1-3) and also
confirmed the identifying peaks for the inversion of conversion during HPLC analysis. The
preliminary result prompted us to study the influence of the reaction parameters such as solvent,
temperature and additive.
Achieving a result of 46% ee for the L1 ligand using THF as a choice of solvent driven us to
explore the source of different Pd(0) which sometimes ensure the better selectivity of the
nucleophilic attack [134]. That is the reason researcher explored different source of catalyst. We
have achieved a low enantioselectivity compare to Pd2(dba)3.CHCl3 (Table 3). Whenever
screening that we didn’t find an alternative source of palladium to explore as shown in Table 3.
Basically, the conversion was almost in good range whenever screening the alternative palladium
source such as [Pd(C3H5)Cl]2, (entries 1-6, 8-11) but stereoselectivity was not satisfactory and the
other sources proved to be unproductive (entries 7 and 12). But We got an idea that the catalyst
Pd2(dba)3.CHCl3 might be the right choice along with the (R,R)-L1 (DACH-Napthyl Trost ligand)
considering THF as a choice of solvent based on the results we obtained so far. increase of
enantioselectivity for using BSA (Bis(trimethyl silyl) acetamide) (entry 17) but the conversion was
low (20%).
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Table 3. Selected optimization of catalyst, ligand, and their loading for the Pd-AAA of
compound 1

a

entrya

Solvent

Ligand
(mol%)

catalyst

temp
[oC]

conv.c
[%]

eed
[%]

1e

toluene

(R,R)‐L1(7.5 mol%)

[Pd(C3H5)2Cl]2

‐10

95

35

2

toluene

(R,R)‐L1(6.0 mol%)

[Pd(C3H5)2Cl]2

‐10

72

29

3e

THF

(R,R)‐L1(7.5 mol%)

[Pd(C3H5)2Cl]2

rt

90

27

4

THF

(R,R)‐L1(6.0 mol%)

[Pd(C3H5)2Cl]2

rt

81

22

5

THF

(R,R)‐L1(5.0 mol%)

[Pd(C3H5)2Cl]2

‐10

70

15

6

THF

(R,R)‐L1(6.0 mol%)

[Pd(C3H5)2Cl]2

0

69

22

7

THF

(R,R)‐L1(6.0 mol%)

Pd(OAc)2Cl2

rt

<10

n.d.

8g

toluene

(R,R)‐L1(6.0 mol%)

[Pd(C3H5)2Cl]2

‐10

72

29

9g

toluene

(R,R)‐L1(7.5 mol%)

[Pd(C3H5)2Cl]2

‐10

95

35

10h

THF

(R,R)‐L1(7.5 mol%)

[Pd(C3H5)2Cl]2

‐10

27

11

11i

THF

(R,R)‐L1(7.5 mol%)

[Pd(C3H5)2Cl]2

‐10

34

13

12

THF

[Rh(COD)Cl]2

rt

<10

n.d

(R,R)‐L1(6.0 mol%)

All reactions have carried out in 0.105-0.210 mmol scale. bConversions were calculated from NMR. cEnantiomeric

excess calculated by chiral HPLC. e 7.5 mol% of ligand used. g 1,2 equiv of DIPEA, h2 equiv of tBuOH added. i3 equiv
of tBuOH added, n.d.-Not Determined

Then we thought to explore different bases which may help to deprotonate the enolic proton to
form the enolate and accelerate the attack of the nucleophile to the Pd-L*-electrophile complex.
Another idea is the in-situ formation of the salt (such as the TEA can form a salt with the enolate
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geometry) that sterically benefit the attack of the nucleophile from one site compared to the other
site towards the electrophile. Screening the most widely used organic bases such as DIPEA
Table 4 Optimization of solvents with bases for the intermolecular Pd-AAA of 3-hydroxy-2nitro phenyl acrylate 1

entrya

solvent

baseb

temp. [oC]

conv.c
[%]

eed
[%]

1

DCM

DIPEA

rt

100

rac

2

DCM

CsF

‐20

100

20

3

toluene

CsF

rt

100

38

4

toluene

DIPEA

‐10

81

36

5

THF

DIPEA

‐20

100

53

6

THF

CsF

‐20

99

55

7

THF

CsF

‐10

100

57

8

THF

CsCl

‐10

52

29

9

THF

quinine

‐20

100

50

10

THF

(DHQ)2AQN

‐10

40

60

11

THF

(DHQ)2AQN

rt

81

40

12

THF

KOtBu

‐20

100

45

13

THF

DPG

‐10

99

48

14

THF

TMG

‐10

75

24

15

THF

TMG

0

67

23

16

THF

TEA

rt

40

17

17

THF

BSA

‐10

20

87

94

a

All reactions have carried out in 0.105-0.210 mmol scale, b Used in 2-3 equiv, cConversions were calculated from

NMR dEnantiomeric excess calculated by chiral HPLC.

provided the racemic formation of the compound using DCM solvent (entry 1, Table 4). During
the study we saw that the other based like CsF, DIPEA and DPG (diphenyl guanidine), quinine,
(DHQ)2AQN (Hydroquinine anthraquinone-1,4-diyl diether) delivered decent percentage of ee
(entries 5, 6, 7, 9, 10 and 13) at lower temperature. We have considered that the effect of getting
better enantiobenefit is because of Cs+ counterion with the carbonyl group of the ligand but the
maximum we managed is 57% ee with quantitative conversion (entry 7). Though the ee using
(DHQ)2AQN was high but the use of chiral auxiliaries (like quinine containing bases) in
stoichiometric amount limited the scope of further exploring that. Moreover, bases like CsCl,
KtOBu, TMG (tetramethyl guanidine) and TEA (entries 8, 12, 14-16) could not add any value to
achieving our targeted results. An attempt to tune the solvent with base using toluene and DCM
remain unsuccessful (entries 2-4).
Now a days, the role of additive is one of the known approaches, although the mechanism of action
for most of them is either unknown or not clear. Our screening of the additive was mainly based
on the previously published literature for inducing high asymmetry. Few of these additives
provided mentionable enantioselectivity in our case are tBuOH and NaHSO3 (entries 14 and 16).
tBuOH as additives has been employed before by Trost and co-workers with significant
improvement in ee, which proved to be true for our case as well. [135] It participated in the
enantiodiscriminative process most satisfactorily so far with 65% ee (entry 14). We assume the
reason is the H-bond interaction of tertiary alcohol and its bulkiness fits one of the enol structures
favorable then the other one. NaHSO3 is another interesting additive we have found that provided
us as much as 53% ee (entry 16). Since tertiary alcohol tBuOH provided relatively better ee, we
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tried to use different alcohols such as BINOL, isopropyl alcohol, MeOH, amyl alcohol, isoamyl
alcohol, CF3CH2OH and phenol but none of them provided further improvement of the
Table 5. Optimization of additives for the intermolecular Pd-AAA of compound 1

entrya

additiveb

conv.f [%]

eeg [%]

1

HMPAe

83

30

2

nBu4NIb,c

100

0

3

nBu4NFb,c

100

44

4

Ph3SiClb

‐

‐

5

KHSO3e

63

18

6

B(OMe)3b

100

35

7

CH3COOH

10

‐

8

C6H5OHe

64

37

9

R‐Binold

100

30

10

MeOHe

60

37

11

amyl alcohole

87

09

12

isoamylalcohole

85

41

13

iPAe

70

13

14

tBuOHe

100

65

15

H2Oe

65

40

16

NaHSO3e

90

53

17

tBuOHd & Zn(OAc)2e

60

23

18

DMEe

33

11

19

CF3CH2OHe

100

43

20

NMPh

100

34

96

a

All reactions have carried out in 0.105-0.210 mmol scale b1.2 equivalent of additives, unless otherwise mentioned.

c

30 mol%. d10 mol%. e2-3 equivalent, fConversions calculated from NMR gEnantiomeric excess calculated by chiral

HPLC, hReaction ran at rt.

Enantiomeric excess (entries 8-13, 19). Further investigation of different organic salts and acids
were screened without much success (entries 1-6, 17, 18 and 20).
During screening different additives with our choice of solvent THF, we have also tried to see the
impact of some selected additives with other solvents to explore the feasibility of tuning other
solvents. As we expect from the previous screening that
Table 6 Screening additives for intermolecular Pd-AAA of 1 in different solvents
entrya

Solvent

Temperature [oC]

additiveb

conv.c [%]

eef [%]

1

Cyclohexane

rt

DIPEA

100

23

2

Cyclohexane

rt

tBuOHd

100

27

3

Cyclohexane

10

DIPEA

80

27

4

Cyclohexane

10

tBuOHd

80

25

5

Cyclohexane

10

tBuOHe

40

81

6

Cyclohexane

10

tBuOH

40

55

7

Cyclohexane

rt

tBuOHe

20

73

8

1,4‐dioxane

rt

tBuOH

27

29

9

1,4‐dioxane

rt

K2CO3

25

37

10

CF3CH2OH

‐10

LiCl

20

n.d.

11

CF3CH2OH

‐10

tBuOH

10

n.d.

12

tBuOH

‐10

NaHSO3

30

40

13

DME

‐10

tBuOH

30

10

14

Hex: Tol

‐10

tBuOHd

75

25

15

Toluene

rt

CsF

100

38

97

a

All reactions have carried out in 0.105-0.210 mmol scale b1.2 equivalent of additives, unless otherwise mentioned.

c

30 mol%. cConversions calculated from NMR d2 equiv of DIPEA added, e1 equiv of tBuOH added, e2-3 equivalent,

f

enantiomeric excess calculated by chiral HPLC.

the room temperature might not be a good choice for reaction, got the same feedback from solvent
cyclohexane, 1,4-dioxane and toluene (Table 6, entries 1, 2, 7-9, and 15). Considering the high
freezing point of cyclohexane, we had to run the reaction at 10 oC. We tried to optimize the quantity
of the tBuOH as a choice of additive and obtained up to 81% ee but the conversion was low (entry
5 vs entries 4 and 6). Choice of dioxane with the additives proved to be a random selection. Other
solvent-additive pairing could not change our obtained results so far.
Hoping to explore more to increase the enantioselectivity, we then choose different electrophiles
based on the change alkyl/aryl groups (cinnamyl acetate and prenyl acetate) and leaving groups
(allyl alcohol, cinnamyl mesylate). The idea is that the phenyl group might introduce a steric effect
on the electrophile and help to manage lower dihedral angle compared to allyl acetate, thus
susceptible to more stereoselectivity. The choice of prenyl acetate was considered based on making
the allyl group more stable by forming tertiary carbocation. We thought the relatively bulky
mesylate group might help to make the nucleophilic attack more selective. We have seen the same
results that the cinnamyl acetate resulted the ee value of up to 70% with low conversion of 71%
compare to the allyl acetate (65% ee with quantitative conversion) shown in Table 7 entry 3 using
DIPEA as an additive at -10 oC. Whereas other additives like tBuOH, TEA and variation of
temperature as well as catalyst (entries 1, 2, 4-7) could not result anything better. Formation of Oallylated 13’ have also noticed during screening additives with [Pd(C3H5)Cl]2 (entry 8-9). Other
electrophiles resulted either racemic product (entry 10) or the lower conversion of the expected
product 13 (entries 11-12).
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Table 7 Screening electrophile for intermolecular Pd-AAA of 1

Entrya

Temp
[oC]

Addtv.
(2 eqv)

Conv.[%]b ee[%]c

R = H, Ar = Ph, X =OAc

rt

DIPEA

55

40

Pd2(dba)3.CHCl3

R = H, Ar = Ph, X =OAc

0

DIPEA

99

53

6.0

Pd2(dba)3.CHCl3

R = H, Ar = Ph, X =OAc

‐10

DIPEA

71

70

4

6.0

Pd2(dba)3.CHCl3

R = H, Ar = Ph, X =OAc

0

DIPEAd

69

8

5

6.0

[Pd(C3H5)Cl]2

R = H, Ar = Ph, X =OAc

50

DIPEA

40

14

6

7.5

Pd2(dba)3.CHCl3

R = H, Ar = Ph, X =OAc

rt

tBuOH

20‐30

n.d.

7

7.5

Pd2(dba)3.CHCl3

R = H, Ar = Ph, X =OAc

rt

TEA

40

34

8

6.0

[Pd(C3H5)Cl]2

R = H, Ar = Ph, X =OAc

‐10

DIPEA

Catalyst
(2.5 mol%)

Electrophile

1

Ligand,
L1*
(mol%)
6.0

Pd2(dba)3.CHCl3

2

6.0

3

9

7.5

[Pd(C3H5)Cl]2

R = H, Ar = Ph, X =OAc

‐10

tBuOH

10

6.0

Pd2(dba)3.CHCl3

R = H, R’ = H, X = ‐OH

rt

tBuOH

11

6.0

Pd2(dba)3.CHCl3

rt
rt

R = CH3, R’ =CH3, X = ‐
OAc
12
7.5
[Pd(C3H5)Cl]2
R = CH3, R’ =CH3, X = ‐
OAc
a
All reactions have carried out in 0.105-0.210 mmol scale
C

enantiomeric excess calculated by chiral HPLC.

99

b

Cpd 13’ as a major
product
80

racemic

‐

10‐20

n.d.

‐

10‐20

n.d.

Conversions calculated from NMR.

Since we have achieved 65% ee (with quantitative conversion) of compound 2 using allyl acetate
from the Pd-AAA reaction of 1 (see Table 5, entry 14) and 70% ee compound 13 (with 71%
conversion) from the allylation using cinnamyl acetate, we went on to implement the
intramolecular Pd-AAA technique for further increase the ee.
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1.2.2 Optimization study of intramolecular Pd mediated decarboxylative
asymmetric allylation (Pd-DAAA) reaction
At first, we tried to explore Pd catalyzed asymmetric allylic alkylation (Pd-DAAA). We therefore
made the carboxy allyl enol compound 10 from compound 1 using NaHMDS/LiHMDS as a base.
Optimizing the required amount of base (1 equiv) along with a activating agent TMEDA
(tetramethyl ethylenediamine), we obtained the desired compound 10 with quantitative
conversion. It should be mentioned that the role of the activating agent is to form chelated complex
with the NaHMDS/LiHMDS base which helps to deprotonate the enolic proton in a controlled
manner. Addition of more activating agent could not influence the percentage conversion.
Scheme 64 Synthesis of carboxyallyl acrylate and the Pd-DAAA to form compound 2

One we obtained compound 10, the next step was to rearrange the compound ethyl 3(((allyloxy)carbonyl)oxy)-2-(2-nitrophenyl)acrylate 10 to form compound 2 by decarboxylative
manner (loss of CO2 as a gas). But the synthesis of compound 2 needs a systematic optimization
of variables like solvents, ligands, and temperature to achieve a better optical selectivity.
Therefore, we have screened the parameters as shown in Table 8.
By using our previously optimized reaction conditions i.e considering THF as a choice of solvent,
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five different ligands L1-L5 were applied for screening initially where ligand L1 provided
reasonable enantioselectivity (44% ee) providing compound 2 (Table 8, entry 1-6) at -20 oC. Later,
the use of solvent DME and toluene produced the desired product with roughly similar
enantiobenefit (Table 8, entry 7 and 8). Switching to a mixed solvent system such as THF-toluene
or THF-hexane, we observed a decreasing value of both conversion and ee (Table 8, entries 9 and
10). We subsequently explored less polar solvent mixture of toluene-hexane (2:1) at different
temperatures; the best results obtained at -10 °C (Table 8, entry 13 vs entries 11, 12 and 14).
Increasing or decreasing ratio of toluene/hexane didn’t
Table 8 Selected optimization studies for decarboxylative rearrangement of O-Carboxy
alkylated Product 10
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a

entry [a]

ligand

solvents

temp[˚C]

conv.[b][%]

ee[c] [%]

1

(R,R)‐L1

THF

rt

99

32

2

(S)‐L2

THF

rt

99

04d

3

(R,R)‐L3

THF

rt

99

10

4

(R,R)‐L4

THF

rt

99

11

5

(S)‐L5

THF

rt

50

rac

6

(R,R)‐L1

THF

‐20

>99

44

7

(R,R)‐L1

DME

rt

>99

34

8

(R,R)‐L1

toluene

rt

>99

35

9

(R,R)‐L1

THF:tol (1:1)

rt

85

25

10

(R,R)‐L1

THF:hex (1:1)

rt

90

21

11

(R,R)‐L1

tol:hex (2:1)

rt

95

43

12

tol:hex (2:1)

(R,R)‐L1

40

100

38

13

(R,R)‐L1

tol:hex (2:1)

‐10

>99

55

14

(R,R)‐L1

tol:hex (2:1)

‐20

>99

48

15

(R,R)‐L1

tol:hex (1:1)

‐10

67

30

16

(R,R)‐L1

tol:hex (3:1)

‐10

48

21

17

(R,R)‐L1

Tol:hex(2:1)

40

100

38

18

(R,R)‐L1

toluene

‐78‐rt

100

28

19

(R,R)‐L1

dioxane

rt

10‐20

n.d.

20

(R,R)‐L1

THF

0

85

19

21

(R,R)‐L1

DCM

rt

75

23

22

tol:hex (2:1)

(R,R)‐L4

‐10

99

08

23

tol:hex (2:1)

(R,R)‐L4

rt

99

racemic

24

tol:hex (2:1)

(R,R)‐L9

rt

nr

‐

25

tol:hex (2:1)

(R,R)‐L8

rt

<15

n.d.

All reactions have carried out in 0.1-0.2 mmol scale, bConversions were calculated from NMR cenantiomeric excess

calculated by chiral HPLC
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improved the enantioselectivity (Table 8, entry 15 and 16). Use of similar solvent mixture at
different temperature resulted either low conversion of lower enantioselectivity as shown in table
9 (entries 17-21). Later, we decided to screen more ligands like L8 and L9 along with L4 and
ended up with either racemic or a very low enantioselectivity (entries 21-24).
We believe that the reason of getting low enantioselectivity is the non-regioselective formation of
carboxy enol acrylate 10 i.e., the formation of racemic 10.
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1.2.3

Optimization

study

of

intramolecular

Pd-

mediated

Claisen

rearrangement
As we did not achieve a higher enantiobenefit from the intermolecular approach, we embarked
upon our investigation of another intramolecular Pd-AAA involving intramolecular Claisen type
rearrangement of O-allylated compound 9 for preparing compound 2. Compound 9 was prepared
under alkaline conditions from the reaction of 1 and allyl bromide/allyl iodide (1.2 equiv) using
nBu4NI as a phase transfer catalyst. (Scheme 65).
Scheme 65 Synthesis of O-allylated enol 9 and the Pd induced rearrangement to form
compound 2

The formation of compound 9 with quantitative conversion encourage us to move towards the
rearrangement approach using Pd with different ligand. This approach is very less explored and
limited to the substrate scope as well. After a general screening of ligands L1-L4, L9 and L12 in
toluene : MeOH (20 : 1), we found ligand L1 was promising to acheive better enantioselectivity
(32% ee) of compound 2 at -20 oC (Table 9, entry 7 vs entries 1-7). Elevation of tempertaure
decreased the enantioselectivty for L1 (entry 8). Increasing the percentage of toluene in MeOH
(30:1) retained almost the same ee with a considerably higher conversion (entry 9) at -10 °C.
Additionally, a slight improvement of selectivity was observed in pure toluene at room temperature
and -20 °C (entries 10 and 11). We believe that the low polarity systems may help to improve
stereoinduction by helping to form tight ion pairs via the formation of “solvent cages”, and thus
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bring the enolate and Pd π-allyl complex closer together.[136] Therefore, we drew our attention to
a methodical decrease in polarity of toluene by adding hexane. A lower value of both conversion
and ee were obtained using a 2:1 ratio of toluene-hexane solvent (entry 12). An equal volume of
hexane and toluene (1:1) resulted a slight increase of ee (entry 13 vs entry 14); lowering the
temperature from 25 °C to -10 °C strikingly increased the value of ee (58%) with an excellent
conversion (entry 14). Higher ratio of hexane/toluene (2:1 and 3:1) at -10 °C demonstrated lower
value of the obtained results (entries 15 and 16). Moreover, use of polar solvents such as DCM or
THF provided inferior results compared to toluene or toluene/hexane (entries 17 and 18 vs entries
10-16). Screening similar solvent system at different temperature did not prove to be helpful for
this approach as well (entries 19-22)
Table 9 Optimization studies for Claisen rearrangement of O-alkylated product 9 (Method
B)
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a

entrya

ligand

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

L1
L2
L3
L4
L9
L12
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1
L1

solvent

temp,˚C

tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (20:1)
tol:MeOH (30:1)
toluene
toluene
tol:hex (2:1)
tol:hex (1:1)
tol:hex (1:1)
tol:hex (1:2)
tol:hex (1:3)
DCM
THF
THF
hexane
DCM
THF:DCM(1:1)

rt
rt
rt
rt
rt
rt
-20
40
-10
rt
-20
rt
rt
-10
-10
-10
rt
rt
-10
rt
-78-rt
-10

% conv.b

% e.r.c

95
67
75
30
n.r.
<10
80
100
95
85
90
70
99
99
86
78
99
99
63
10-20
99
71

63:37
46:54
rac
61:39
n.d.
n.d.
66:34
67:23
65:35
68:32
67:33
61:39
64:36
79:21
70:30
69:31
62:38
62:38
60:40
n.d.
62:38
59:41

All reactions have carried out in 0.1-0.2 mmol scale, bConversions were calculated from NMR cenantiomeric excess

calculated by chiral HPLC
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From the above studies, it is noteworthy that both the yield and ee (of compound 2) remained
roughly unaffected whether the Pd-AAA reaction was performed intermolecularly or
intramolecularly. However, the intermolecular approach, Method A appears to be more appealing
than the intramolecular approaches, Method B and C because it requires one less step to prepare
compound 2 and gave better results (Scheme 66). For further improvement of enantioselectivity,
we decided to recrystallize compound 2 prepared by Method A. [137] Upon recrystallization from
hexane, the supernatant led the enantioenriched product to 85% ee with 58% yield (Scheme 66).
Scheme 66 Intermolecular vs Intramolecular Pd-AAA

Method B

O

Pd2(dba)3.CHCl3 (2.5 mol%)
L* (6 mol%), tol:hex (1:1), -10 0C

O
O
NO2

Yield ee
84 57
OH
Method A

O
O
NO2
1

9

O
O

tBuOH (2 equiv), THF, -10 0C
Pd2(dba)3.CHCl3 (2.5 mol%)
L* (6 mol%), allyl acetate (1.2 eqiv)

a
a

Yield ee
93 65
58 86

O
NO2

O

Method C

a

after single crystallization

OCO2allyl

2

O
NO2

Pd2(dba)3.CHCl3 (2.5 mol%)
L*(5.5 mol%), tol:hex (2:1),-10 0C

Yield ee
85 55
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10

1.2.4 Optimization of synthetic steps involving chiral 3,3-disubstituted oxindole
Since we have achieved 86% ee of compound 2 from the Pd-AAA reaction of 1, we went on to
synthesize our targeted 3,3′-disubstituted oxindole framework 4 in order to show the application
of the developed acyclic quaternary molecule 2 in the synthesis of a significantly accessible
building block 4 (Scheme 67). Reduction of aldehyde using NaBH4 of 2 provided compound 3
with more than 99% yield. Then selective reduction of nitro group of 3 has targeted through
different approaches shown in Table 10. Use of reducing agent like Sn with HCl or Fe with HCl
and Zn with TiCl4 provided trace to low yielding of the product (Table 10, entries 1-3). But the
Zn with NH4Cl whenever used in the ratio of 1:1.25 yielded less product (Table 10 entry 4);
increase ratio of that 1: 2.25 proved to be optimized (Table 10, entry 5). Increasing amount of
NH4Cl showed complexity of separating the compound from the crude mixture. An attempt to get
rid of NH4Cl during the reaction using a aqueous solution of surfactant to ethanol proved
detrimental to the formation of the oxindole, 4. (Table 10, entry 6).
Scheme 67 Asymmetric synthesis of chiral 3,3-disubstituted oxindole
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Table 10 Optimization for the formation of chiral 3,3 disubstituted oxindole from 2

a

Entrya

Reagent

Solvent

Remarksd

1

Fe (4-5 equiv), HCl, NH4OAcb

EtOH : H20 (2:1)

Trace/no product

2

Sn (4-5 equiv), HCl, NH4OAcb

EtOH : H20 (2:1)

Trace/no product

3

Zn (3-4 equiv), TiCl4 (2 equiv)

Ether : H20 (1:1)

Trace/no product

4

Zn (4 equiv), NH4Cl (5 equiv)

EtOH : H20 (4:1)

10-20%

5

Zn (8 equiv), NH4Cl (9.5 equiv)

EtOH : H20 (4:1)

85%

6

Zn (8 equiv), NH4Cl (9.5 equiv)

EtOH : H20 (1:1)c

Trace/no product

all reactions have conducted 1-2 mmol, bused for adjusting pH of the solution, c1 equiv of PEG surfactant had added.

d

isolated yield

One new finding during the attempt of synthesizing oxindole, 4 from compound 3 is that whenever
we tried to cyclize the Mesyl protected allyl alcohol, 14 we ended up with the formation of 3,3disubstituted indoline,18 instead of the expected formation of Mesyl protected oxindole (Scheme
68). We believe that because of the bulky mesyl group; allows the rotation of the ester functionality
distant from the reduced amine to form compound 15. This approach therefore introduces a new
dimension of exploring various substrate scope of compound 15 for future research.
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Scheme 68 Formation of 3,3-disubstituted indoline

However, when we get out key intermediate, 4 we therefore planned a route for the total synthesis
of rarely explored (-)-coerulescine moiety. Oxidative cleavage using the conventional oxidant like
K2OsO4.2H2O, OsO4, ozonolysis and classical RuCl3.3H2O provided trace or no product almost
each instance shown in scheme Table 11(entries 1-5). We therefore found the formation of lactol
derivative (an acetal ring), 12 during oxidative cleavage which happened because of the cyclization
of the in-situ formed aldehyde after oxidation and intramolecular cyclization with the alcoholic OH functionality in compound 4 (Table 11, entries 6 and 7).
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Scheme 69 Proposed synthesis of (-)-coerulescine

a

All reactions have conducted 1-2 mmol scale

Table 11 Optimization reaction conditions for the oxidation of oxindole 4

entrya

reagent

Solvent /temp /time

remarks

1

i. OsO4 (2 mol%), 2,6-Lutidine (2
equiv),
ii. NaIO4 (4 equiv),

Dioxane: H2O (5:1), 25 oC,
22 h

Trace / no
product

2

i. K2OsO4.2H2O (20 mol%), NMO (5
equiv),
ii. NaIO4 (5 equiv),

THF : H2O (3:1), rt, 12 h

Trace / no
product

3

O3 (1 min/mmol), -780C, Pyridine (3
equiv),

DCM, -78 oC

Trace / no
product

4

RuCl3 (3.5 mol%), Oxone (1.5 equiv),
NaHCO3 (4.7 equiv),

ACN / H2O (1.5/1), rt, 6-8 h

Trace / no
product

5

RuCl3 (3.5 mol%), Oxone (1.5 equiv),
NaHCO3 (4.7 equiv),

ACN / H2O (6/1), rt, 6-8 h

Trace / no
product

6

RuCl3 (3.5 mol%), NaIO4 (2.6 equiv)

ACN / H2O (6/1), rt,

Small Cpd 12

7

RuCl3 (3.5 mol%), NaIO4 (2.6 equiv)

ACN / H2O (6/1), rt,

15% cpd 12
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Therefore, we decided to protect the hydroxy group (which is interfering the formation of
aldehyde) with various protecting groups such as TIPS, tosyl and mesyl. At first the hydroxy group
was protected by TIPS group to prepare compound 16 and then the oxidation was successfully
carried out using classical oxidant RuCl3.3H2O/NaIO4 to prepare 17. The following step of
reductive amination cyclization could not proceed with the TIPS protected oxindole 17. We
believe that the bulky TIPS group made the oxygen more hindered; only identified the product 17’
(by mass spectrometry) rather getting the expected product 7.
Scheme 70 Attempted oxidation of 4 after TIPS protection and reductive amination
cyclization

Secondly, the attempt of oxidation followed by tosyl protection of compound 4 proceeded well but
lability of tosyl group in the ACN : H2O solvent system resulted the formation of compound 12 as
shown in Scheme 71. After exploring TIPS and tosyl protection, we decided to mesylate group
which is in fact not that bulky (like TIPS) or as labile as (Tosyl). The oxidation was optimized
Scheme 71 Attempted oxidation of 4 after tosyl protection and reductive amination
cyclization
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(as shown in Table 12) followed by the mesyl protection. The use of oxone /NMO as a co-oxidant
along with NaHCO3 resulted trace product (Table 12, entries 1 and 6). But NaIO4 as terminal
oxidant in a solvent system of ACN:H2O-1.5:1 gave us 30% yield of the expected product 6 (Table
12, entry 2). A fine tuning of binary solvent system ACN:H2O (6:1) provided 85% of isolated yield
(Table 12, entries 3-5). Though we achieved an excellent outcome of desired oxidation
Scheme 72 Attempted oxidation of 4 after mesityl protection

Table 12 Optimization for the oxidation of Ms-protected Oxindole 5

entrya

reagents

solvent
ACN:H2O-1.5:1

2

Oxone (1.5 equiv), NaHCO3
(4.7 equiv)
NaIO4 (2 equiv)

ACN:H2O-1.5:1

30%

3

NaIO4 (2.6 equiv)

ACN:H2O-1.5:1

35-40%

4

NaIO4 (2 equiv)

ACN:H2O-6.0:1

50%

5

NaIO4 (2.6 equiv)

ACN:H2O-6.0:1

85%

6

NMO (5 equiv), NaIO4 (5 equiv)

THF:H2O-3.0:1

Trace product

1

a

yield(%)
Trace / no product

1-2 mmol of the compound 4 and 5 was used

(compound 6), we needed to explore the way to form the pyrolidine ring from 6. Therefore, we
started screening various condition of reductive amination cyclization shown in Scheme 73.
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Scheme 73 One pot reductive amination cyclization to synthesize (-)-coerulescine

Table 13: Optimization of One-pot reductive amination cyclization of Ms-Protected oxindole
aldehyde 6
entrya

Reaction conditions

remarks

1

i.MeNH2 (in EtOH) (1 equiv), DCE, rt, 2h
ii. NaBH3CN (1 equiv), pH= 6‐7, overnight

Trace / no
product

2

i.MeNH2 (in EtOH) (1. equiv), DCE, rt, 4A0 mol. sieve, 2h
ii. NaBH4 (1.2 equiv), 2h

3

i. MeNH2.HCl (1.05 equiv), TEA (1.5 equiv), DCE, rt, 2h
NaBH4 (1.5 equiv), 3.5 h

4

MeNH2 (in EtOH) (1.05 equiv), Ti(OiPr)4 (2 equiv), EtOH, rt, 3h; NaBH4 (1.5
equiv), 3 h

5

i. MeNH2 (in THF) (1.25 equiv), THF, rt, 3h
ii. NaBH4 (1.5 equiv), 4 h

6

i. MeNH2 (in THF) (1.25 equiv), THF, rt, 3h
ii. NaBH4 (1.5 equiv), CH3COOH (1 equiv), 4 h

7
a

MeNH2 (in THF) (1.05 equiv), Ti(OiPr)4 (2 equiv), rt, 3 h
NaBH4 (1.1 equiv), 2 h

Trace / no
product
Trace / no
product
15‐20%
Trace / no
product
Trace / no
product

95% product

1-2 mmol of the compound 6 was used for optimization study

Through the study, use of MeNH2 (in EtOH) along with NaBH3CN/NaBH4 and additives
(triethylamine, CH3COOH) in 1,2-DCE as solvent did not result any considerable amount of
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product for isolation (entries 1-3, 5-6). But the use of Ti(OiPr)4 with MeNH2 in EtOH resulted
15% of the isolated product which was a promising result for further screening. Fortunately, a
source of MeNH2 in THF and Ti(OiPr)4 provided 95% of the desired compound (-)-coerulescine
which exactly matches the NMR spectra and optical rotation of Hyaashi et al. We believe the
cyclization was pursued by the formation of the non-isolated intermediate 6’.
In summary, our overall synthesis can be shown by the Scheme 74. Our synthesis commenced
with a reduction of aldehyde functionality of compound 2 by sodium borohydride in methanol to
provide alcoholic product 3. The ortho-nitro functional group of compound 3 was selectively
reduced to afford the desired oxindole 4. Later, the hydroxy group of the compound 4 was
protected by mesyl group to prepare compound 5. The oxidative cleavage of 5 using an optimized
amount of NaIO4 (2.4 equiv) along with RuCl3.3H2O (3.5 mol%) afforded compound 6. Finally,
one pot reductive amination-cyclization of 6 using commercially available methyl amine solution
in presence of titanium isopropoxide yielded the desired product (-)-coerulescine with an overall
yield of 34%. The NMR of 7 was matched with the values reported in the literature. [138]
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Scheme 74 Total Synthesis of (-)- coerulescine and (-)-coixspirolactam A

Conditions: [A] Allyl acetate, [Pd2(dba)3.CHCl3], L*, -10 °C, 58%. [B] NaBH4, MeOH, 0 °C - rt,
1 h, 99%. [C] Zn, NH4Cl, EtOH:H2O (4:1), reflux, 2 h, 80%. [D] MsCl, NEt3, DCM, 0 °C, 4 h,
85%. [E] (i) RuCl3.3H2O, 1,2-DCE: H2O (2:1) (ii) NaIO4 (3 equiv), 32 h, 68%. [F] (i) RuCl3.3H2O,
ACN: H2O (6:1) (ii) NaIO4 (2.4 equiv), 12-14 h, 80%. [G] (i) MeNH2, Ti(OiPr)4, MeOH, rt, 5 h.
(ii) NaBH4, rt, 2 h, 95%.
In order to synthesize another targeted natural product coixspirolactam A 8, compound 5 was
oxidized with an optimized quantity of RuCl3.3H2O (3.5 mol%) with higher equivalent of NaIO4
(3 equiv) involving prolonged reaction time (32 h). We assume that the formation of such lactone
is due to intramolecular lactonization of non-isolated carboxylic acid 8a. [139] The desired product
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8 was obtained with an overall yield of 32% in five steps and NMR was matched with the values
reported in the literature. [140]
In summary, we have explored different approaches of Pd-AAA for the enantioselective synthesis
of acyclic all carbon quaternary aldehyde starting from a rare prochiral ortho-nitro arylacrylate.
The efficient intermolecular Pd-AAA was forwarded to develop a unique route to synthesize chiral
3,3-disubstituted oxindole 4. By utilizing the present methodology as a key step, the concise
synthesis of spirocyclic (-)-coerulescine 7 and (-)-coixspirolactam A 8 have been described. We
believe that this protocol is going to be a beneficial tool for synthetic chemists in the total synthesis
of natural products and drug discovery either in academic or industrial laboratories.
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1.3 General methods and experimental
Experimental procedures and tabulated characterization data
Compound 1, (Z)-ethyl-3-hydroxy-2-nitro-phenylacrylate was synthesized by using our published
procedure.1 Isolated Yield: 78%. The identity of this compound was confirmed by 1H, 13C NMR
and HRMS.[141]
1

H NMR (CDCl3, 300 MHz): δ 11.98 (d, J = 12.0 Hz, 1H), 7.99 (d, J = 6.0 Hz, 1H), 7.61 (t, J =

7.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 1H), 7.29 (t, J = 6.0 Hz, 1H), 4.22 (brs, 2H), 1.15 (t, J = 7.5 Hz,
3H).
13

C NMR (CDCl3, 75 MHz): δ 170.0, 162.2, 149.2, 133.3, 133.2, 129.2, 128.6, 124.9, 106.6, 61.3,

13.7.
HRMS (ESI+): Calculated (m/z) for C14H16NO5 (M-H)- : 236.0564, Found 236.0562.
Melting Point: 88-90 oC
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1.3.1 General procedure for the synthesis of Ethyl 2-formyl-2-(2nitrophenyl)pent-4 enolate, 2 (Method A-Intermolecular Approach)

In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (5.4 mg,
0.00525 mmol, 2.5 mol%) and (R, R)-L* (10.0 mg, 0.0126 mmol, 6 mol%). The test tube was then
evacuated and backfilled with argon three times. Previously distilled and degassed tetrahydrofuran
(THF) was added to the flask and the mixture was stirred for 15 min until it was homogeneous,
and an orange color persisted. Then, allyl acetate (28 μL, 0.252 mmol, 1.2 equiv) was added to the
system and the solution was stirred at room temperature for an additional 5 min. In the meantime,
the other test tube was charged with 3-hydroxy 2-nitro phenyl acrylate 1 (50.0 mg, 0.210 mmol,
1.0 equiv) with the addition of 2 mL of degassed tetrahydrofuran (THF) and it was finely dissolved
in solvent. Then the cat-L*-allyl acetate mixture was added to the solution of 3-hydroxy 2-nitro
phenyl acrylate 1 via cannula. Additive, tBuOH (39 µL, 0.420 mmol, 2.0 equiv) was added into
the reaction mixture. The mixture was stirred at room temperature and confirmed the completion
of reaction by TLC monitoring. The crude was passed through a thick pad of silica (2 cm) and
solvent was decanted. The crude was then purified by column chromatography on silica gel
elution (hexane/EtOAc = 19/1) and 53.5 mg (93% yield) of white solid product 2 was obtained.
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1

H NMR (CDCl3, 300 MHz): δ 10.16 (s, 1H), 8.16 (d, J = 9.0 Hz, 1H), 7.72 (t, J = 10.5 Hz, 1H),

7.64 (t, J = 9.0 Hz, 1H), 7.54 (td, J = 15.0, 1.5 Hz, 1H), 5.80-5.67 (m, 1H), 5.29-5.17 (m, 2H), 4.22
(q, J = 9.0 Hz, 2H), 3.04 (d, J = 3.0 Hz, 2H), 1.24 (t, J = 7.5 Hz, 3H).
13

C NMR (CDCl3, 75 MHz): δ 196.9, 169.4, 148.4, 133.7, 131.1, 130.7, 130.5, 129.0, 125.9,

120.4, 63.9, 62.0, 37.8, 14.0.
HRMS (ESI+): Calculated (m/z) for C14H16NO5 (M+Na)+ : 300.0842, Found 300.0834. Melting
point: 101-103 °C
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1.3.2 General procedure for the synthesis of general procedure for the Oallylation of prochiral enol acrylate: Synthesis of (E/Z)-ethyl 3-(allyloxy)-2-(2nitrophenyl)acrylate, 9

(Z)-Ethyl 2-nitro-3-hydroxyphenylacrylate, 1 (50.0 mg, 0.210 mmol, 1.0 equiv) was dissolved in
freshly distilled dichloromethane (5 mL) under argon. nBu4NI (7.8 mg, 0.021 mmol, 0.1 equiv),
allyl bromide (22.0 µL, 0.252 mmol, 1.2 equiv), and potassium hydroxide (118.0 mg, 2.10 mmol,
10 equiv) were added, and the reaction mixture was stirred at room temperature until reaction
completion was confirmed by NMR. The reaction was quenched by adding saturated NH4Cl
solution, and the aqueous layer was extracted with diethyl ether (2 × 25 mL). The organic portions
were combined and dried over Na2SO4. Then, the organic layer was then passed through a cotton
plug and the solvent was removed by rotary evaporation. Pure product 9 was isolated by flash
chromatography on silica gel elusion (hexane/EtOAc= 9/1) as (58.0 mg, 99.2% yield) a lightyellow oil.
1

H NMR (300 MHz, CDCl3): δ 8.05 (d, J = 6.0 Hz, 1H), 7.65 (s, 1H), 7.61 (t, J = 4.5 Hz, 1H),

7.46 (dd, J = 6.0, 3.0 Hz, 2H) 5.96-5.88 (m, 1H), 5.34 (dd, J = 9.0, 6.0 Hz, 2H), 4.54 (d, J = 3.0
Hz, 2H), 4.18 (q, J = 7.5 Hz, 2H), 1.23 (t, J = 4.5 Hz, 3H);
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13

C NMR (75 MHz, CDCl3): δ 166.1, 157.9, 148.9, 133.3, 132.6, 132.1, 128.3, 128.2, 124.5,

119.3, 127.6, 75.3, 60.7, 14.1.
HRMS (ESI+): Calculated (m/z) for C14H15NO5 (M+H)+ : 278.1023, Found 278.1013.
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1.3.3 General procedure for the Pd-mediated rearrangement of compound 9 to
prepare Ethyl 2-formyl-2-(2-nitrophenyl) pent -4 enolate, 2 (Method B)

Except for the variation in solvent, ligand and temperature, all O-allyl rearrangement reactions
were carried out by the following general procedure:
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (4.7 mg,
0.0045 mmol, 2.5 mol%) and (R,R)-L1 (8.6 mg, 0.010 mmol, 6.0 mol%). The test tube was then
evacuated and backfilled with argon three times. Previously degassed (1:1) hex: tol (5 mL) was
added to the flask and the mixture was stirred for 15 min until it was homogeneous, and an orange
color persisted. In the meantime, another test tube was charged with Ethyl-3-(allyloxy)-2nitrophenylacrylate 9 (50.0 mg, 0.180 mmol, 1.0 equiv), evacuated and backfilled with Argon, and
then degassed solvent hex: tol (1 mL: 1 mL) was added to dissolve. Both the test tubes were then
put into -10 C cooling bath and stir for another 15 min before transferring the substrate solution
into the catalyst mixture via a cannula. The reaction was stirred for 24 h, unless otherwise
mentioned. The reaction mixture was then passed through a thick pad of silica plug and the solvent
was removed in vacuo. The pure product, 2 was isolated (42.1 mg, 84.2 % yield) by flash column
chromatography eluting through silica gel (hexane / EtOAc = 10/1) as a white solid and confirmed
by 1H NMR. and 13C NMR.
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1.3.4 General procedure for the carboxy allylation of prochiral enolacrylate to
prepare Ethyl 3-(allyloxy)carbonyl)oxy)-2-(2-nitrophenyl)acrylate, 10

To a flask was added anhydrous THF (2 mL) via syringe, followed by NaHMDS (1M solution in
THF); (43.0 µL, 0.210 mmol, 1.0 equiv) and TMEDA (31.5 µL, 0.210 mmol, 1.0 equiv), both
reagents being added at room temperature. After the mixture was stirred for 5 min, 3-hydroxy-2nitro-phenylacrylate, 1 (50.0 mg, 0.210 mmol, 1.0 equiv) was dissolved in anhydrous THF (2 mL)
in a separate flask and is then transferred to the reaction flask containing the NaHMDS / TMEDA
mixture via syringe at room temperature. The mixture allowed stirring at room temperature for 20
min, at which point allylchloroformate (25 µL, 0.231 mmol, 1.1 equiv) was added dropwise via
syringe at rt. The resulting solution was then allowed to stir at temperature for 45 minutes. The
reaction was monitored by taking a small aliquot (0.1 mL) via syringe from the reaction flask,
passing it through a small silica plug, concentrating the solvent under vacuum and taking a 1H
NMR. When the reaction completed, the crude mixture was passed through a silica plug (4 cm
diameter medium porosity fritted funnel, 2 cm of silica). The silica plug was rinsed through with
additional solvent (10 mL) to ensure quantitative elution of product. The solvent was then
concentrated under reduced pressure at room temperature. Finally, the crude yellow powder
product 10 (67 mg, 99% yield) was pure enough for next step reaction.
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1

H NMR (300 MHz, CDCl3): δ 8.38 (s, 1H), 8.17 (d, J = 3.0 Hz, 1H), 7.68 (t, J = 4.5 Hz), 7.55

(t, J = 6.0 Hz, 1H), 7.41 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 5.97-5.97 (m, 1H), 5.42 -5.32 (m, 2H),
4.73 (d, J = 3.0 Hz, 2 H), 4.24 (q, J = 3.0 Hz, 2H), 1.27 (t, J = 4.5 Hz, 3H)
13

C NMR (75 MHz, CDCl3): δ 164.8, 151.3, 148.2, 145.9, 133.3, 132.8, 130.3, 129.4, 127.1,

124.9, 120.6, 116.6, 70.1, 61.5, 14.1.
HRMS (ESI+): Calculated (m/z) for C15H15NO7 (M+H)+ : 322.0921, Found 322.0910.
Melting Point: 72-74 oC.
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Preparation of Ethyl 2-formyl-2-(2-nitrophenyl) pent -4 enolate, 2 using
DAAA: (Method C)

Except for the variation in solvent, ligand, and temperature, all DAAA reactions were carried out
by the following general procedure:
To a dry flask was added Pd2(dba)3.CHCl3 (4.0 mg, 0.004 mmol, 2.5 mol%) followed by (R, R)DACH-naphthyl Trost ligand L1 (7.0 mg, 0.0088 mmol, 5.5 mol%). To the flask was added a
mixture of dry and degassed THF (3 mL) at room temperature and the mixture stirred for 15
minutes. After several minutes of stirring, the mixture turned into a bright yellow color
(occasionally a slight pink hue is observable) with a small amount of beige precipitate. The
resulting mixture was cooled down to -10 °C and was transferred via cannula to a separate
flask containing compound 10 (50.0 mg, 0.16 mmol, 1.0 equiv) dissolved in THF (2 mL) which
was already cooled down to -10 °C. The reaction mixture stirred at this temperature until the
reactant completely disappeared (monitored by TLC) and a cloudy yellow/green solution was
obtained. After the reaction, the solution was passed through a silica plug (1 cm fritted funnel, 2
cm silica, medium porosity filter) which was washed through with DCM (10 mL). The solvent
was concentrated under vacuum and the residue was purified with flash column chromatography
on silica gel (hexane/EtOAc = 20/1) to afford compound 2 (37.0 mg, 85.7 % yield) as a white
solid.
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Synthesis of (Ethyl 2-(hydroxymethyl)-2-(2nitrophenyl)pent-4-enoate (3)

Ethyl 2-formyl-2-(2-nitrophenyl)pent -4 enolate, 2 (430.0 mg, 1.55 mmol, 1.0 equiv) was added
to a 100 mL round bottom flask and placed in an argon atmosphere. 30 mL of anhydrous methanol
was added, and it could dissolve through stirring. The reaction flask was then bought down to 0
o

C and NaBH4 (294.0 mg, 7.76 mmol, 5.0 equiv) was the added to the stirring

mixture. Subsequently the mixture was removed from the ice for 5 min and returned it until the
reaction monitored through the end by Thin layer chromatography (TLC). 10 ml of water was
added to quench the reaction and then extracted using DCM (3 x 30 mL). The organic fraction was
then dried with Na2SO4 and concentrated in vacuo. The crude was purified by column
chromatography on silica gel eluted with 20% EtOAc in hexane to afford the abovementioned product, 3 as colorless viscous liquid (429.0 mg, >99% yield).
1

H NMR (CDCl3, 300 MHz): δ 7.93(t, J = 4.5 Hz), 7.65 (t, J = 4.5 Hz, 1H), 7.57 (d, J = 3.0 Hz,

1H), 7.49-7.45 (m, 1H), 5.67-5.61 (m, 1H), 5.11 (dd, J = 15.0 , 6.0 Hz, 2H), 4.36 (d, J = 9.0 Hz,
1H), 4.20-4.10 (m, 2H), 3.98 (d, J = 6.0 Hz, 1H), 3.11-2.96 (m, 2H), 2.41 (brs, 1H), 1.24 (t, J= 4.5
Hz);
13

C NMR (CDCl3, 75 MHz): δ 172.8, 150.2, 133.3, 132.9, 132.6, 130.4, 128.2, 125.7, 119.0, 67.2,

61.3, 55.1, 39.3, 14.0.
HRMS (ESI+): Calculated (m/z) for C14H17NO5 [M+H]+: 280.1179, Found: 280.1173
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Synthesis of 3-allyl-3-(hydroxymethyl)indolin-2-one (4)[142]

Ethyl 2-(hydroxymethyl)-2-(2nitrophenyl)pent-4-enoate, 3 (200 mg, 0.72 mmol, 1.0 equiv)
zinc powder (400 mg, 6.12 mmol, 8.5 equiv) and solid NH4Cl (370.0 mg, 6.92 mmol, 9.6 equiv)
were taken in a round bottom flask in an argon atmosphere. A degassed solvent mixture of EtOH:
H2O (4:1) mixture was added to the flask via syringe followed by vigorous stirring under reflux
temperature. The mixture was then allowed to react for 2 h and monitored by TLC before cooling
down to the room temperature. Then a cotton plug was used to separate the Zn dust and the solvent
was removed by rotary evaporation. The crude was then extracted by ethyl acetate and finally
purified via column chromatography using neutral alumina as a stationary phase with MeOH/DCM
= 1/10, which yielded the desired oxindole 4, as pale-yellow solid powder (0.13 g, 85% yield)7.
1

H NMR (CDCl3, 300MHz): δ 8.40 (s, 1H), 7.41-7.22 (m, 2H), 7.10 (t, J = 7.5 Hz, 1H), 6.95 (d,

J = 9.0 Hz, 1H), 5.55-5.43 (m, 1H), 5.09-4.96 (m, 2H), 3.97 (d, J = 9.0 Hz, 1H), 3.83 (d, J = 9.0
Hz, 1H), 2.71-2.59 (m, 2H), 1.97 (s, 1H);
13

C NMR (CDCl3, 75MHz): δ 180.5, 140.9, 131.6, 129.9, 128.5, 123.7, 122.7, 119.3, 109.8, 66.5,

54.6, 37.3.
HRMS (ESI+): Calculated (m/z) for C12H13NO2 (M+H)+ : 204.1001, Found 204.1019.
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(S)-(3-allyl-2-oxoindolin-3-yl)methyl methanesulfonate (5)

To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin2- one 4 (70.0 mg, 0.35 mmol, 1.0 equiv), Then triethylamine (117.1 µL, 0.84 mmol, 2.4 equiv)
was added and the solution was maintained in an ice bath for 30 minutes under argon
atmosphere. After that, MsCl (32.0 µL, 0.42 mmol, 1.2 equiv) was added and ran the reaction until
the consumption of the starting material, as judged by TLC analysis. The mixture was neutralized
by 10 mL of 1M HCl then the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The organic
fraction was washed with NaHCO3 (saturated) and brine (1 x 10 mL). The combined organic layer
was dried over anhydrous MgSO4; evaporated using rotary evaporator. The crude product was
purified by silica gel column chromatography (50/50 = EtOAc/hexane) to afford 5 as a lightyellow oil (87.0 mg, 90% yield).
1

H NMR (CDCl3, 500 MHz): δ 7.79 (brs, 1H), 7.32 (d, J = 5.0 Hz, 2H), 7.12 (t, J = 15 Hz, 1H),

6.93 (d, J = 5.0 Hz, 1H), 5.56-5.47 (m, 1H), 5.12 (d, J = 15 Hz), 5.05 (d, J = 10 Hz, 1H), 4.56 (d,
J = 10.0 Hz, 1H), 4.46 (d, J = 10.0 Hz, 1H), 2.84 (s, 3H), 2.62 (d, J = 5.0 Hz, 2H);
13

C NMR (CDCl3, 125 MHz): δ 177.6, 140.8, 130.2, 129.0, 127.8, 124.2, 122.9, 120.3, 110.0,

71.8, 52.7, 37.9, 37.2.
HRMS (ESI+): Calculated (m/z) for C13H15NO4S [M+H]+: 282.0795, Found: 282.0782.
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(S)-2-oxo-3-(2-oxoethyl)indolin-3-yl)methyl methanesulfonate (6)[143]

To a stirred mixture of compound 6 (30.0 mg, 0.11 mmol, 1.0 equiv) and RuCl3 stock solution (15
µL, 0.0037 mmol, 3.5 mol%) in CH3CN (3.0 mL) and distilled water (0.5 mL) was added in
portions NaIO4 (61.2 mg, 0.286 mmol, 2.6 equiv) over a period of 5 minutes at room temperature.
The color of the mixture color changed from the black to yellowish brown. Then the reaction was
monitored by TLC until the starting material disappeared completely. Adding 2 mL of saturated
Na2S2O3 solution quenched the reaction. The organic layer was then separated and extracted three
times using DCM. The combined organic layer was washed with water and brine, respectively.
Then it was dried over MgSO4 and filtered through a cotton plug and finally decanted. The crude
purified via column chromatography using silica gel as a stationary phase with MeOH/DCM =
1/9, which yielded the desired product 7, as pale-yellow oil (25.7 mg, 85% yield).
1

H NMR (CDCl3, 500 MHz): δ 9.58 (s, 1H), 8.10 (s, 1H), 7.33-7.29 (m, 2H), 7.10 (t, J = 11.40

Hz, 1H), 6.97 (d, J = 7.70 Hz, 1H), 4.58 (d, J = 9.85 Hz, 1H), 4.32 (d, J = 9.85 Hz, 1H), 3.22 (d, J
= 18.0 Hz, 1H), 3.13 (d, J = 18.0 Hz, 1H), 2.87 (s, 3H);
13

C NMR (CDCl3, 125 MHz): δ 197.1, 177.5, 141.3, 136.4, 129.5, 128.0, 124.0, 123.0, 110.6,

71.9, 49.3, 46.1, 37.4.
HRMS (ESI+): Calculated (m/z) for C13H15NO4S [M+H]+: 284.302, Found: 284.303.
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Synthesis of (-)-Coerulescene (7) [144]

Titanium (IV) isopropoxide (128.0 μL, 0.42 mmol, 2.0 equiv) was added to a commercially
available solution of methylamine in THF (2 M) (9.0 μL, 0.22 mmol, 1.05 equiv) followed by the
addition of the compound 7 (59.1 mg, 0.21 mmol, 1.0 equiv). The reaction mixture was stirred at
ambient temperature for 5 h, after which sodium borohydride (8.0 mg, 0.21 mmol, 1.0 equiv) was
added and the resulting mixture was further stirred for another period of 2 h. The reaction was then
quenched by the addition of water (2 mL), the resulting inorganic precipitate was filtered and
washed with diethyl ether (10 mL). The organic layer was separated, and the aqueous part was
further extracted with ethyl acetate ether (2 x 10 mL). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo and obtained (40.1 mg, 95% yield) (-)-coerulescine 7 with high
purity. The proton NMR, carbon NMR and the optical rotation is exactly matched with the data
reported by Hayashi et al. [145]
1

H NMR (CDCl3, 300 MHz): δ 8.81 (s, 1H), 7.41 (d, J = 10.0 Hz, 1H), 7.20 (t, J = 7.50 Hz, 1H),

7.06 (t, J = 7.5 Hz, 1H), 6.92 (d, J = 5.0 Hz, 1H), 3.04-2.79 (m, 4H), 2.49 (s, 3H), 2.46-2.42 (m,
1H), 2.15-2.10 (m, 1H).
13

C NMR (CDCl3, 75 MHz): δ 182.8, 140.0, 136.2, 127.8, 123.4, 122.9, 109.5, 66.4, 56.8, 53.7,

41.9, 38.0.
HRMS (ESI+): Calculated (m/z) for C12H14N2O [M+H]+: 203.1186, Found: 203.1179: [α]27D
+1.1 (c 2.0, CHCl3). Enantiomeric excess = 85%
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Synthesis of (-)-coixspirolactam A (8)[146]

To a stirred mixture of compound 6 (61.0 mg, 0.22 mmol, 1.0 equiv) and RuCl3 stock solution (29
µL, 0.0075 mmol, 3.5 mol%) in 1,2-dichloroethane (3 mL) and distilled water (3 mL) was added
in portions NaIO4 (141.2 mg, 0.66 mmol, 3.0 equiv) over a period of 5 minutes at room
temperature. The color of the mixture changed from the black to yellowish brown. Then the
reaction was monitored by TLC until the starting material disappeared completely. After 32 h the
reaction was quenched by adding 2 mL of saturated Na2S2O3 solution. The organic layer was then
separated and extracted three times using DCM. The combined organic layer was washed with
water and brine, respectively. Then it was dried over MgSO4 and filtered through a cotton plug
and finally decanted. The crude was eluted through silica gel using 80% EtOAc in hexane solvent
mixture and the product 8 was separated as a white solid powder (29.9 mg, 68% yield). The proton
NMR, carbon NMR and the optical rotation is exactly matched with the data reported by Andrade
et al. [147]
1

H NMR (500 MHz, CDCl3): δ 7.92 (s, 1H), 7.33 (d, J = 10 Hz, 2H), 7.15(t, J = 12.5 Hz, 1H),

6.97 (d, J = 10.0 Hz, 1H), 4.63 (d, J = 5.0 Hz, 1H), 4.42 (d, J = 10.0 Hz, 1H), 3.19 (d, J = 15.0 Hz,
1H), 2.75 (d, J = 15.0 Hz, 1H);
13

C NMR (125 MHz, CDCl3): δ 177.4, 174.2, 139.8, 131.0, 129.6, 123.8, 122.8, 110.5, 74.8, 51.0,

38.4.
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HRMS (ESI+): Calculated (m/z) for C11H9NO3 [M+H]+: 204.0660, Found: 203.0652.

Synthesis of

(S)-(3-allyl-2-oxoindolin-3-yl)methyl 4-methylbenzenesulfonate

(11)

To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin2- one 4 (98.0 mg, 0.48 mmol, 1.0 equiv), Then pyridine (78.1 µL, 0.96 mmol, 2.0 equiv) was
added dropwise and the solution was maintained in an ice bath for 30 minutes under argon
atmosphere. After that, TsCl (106.0 µL, 0.72 mmol, 1.5 equiv) was added and ran the reaction
until the consumption of the starting material, monitored by TLC analysis. The mixture
was neutralized

by 10

mL

of

1M HCl then the

aqueous

layer

was extracted with CH2Cl2 (3 x 10 mL). The organic fraction was washed with NaHCO3
(saturated) and brine (1 x 10 mL). The combined organic layer was dried over anhydrous MgSO4;
evaporated using

rotary

evaporator.

The

crude

product

was

purified by silica gel

column chromatography (25/75 = EtOAc/hexane) to afford compound 11 as a yellow viscous
oil (155.3 mg, 90% yield).
1

H NMR (CDCl3, 300 MHz): δ 7.89 (brs, 1H), 7.25 (t, J = 4.5 Hz, 5H), 7.09 (t, J = 7.5 Hz, 2H),

6.91 (d, J = 6.0 Hz, 2H), 5.59-5.45 (m, 1H), 5.10-4.97 (m, 2H), 3.94 (d, J = 6.0 Hz, 1H), 3.83 (d,
J = 9.0 Hz, 1H), 2.75-2.59 (m, 2H), 2.04 (s, 3H),
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13

C NMR (CDCl3, 125 MHz): δ 177.6, 140.8, 130.2, 129.0, 127.8, 124.2, 122.9, 120.3, 110.0,

71.8, 52.7, 37.9, 37.2.

Synthesis of (3S)-5-hydroxy-4,5-dihydro-2H-spiro[furan-3,3'-indolin]-2'-one
(12)

To a stirred mixture of compound 4 (100.0 mg, 0.49 mmol, 1.0 equiv), RuCl3 stock solution (68
µL, 0.0171 mmol, 3.5 mol%) in CH3CN (3.0 mL) and distilled water (0.5 mL) was added in
portions NaIO4 (272.6 mg, 1.28 mmol, 2.6 equiv) over a period of 5 minutes at room temperature.
The color of the mixture color changed from the black to yellowish brown. Then the reaction was
monitored by TLC until the starting material disappeared completely. Added 2 mL of saturated
Na2S2O3 solution quenched the reaction. The organic layer was then separated and extracted three
times using DCM. The combined organic layer was washed with water and brine, respectively.
Then it was dried over MgSO4 and filtered through a cotton plug and finally decanted. The crude
purified via column chromatography using silica gel as a stationary phase with MeOH/DCM =
1/8, which yielded the desired product 12, as yellow oil (52.1 mg, 52 % yield).
1

H NMR (CDCl3, 500 MHz): δ 8.31 (s, 1H), 7.32-7.25 (m, 2H), 7.10 (d, J = 10.0 Hz, 1H), 6.94

(d, J = 15.0 Hz, 1H), 4.25 (d, J = 3.0 Hz, 1H), 4.34 (s, -C-OH, 1H), 4.21 (d, J = 3.5 Hz, 1H), 4.09
(d, J = 14.0 Hz, 1H), 3.98 (d, J = 14.2 Hz, 1H), 2.61 - 2.52 (m, 1H), 2.12 - 2.11 (m, 1H)
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13

C NMR (CDCl3, 125 MHz): δ 197.1, 177.5, 141.3, 136.4, 129.5, 128.0, 124.0, 123.0, 110.6,

71.9, 49.3, 46.1, 37.4;
MS (20:20): Calculated (m/z) for C11H11NO3 [M+H]+: 205..21, Found: 205.16 (100%), 206.11
(17%).

General procedure for the synthesis of (E/Z)-ethyl 2-formyl-2-(2-nitrophenyl)5-phenylpent-4-enoate (13)

In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (5.4 mg,
0.00525 mmol, 2.5 mol%) and (R, R)-L* (10.0 mg, 0.0126 mmol, 6 mol%). The test tube was then
evacuated and backfilled with argon three times. Previously distilled and degassed tetrahydrofuran
(THF) was added to the flask and the mixture was stirred for 15 min until it was homogeneous,
and an orange color persisted. Then, cinnamyl acetate (42 μL, 0.252 mmol, 1.2 equiv) was added
to the system and the solution was stirred at room temperature for an additional 5 min. In the
meantime, the other test tube was charged with 3-hydroxy 2-nitro phenyl acrylate 1 (50.0 mg,
0.210 mmol, 1.0 equiv) with the addition of 2 mL of degassed tetrahydrofuran (THF) and it was
finely dissolved in solvent. Then the cat-L*-allyl acetate mixture was added to the solution of 3hydroxy 2-nitro phenyl acrylate 1 via cannula. Additive, tBuOH (39 µL, 0.420 mmol, 2.0 equiv)
was added into the reaction mixture. The mixture was stirred at room temperature and confirmed
the completion of reaction by TLC monitoring. The crude was passed through a thick pad of silica
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(2 cm) and solvent was decanted. The crude was then purified by column chromatography on silica
gel elution (hexane/EtOAc = 10/1) and 37.0 mg (55% yield) of clear oily liquid product 13 was
obtained. During the column chromatography some decarbonylated product formed. The NMR of
that compound 13a has attached.
NMR for compound 13:
1

H NMR (CDCl3, 300 MHz): δ 10.24 (s, 1H), 8.17 (d, J = 9.0 Hz, 1H), 7.74 (d, J = 6.0 Hz, 2H),

7.58 (t, J = 4.5 Hz, 1H), 7.31-7.26 (m, 5H), 6.60 (d, 1H), 6.11 (t, J = 7.5 Hz, 1H), 4.20 (q, J = 7.5
Hz, 2H), 3.23 (d, J = 9.0 Hz, 2H), 1.20 (t, J = 7.5 Hz, 3H);
13

C NMR (CDCl3, 75 MHz): δ 196.8, 169.4, 148.4, 133.7, 131.1, 130.7, 130.5, 129.0, 125.9,

120.4, 63.9, 62.0, 37.8, 14.0;
NMR for compound 13a:
1

H NMR (CDCl3, 300 MHz): δ 7.92 (d, J = 6.0 Hz, 1H), 7.61 (d, J = 3.0 Hz, 2H), 7.46 – 7.41

(m, 2H), 7.31 – 7.21 (m, 5H), 6.44 (d, J = 18 Hz, 1H), 6.22 – 6.14 (m, 1H) 4.39 (t, J = 7.5 Hz, 1H),
4.21 – 4.13 (m, 2H), 3.11 - 3.02 (m, 1H), 2.85 – 2.78 (m, 1H) 1.22 (t, J = 10.5 Hz, 3H).
13

C NMR (CDCl3, 75 MHz): δ 172.07, 149.5, 137.1, 133.0, 132.9, 130.0, 128.5, 128.2, 127.3,

126.2, 124.8, 61.3, 46.6, 36.3, 14.1.
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Synthesis of (S)-ethyl 2-(((methylsulfonyl)oxy)methyl)-2-(2-nitrophenyl)pent-4enoate (14)

To a clean flame dried flask, DCM (6mL) was added to dissolve compound
3 (200.0 mg, 0.72 mmol, 1.0 equiv). Then triethylamine (201 µL, 1.44 mmol, 2.0 equiv) was
added and the solution was maintained in an ice bath for 30-45 minutes under argon
atmosphere. After that, MsCl (66.0 µL, 0.86 mmol, 1.2 equiv) was added and ran the reaction until
the consumption of the starting material, as judged by TLC analysis. After confirming the
disappearance of the starting material, the mixture was neutralized by 1M HCl (as required
observed by pH paper) then the aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The
organic fraction was washed with NaHCO3 (saturated) and brine (1 x 25 mL). The combined
organic layer was dried over anhydrous MgSO4; evaporated using rotary evaporator. The crude
product was purified by silica gel column chromatography (25/75 = EtOAc/hexane) to afford 14
as a colorless oil oil (225.6 mg, 88% yield).
1

H NMR (CDCl3, 500 MHz): δ 7.93 (d, J = 10 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.59 (d, J = 10.0

Hz, 1H), 7.54-7.50 (m,1H), 5.68-5.60 (m, 1H), 5.32-5.15 (m, 2H), 4.93 (d, J = 10 Hz, 1H), 4.87 (d,
J = 10.0 Hz, 1H), 4.21-4.08 (m, 2H), 3.05 (t, J = 7.6 Hz, 2H), 2.84 (s, 3H), 1.24 (t, J = 7.5 Hz, 3H)
13

C NMR (CDCl3, 125 MHz): δ 169.9, 149.9, 132.7, 132.0, 131.4, 130.9, 128.8, 125.8, 120.2,

71.6, 61.7, 53.4, 39.3, 37.1, 14.0.
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Synthesis of ethyl 3‐allylindoline‐3‐carboxylate (15)

Compound 14 (220 mg, 0.62 mmol, 1.0 equiv) zinc powder (182 mg, 2.77 mmol, 4.5 equiv) and
solid NH4Cl (281.8 mg, 5.27 mmol, 8.5 equiv) were taken in a round bottom flask in an argon
atmosphere. A degassed solvent mixture of EtOH: H2O (4:1) (20 mL) mixture was added to the
flask via syringe followed by vigorous stirring under reflux temperature. The mixture was then
allowed to react for 3h and monitored by TLC before cooling down to the room temperature. Then
a cotton plug was used to separate the Zn dust and the solvent was removed by rotary evaporation.
The crude was then extracted by ethyl acetate and finally purified via column chromatography
using neutral alumina as a stationary phase with MeOH/DCM = 1/20, which yielded the desired
indole 15, as colorless liquid (0.11 g, 78% yield).
1

H NMR (CDCl3, 500MHz): δ 7.36 (s, 1H), 7.12 (t, J = 7.5 MHz, 1H), 6.80 – 6.77 (m, 1H), 6.69

(d, J = 10 Hz) 5.73 – 5.68 (m, 1H), 5.15 – 5.10 (m, 1H), 4.23 (q, J = 7.5 Hz, 2H), 3.52 (d, J = 5.0
Hz) 2.86 (t, J = 7.5 Hz, 1H), 2.77 – 2.55 (m, 1H) 1.31 (t, J = 7.5 Hz)
13

C NMR (CDCl3, 125 MHz): δ 177.3, 150.5, 133.3, 130.1, 128.8, 124.7, 119.0, 118.7, 110.2,

61.2, 56.3, 53.5, 42.5, 29.7.
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Synthesis of (S)-3-allyl-3-(((triisopropylsilyl)oxy)methyl)indolin-2-one (16)

To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin2- one 4 (180.0 mg, 0.89 mmol, 1.0 equiv), Then the base 2,6-Lutidine (308.0 µL, 3.0 equiv) was
added and the solution was maintained at room temperature for 30 minutes under argon
atmosphere. After that, TIPS-OTf (359.0 µL, 1.5 equiv) was added and ran the reaction until
the consumption of the starting material, as judged by TLC analysis. The crude mixture was then
extracted 3X by using water. The combined organic layer was dried over anhydrous MgSO4;
evaporated using

rotary

evaporator.

The

crude

product

was

purified by silica gel

column chromatography (30/70 = EtOAc/hexane) to afford 16 as a light-yellow oil (273.0 mg,
70% yield).
1

H NMR (CDCl3, 500 MHz): δ 8.48 (s, 1H), 7.31-6.87 (m, 4H), 5.52-5.46 (m,1H), 5.07-

4.91 (m, 2H), 4.02-3.92 (m, 2H), 2.73-2.54 (m, 2H), 1.28-1.00 (m, 21 H).
13

C NMR (CDCl3, 125 MHz): δ 177.3, 150.5, 133.3, 130.1, 128.8, 124.7, 119.0, 118.7, 110.2,

61.2, 56.3, 53.5, 42.5, 29.7.
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Synthesis

of

(S)-2-(2-oxo-3-(((triisopropylsilyl)oxy)methyl)indolin-3-

yl)acetaldehyde, 17

To a stirred mixture of compound 16 (70.0 mg, 0.19 mmol, 1.0 equiv) and RuCl3 stock solution
(28 µL, 0.007 mmol, 3.5 mol%) in CH3CN (6.0 mL) and distilled water (4.0 mL) was added. Then
63.9 mg (0.76 mmol, 4 equiv) of NaHCO3 charged to the reaction vessel all at once along with the
addition of 43.37 mg (0.285 mmol 1.5 equiv. The color of the mixture color changed from the
brown to dark black. Then the reaction was monitored by TLC until the starting material
disappeared completely. We have added saturated Na2S2O3 solution quenched the reaction. The
organic layer was then separated and extracted three times using ethyl acetate. The combined
organic layer was washed with water and brine, respectively. Then it was dried over MgSO4 and
filtered through a cotton plug and finally decanted. The crude purified via column chromatography
using silica gel as a stationary phase with EtOAc/hexane =6/1, which yielded the desired product
17, as pale-yellow oil (28.2 mg, 40% yield).
1

H NMR (CDCl3, 300 MHz): δ 9.40 (s, 1H), 7.43 (s, 1H), 7.27-7.22 (m, 2H), 7.02 (t, J = 4.5 Hz,

1H), 6.90 (d, J = 6.0 Hz, 1H), 4.00 (d, J = 9.0 Hz, 1H), 3.84 (d, J = 9.0 Hz, 1H), 3.22 (d, J = 18.0
Hz, 1H), 3.13 (d, J = 18.0 Hz), 0.94-0.98 (m, 21H);
13

C NMR (CDCl3, 125 MHz): δ 179.9, 141.1, 132.2, 131.4, 127.8, 124.3, 122.1, 118.7, 109.2,

55.8, 55.7, 37.3, 29.8, 17.9, 17.5, 12.5, 12.4, 12.3.
MS (ESI+): Calculated (m/z) for C20H31NO3Si, Found: 339.30 (100%), 360.35(40%).
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Chapter 1: Synthetic Scope of Brønsted Acid Catalyzed Reactions of
Carbonyl Compounds and Ethyl Diazoacetate‐Part B
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5.1 Introduction
To an intension of exploring the synthetic scope of the 3-hydroxy aryl acrylate beyond the
limitations of aromatic aldehydes, we decided to work on the aromatic ketones along with the
aliphatic ketone and aldehydes. Our focus was mainly the development of the quaternary ketones
which

can

be

implemented

for

the

synthesis

ofnatural

and

synthetic

products

like elacomine, flustramine, spirotryprostatin etc as shown in Figure 10.

Figure 10 Synthetic scope of ketone derived acrylates for both natural and
synthetic drug candidates
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5.1.1 Synthetic approaches for the preparation of 3-hydrocy aryl acrylates:
5.1.1.1 Lewis acid catalyzed reactions
In our previous work, we reported the formation of 3-hydroxy-2-aryl acrylates by 1,2-aryl
migration from the reactions of aromatic aldehydes with ethyl diazoacetate (EDA) in the presence
of an iron Lewis acid catalyst. [131] The approach proceeded by iron Lewis acid catalyst, [ɳ5(C5H5)Fe+(CO)2(THF)]BF4 1, catalysed reaction with the formation of desired compound 2 along
with β-ketoester 2’ from moderate to excellent yields (Scheme 75). Our group reported that

Scheme 75 Iron Lewis catalysed synthesis of 3-hydroxy aryl acrylate by Hossain
et al
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benzaldehyde having electron donating groups provided higher yield of product 2 (2b, 2c and 2e)
compared to having electron withdrawing groups (2d and 2f). Later on, other groups also reported
the similar type of reactions by using different Lewis acid catalysts. [146-151]. One of such
noticeable work was published by Kirchner and coworkers. The specially of their approach is the
regioselective formation of 2 (consistently got <3% of 2’) by using cationic iron pincer complexes
such as [Fe(PNP)(CH3CN)3](BF4)2 and [Fe(PNP)(CO)(CH3CN)2](BF4)2, where PNP are various

Scheme 76 Iron Lewis acid catalyzed synthesis of 2 by Kirchner et al
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tridentate pincer-type ligands based on 2,6-diaminopyridine, and R = Ph, iPr, biphenol, PhHex. The
most effective catalyst was found to be cis-[Fe(PNP-iPr)(CO)(CH3CN)2]BF4 (Scheme 76). [145]
Based on their proposed mechanism, the presence of CO ligand makes CH3CN more labile in the
catalyst 3, due to its stronger trans-effect and easily substituted by incoming aromatic aldehyde 4
to form [Fe (PNP-iPr)(CO)(CH3CN)(κ1(O)-aldehyde)]2+ complex 5. Then the ligand substituted
complex 5 was attacked by 6 and formed the complex 7 by subsequent liberation of N2. Preferential
migratory tendency of the aryl group over hydride led to a κ1O-coordinated aldehyde ester ligand
8. Finally, the aldehyde ester ligand was easily removed from 8 by an incoming CH3CN, and
rapidly tautomerized to yield the thermodynamically more stable 2 (Scheme 76).
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5.1.1.2 Bronsted Acid catalyzed reactions
In 2004, our group explored the catalyst scopes to produce 3-hydroxy-2-aryl acrylates and 3-oxoesters with Brønsted type acids by using similar substrates. [152] We have screened several
commercially available Brønsted acids, such as HNO3, H2SO4, HClO4, HCl besides HBF4, to see
the protonation tendency and the counterion effect on selective product formation. They found that

Scheme 77 Role of commercially available Bronsted acid for the decomposition
of 6

the acids with nucleophilic counterions, such as Cl-, AcO-, and NO3-, provided a small amount of
product 1 since these acids readily quenched by EDA 6 and formed byproduct 9 (Scheme 77).
However, HBF4 did not quench by EDA due to the presence of non-nucleophilic counterion (BF4) rather protonated the carbonyl oxygen to access O-protonated benzaldehyde 10 which initiated
the reaction (Scheme 77). Therefore, they explored the substrate scope (Scheme 78) with their
developed simplified protonation technique. Unfortunately, no more precedence of other Bronsted
acid catalyzed approached have been reported so far. Later Kirchner et al synthesized the acrylates
following the same protocol for the computational study of the migratory tendency or aryl group
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relative to the alkyl group. [153a]

Scheme 78 First Bronsted acid catalyzed coupling of aromatic aldehyde, 4 and
EDA, 6 by Hossain et al
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5.1.1.3 Organic base catalysed reaction
In 2007, Wang et al. reported 1, 8-diazabicyclo [5.4.0]undec-7-ene (DBU) catalysed nucleophilic
reaction between 4 and EDA 6 to synthesize 2 via β-hydroxy diazo ester 11 as an intermediate.
Initially, the β-Hydroxy group of 11 was protected by trimethylsilyl chloride (TMSCl) to form
compound 12. In the presence of Rh(II)-catalyst, compound 12 underwent 1,2-aryl migration to
provide the final product 1 (Scheme 79). [153b, 153c] The steric factors play an important role in
the 1,2-migratory aptitude of Rh(II)- catalysed reaction. When the substituent was bulkier at the
β-position, such as a siloxy group, aryl migration was favored over hydride migration.

Scheme 79 Organic base catalyzed formation of 3-hydroxy arylacrylate, 2 by
Wang et al
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5.2 Application of hydroxy acrylates for present synthetic point of
view
5.2.1 Quinolone/quinolinone type compounds
4-Quinolones and 2-quinolones captured great interest by medicinal chemists due to their effective
biological properties. [154–156]. 3-aryl-4-quinolones showed antitumor [157a] and antimalarial
activity, [157b] and acted as a platelet aggregation inhibitor, [157c] while 3-aryl-2-quinolones
reported to be acting as an integrin antagonist. [158] The first approach to synthesize 3-aryl-2-

Scheme 80 Synthesis of 2-and 4-Quinolinone derivatives from 3-hydroxy aryl
acrylate 2

quinolones 14 and 3-aryl-4-quinolones 17 from 3-hydroxy-2-aryl acrylate 2 was reported in 1997
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by Bisagni et al. [159] Condensation reactions between 2 and 3,5-dimethoxy aniline 13 formed
non-regioselective E/Z mixture of intermediate 16 which underwent cyclization by refluxing in
Dowtherm A (biphenyl/diphenyl ether mixture 26.5 : 73.5) to prepare 17. On the other hand, by
direct heating of 2 and 13 at 230 °C they obtained 3-phenyl-2-quinolone 14. They also prepared
other quinolone derivatives such as 15, 18, 19, and 20 from quinolones 14 and 15 using a little far
of chemical methodologies (Scheme 80).
5.2.2 Synthesis of Pyrimidine/pyrimidinone type compounds
After years of research on various neurological disorders which mainly related to the GABAergic
system, it has been evident that such disorders can be treated by targeting the GABAA-Receptors
(GABAA-RS). [160] Moreover, development of compounds of different structural classes can
modulate, directly activate or inhibit GABAA-R subtypes. Therefore, different types of fused
nitrogen-containing heterocyclic systems have been extensively investigated to synthesize
GABAA-Receptors sub-type ligands. [161] Selleri et al. described the synthesis of secondgeneration pyrazole-pyrimidine compound 22, containing an aryl ring at 6-position
Scheme 81 Synthesis of pyrazolopyrimidinone from 3-hydroxyarylacrylate 2
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as an isostere of the thiophene ring to evaluate in vitro GABAA-receptors affinity. [162] A single
step approach of preparing compound 22 has proposed by the reaction between a suitable pyrazole
21 and 2 in diglyme at reflux condition (Scheme 81).
5.2.3 Synthesis of Uracil type compounds
Uracil is one of the three basic pyrimidines obtained in naturally occurring nucleic acids.41
Because of structural similarities with nucleosides and nucleotides, uracil plays a pivotal role in
the treatment for human immunodeficiency virus (HIV), [163] hepatitis B virus (HBV), [164]
hepatitis C virus (HCV), [165] herpes simplex virus (HSV), [166] and various types of cancer.
[167]
In 2007, our group has reported NaOEt catalyzed synthesis of a series of derivatives 24 using a
variety of acrylates including both electron donating and electron withdrawing groups (Scheme
82). [168]
Scheme 82 Synthetic application of 3-hydroxy arylacrylate 2 for preparing Uracil derivatives
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Another approach of ssimilar synthetic approach was attempted by Davies and Piggott for the
synthesis of 24 from the reaction of 1 and 68 in the presence of NaOH (Scheme 82). [169]
Interestingly, whenever other amides were attempted to be used in this reaction, no product was
yielded.
5.2.4 Synthesis of Vinyl derivatives
A unique idea of direct trifluoromethylthiolation of CSP2-OH bond activation of 2 using
silvertrifluoromethanethiol 25 has recently explained by Qing and co-workers; a variety of
trifluoromethyl sulfides 26 has been synthesized thereafter. [170] The employment of both of nBu4NI and KI activated 25 to afford the desired product 26 (Scheme 83). This convenient approach
of incorporating an extremely high lipophilic [171] trifluoromethylthio group (SCF3) might
simplify the synthesis of many pharmaceutical and agrochemical compounds such as toltrazuril
[172], fipronil [173] and tiflorex. [174]

Scheme 83 Synthesis of thio vinyl derivatives from 3-hydroxy aryl acrylate
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5.2.5 Synthesis of Chromenone Crown ether
Macrocyclic ethers (depending on the ring size) have been used to estimate cationic recognition
and selective cation binding using different physical approaches such as filtration, absorption etc.
[175-177] Erk et al. reported the synthesis of various 3-phenyl chromenone-crown ether moieties
31 and 32 which was used for the detection of cations such as Li+, Na+, K+, and Rb+ as well as
perchlorates with fluorescence spectroscopy. [178,179] Compounds 31 and 32 were synthesized
by the addition of crown ether (12-Crown-4, 15-Crown-4, and 18-Crown-6) to chromenones 29
and 30; which was obtained from the cyclization of triacetate 27 or triol 28 with compound 2
(Scheme 84).
Scheme 84 Synthesis of Chromenone-Crown Ethers from 3-hydroxy arylacrylate 2
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Therefore, we attempted to unfold the scope of these underdeveloped substrates. We expected to
obtain product mixture of the migrated products due to the variation of migratory tendency of
different alkyl/aryl groups and investigated the relative product ratios (from crude by NMR
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analysis or possibly from isolated products). However, reactions of more sterically hindered and
less electrophilic aromatic/aliphatic ketones or aliphatic aldehydes with EDA in the presence of
a Brønsted acid catalyst are certainly rare. Before starting our investigation, we have outlined a
general mechanism for the 1,2-aryl migration of carbonyl substrates considering EDA as a reaction
partner with an optimized amount of HBF4.OEt2 as a catalyst (Scheme 85). To expand the scope
of this reaction, benzophenones, aliphatic ketone (both symmetric and nonsymmetric) along with
aliphatic aldehydes were employed as substrates in this transformation.
Scheme 85 Formation of 3-hydroxy aryl acrylate/3-Oxo-Esters in presence of HBF4.OEt2
catalyst by 1,2-migration.
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5.3 Results and Discussion
5.3.1 Development of Benzophenone derived acrylates
We first focused on the synthesis of benzophenone and substituted benzophenones (Scheme 86).
The result obtained from the reaction of benzophenone with EDA was encouraging; the yield is
Scheme 86 Synthetic scope and migratory aptitude of Aryl-Phenyl groups

a

Reaction conditions: 33 (5.0-10.0 mmol), 6 (10.0-20 mmol), HBF4∙OEt2 (1.0-2.0 mmol), CH2Cl2 (15-20 mL) at -

78 oC to rt for 3 days. bThe ratios of the products are calculated from the NMR of the crude mixtures.

low may be because of the sterically hindered and very less reactive structure of benzophenone
which does not allow the nucleophilic EDA to attack with the mild reaction conditions. Though
we expected much better yield from the electron donating para substituted methyl or methoxy
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group in one of the phenyl rings on the benzophenone moiety, but the yield was similar. From our
enquiry, it was revealed that when an electron donating group such as methyl was present in the
monosubstituted benzophenone (34b), both phenyl and para-tolyl migrated products were formed
in a ratio of 1:1.2. Our result agree with the value (1.28 ± 0.09) reported by Curtin and Crew in the
acid catalyzed deamination reaction of 2-amino-l-phenyl-l-p-tolylethanol involving carbocation
intermediate.[180] Moreover, in our study the p-anisyl group in compound 34c provided the
relatively better migration (1.5/1) might be because of the additional interaction energy in the
transition state induce by the para-methoxy group during carbocation formation.[161] In the case
of electron rich 3,4-disubstituted benzophenone (34f and 34g), we obtained exclusively the
disubstituted phenyl-migrated products (34f and 34g) and the yield increase a little. This type of
migration was also found in naphthyl phenyl ketone (34h) where electron rich naphthyl group was
migrated to give the product (34h). The exclusive formation of (34f), (34g), and (34h) may be due
to the better stability of the corresponding phenonium carbocation intermediate. On the other hand,
when an electron withdrawing group (34d and 34e) was present in the monosubstituted
benzophenone, trace or no product was observed which could be due to the instability of
carbocation intermediate. [132]
The above findings could be explained with respect to six probable rotamers A-F (Figure 11) from
the reaction of benzophenones and EDA in the presence of HBF4∙OEt2. Rotamers A-C are
interconvertible due to the rotation of C-C bonds and their diastereomeric form of rotamers, DF are also interconvertible. In both rotamer A and E, migrating phenyl group and leaving
diazonium group were anti to each other, thus the formation of 3-oxo-ester 34 was favorable.
Whereas, in rotamers B and D, the aryl migrating group was anti to the leaving group could favor
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the formation of aryl migrated product 34’. However, the aryl migration from rotamer A/E was
more favorable over phenyl from rotamer B/D due to its ability of the electron donating methyl
and methoxy group to stabilize an intermediate arylonium ion (Figure 11, P) by six electron
resonance participation. Whereas it is also stable for unsubstituted phenyl group (Figure 11, N)
but relatively less compare to P. Therefore, during the crude NMR analysis, we saw more
of 34b, 34c

compared

to 34b’

and 34c’.

In

our

discussion,

we

did

not

consider

rotamers C and F which are perquisite for the formation of epoxide, not observed in our reactions.
Figure 11 Newman projections of six possible rotamers (A-F) and the predicted
intermediates

As we obtained mixture of products from the reactions of para-methyl (33b) and para-methoxy
benzophenone (33c) and EDA, we undertook 2D NMR studies to confirm the structure of the
products. After analyzing HMBC spectra, we observed a cross peak signal between the orthoproton of the benzene ring (a doublet at δ 7.99) and the carbonyl carbon of ester (δ 193.7) (red line

175

in Figure 12), which correlates with the structure of (34b) generated by para-methyl phenyl
migration. On the other hand, a cross peak signal was identified among the ortho-proton (a doublet
at δ 7.89) and the para-methyl carbon of the benzene ring (δ 2.39) as well as with the carbonyl
carbon of ester (δ 192.9) (green line in Figure 12). This cross coupling nicely correlates with (34b’)
formed by phenyl migration. By comparing the peaks at δ 7.89 and δ 7.99 in the crude mixture
(see experimental section), we concluded the product (34b) yielded slightly more product
(34b’) due to the favorable migration of electron donating para-methyl phenyl over phenyl
group.
Figure 12 HMBC cross peak spectra for the products of para-methylbenzophenone
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Similarly, we have confirmed the structure of (34c) by 2D NMR by comparing a cross peak signal
between the ortho-proton of the benzene ring (a doublet at δ 7.98) and the carbonyl carbon of ester
(δ 194.0) (red line in Figure 13) and the structure of 34c’ from the cross peak signal among
the ortho-proton (a doublet at δ 7.97) and the para-methoxy carbon of the benzene ring (δ 3.86)
with the carbonyl carbon of ester (δ 192.0) (green line in Figure 13) (see also experimental
section).
Figure 13 HMBC cross peak spectra for the products of para-methoxybenzophenone
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5.3.2 Development of Aliphatic carbonyl derived acrylates
Lastly, to demonstrate further utility of the reaction, transformation of the aliphatic aldehydes and
ketones were explored. Symmetrical ketone such as 35a-35c provided yield up to 52% and the
nonsymmetrical ketones resulted from 55-64% isolated yield. The aliphatic aldehydes with linear
(35g and 35h) and branched alkyl group (20f) yielded up to 82%. The results of these reactions
are summarized in Scheme 78. For the migratory aptitude of unsymmetrical aliphatic
ketones, increasing the steric bulk of the alkyl group increases its tendency to migrate. The longer
alkyl chain migrated products dominated over the methyl migrated products (35d/35d’
and 35e/35e’=2:1) due to the hyperconjugation effect with longer chain alkyl group, triggered
better stability of the carbocation intermediate. [182] In the case of aliphatic aldehydes, the hydride
migrated products (35f, 35g, and 35h) formed exclusively as observed with aromatic aldehyde.
[183]
Scheme 87 Migratory Aptitude of Alkyl-Hydride Groupsa,b

a

Reaction conditions: 36 (2.0-8.0 mmol), 6 (4.0-16.0 mmol), HBF4∙OEt2 (0.4-1.6 mmol), CH2Cl2 (10-15 mL) at -

78 oC to rt for 3 days. bThe ratios of the products are calculated after isolation.
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In summary, we investigated the reaction of less explored benzophenone/aliphatic ketones as well
as aliphatic aldehydes with EDA employed as the reaction partner. The distinct reactivity between
carbonyl compounds and EDA has allowed the incorporation of a diverse range of substituent
patterns into the product formation. Depending on the migratory aptitudes of hydride, alkyl,
phenyl, and aryl groups, a wide range of 3-oxo-esters are formed. We anticipate that these valuable
synthons will further prove its utility in preparing important building blocks of biologically active
natural and synthetic compounds.
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5.4 General methods and experimental
5.4.1 General Procedure for the One-Pot Synthesis of 3-Oxo-Esters
For each experiment, carbonyl compounds (2.0-8.0 mmol, 1.0 equiv) was dissolved in 10-20 mL
of freshly distilled dichloromethane under nitrogen at -78 oC. A Brønsted acid, HBF4∙OEt2 catalyst
(0.4-1.6 mmol, 0.2 equiv) was added, and the reaction mixture was stirred for 1 hour at the same
temperature. Ethyl diazoacetate (EDA) (4.0-16.0 mmol, 2.0 equiv) was diluted in 5 mL of freshly
distilled dichloromethane and added to the solution over a period of 0.5-1 h. Then, the reaction
mixture was allowed to stir for 72 h at room temperature. After completion of the reaction, it was
quenched by adding THF. The reaction mixture was filtered through a silica plug using
dichloromethane as solvent and the solvent removed by rotary evaporation. Pure products were
isolated by silica gel column chromatography with 0-10% ethyl acetate in hexane.
Ethyl 3-oxo-2,3-diphenylpropanoate (34a). [184a] The compound was prepared according to the
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1).
The title product was isolated as a colorless oil (0.37 g, 20%) from the reaction of benzophenone
(1.25 g, 6.86 mmol, 1.0 equiv) and EDA (1.67 mL, 13.72 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.19 mL, 1.37 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 8.00 (d, J = 6.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 1H), 7.47-7.32 (m,

7H), 5.66 (s, 1H), 4.25 (q, J = 7.5 Hz, 2H), 1.27 (t, J = 7.5 Hz, 3H).
Ethyl

3-oxo-3-phenyl-2-(p-tolyl)propanoate

(34b)

and

ethyl

3-oxo-2-phenyl-3-(p-

tolyl)propanoate (7b’). The compound was prepared according to the general procedure and
purified by silica gel column chromatography (hexane/ethyl acetate = 13:1). The title product was
isolated as a colorless oil (0.36 g, 21%) from the reaction of 4-methylbenzophenone (1.18 g, 6.01
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mmol, 1.0 equiv) and EDA (1.45 mL, 12.02 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.17
mL, 1.20 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 7.98 (d, J = 10.0 Hz, 2H), 7.88 (d, J = 5.0 Hz, 1H), 7.55 (t, J =

7.5 Hz, 1H), 7.44 (q, J = 7.5 Hz, 4H), 7.37 (t, J = 7.5 Hz, 1H), 7.31 (d, J = 10.0 Hz, 3H), 7.24 (d,
J = 10.0 Hz, 2H), 7.18 (d, J = 5.0 Hz, 2H), 5.61 (s, 1H), 5.59 (s, 1H), 4.26-4.22 (m, 4H), 2.40 (s,
2H), 2.34 (s, 3H), 1.26 (t, J = 6.0 Hz, 6H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 193.5, 192.9, 169.0, 168.9, 144.5, 137.9, 135.8, 133.5, 133.3,

133.2, 130.0, 129.6, 129.4, 129.1, 128.9, 128.8, 128.8, 128.1, 66.1, 66.0, 61.7, 60.5, 60.2, 21.7,
21.2, 14.1, 14.0.
HRMS (ESI/Q-TOF): Calculated (m/z) for C18H19O3 (M+H)+ : 283.1329, Found 283.1264.
Ethyl 2-(4-methoxyphenyl)-3-oxo-3-phenylpropanoate (34c) and ethyl 3-(4-methoxyphenyl)-3oxo-2-phenylpropanoate (34c’).[184a] The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 9:1). The title
product was isolated as a colorless oil (0.36 g, 22%) from the reaction of 4-methoxybenzophenone
(1.15 g, 5.42 mmol, 1.0 equiv) and EDA (1.31 mL, 10.84 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.15 mL, 1.08 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 7.99-7.95 (m, 4H), 7.55 (t, J = 6.0 Hz, 2H), 7.44 (t, J = 6.0 Hz,

4H), 7.37-7.28 (m, 4H), 6.90 (d, J = 9.0 Hz, 4H), 5.58 (s, 1H), 5.57 (s, 1H), 4.24 (q, J = 7.5 Hz,
4H), 3.86 (s, 3H), 3.80 (s, 3H), 1.29-1.24 (m, 6H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 193.6, 191.8, 169.1, 169.0, 163.8, 159.4, 135.7, 133.4, 133.4,

131.3, 130.7, 129.5, 129.9, 128.8, 128.7, 128.6, 128.0, 125.0, 114.3, 113.9, 61.7, 60.3, 59.7, 55.5,
55.2, 14.1, 14.0.
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Ethyl 3-(4-chlorophenyl)-3-oxo-2-phenylpropanoate (34d) and ethyl 2-(4-chlorophenyl)-3-oxo3-phenylpropanoate (34d’). [184b] The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 9:1). The title
product was isolated as a colorless oil (trace amount) from the reaction of 4-chlorobenzophenone
(1.21 g, 5.58 mmol, 1.0 equiv) and EDA (1.35 mL, 11.16 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.15 mL, 1.12 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 7.98-7.90 (m, 2H), 7.46-7.35 (m, 8H), 5.60 (s, 0.3H), 5.55 (s,

0.7H), 4.28-4.21 (m, 3H), 1.29-1.24 (m, 5H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 192.1, 168.5, 140.0, 134.0, 133.7, 132.7, 130.9, 130.3, 129.5,

129.1, 129.0, 128.9, 128.9, 128.8, 128.3, 128.2, 62.0, 61.9, 60.6, 59.7, 14.0.
Ethyl 2-(3,4-dimethylphenyl)-3-oxo-3-phenylpropanoate (34f). The compound was prepared
according to the general procedure and purified by silica gel column chromatography
(hexane/dichloromethane = 1:1). The title product was isolated as a colorless oil (0.50 g, 30%)
from the reaction of 3,4-dimethylbenzophenone (1.18 g, 5.61 mmol, 1.0 equiv) and EDA (1.36
mL, 10.22 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.15 mL, 1.12 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 7.49-7.31 (m, 6H), 7.15-7.07 (m, 2H), 5.24 (s, 1H), 4.38-4.24 (m,

2H), 2.24 (s, 3H), 2.28 (s, 3H), 1.21 (t, J = 7.5 Hz, 2H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 169.8, 168.2, 153.4, 152.2, 139.6, 138.3, 137.1, 136.9, 130.3,

130.2, 130.0, 130.0, 129.8, 129.7, 129.4, 129.2, 128.7, 128.6, 128.6, 127.1, 126.9, 126.4, 126.2,
124.8, 99.6, 99.5, 64.2, 19.8, 19.7, 13.8.
HRMS (ESI/Q-TOF): Calculated (m/z) for C19H21O3 (M+H)+ : 297.1485; Found 297.1474.
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Ethyl 2-(3,4-dimethoxyphenyl)-3-oxo-3-phenylpropanoate (34g). [184c] The compound was
prepared according to the general procedure and purified by silica gel column chromatography
(dichloromethane). The title product was isolated as a colorless oil (0.43 g, 28%) from the reaction
of 3,4-dimethoxybenzophenone (1.15 g, 4.75 mmol, 1.0 equiv) and EDA (1.15 mL, 9.50 mmol,
2.0 equiv) in the presence of HBF4∙OEt2 (0.13 mL, 0.95 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 7.99 (d, J = 5.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 2H), 7.45 (t, J = 7.5

Hz, 4H), 6.95 (d, J = 10.0 Hz, 2H), 6.86 (d, J = 10.0 Hz, 4H), 5.56 (s, 1H), 4.24 (q, J = 5.0 Hz,
4H), 3.89 (s, 3H), 3.87 (s, 3H), 1.27 (t, J = 5.0 Hz, 2H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 193.5, 169.0, 149.2, 149.0, 135.8, 133.5, 128.9, 128.7, 125.4,

122.1, 112.5, 111.2, 61.7, 60.0, 56.0, 55.8, 30.9, 14.1.
Ethyl 2-(naphthalen-2-yl)-3-oxo-3-phenylpropanoate (34h). The compound was prepared
according to the general procedure and purified by silica gel column chromatography
(hexane/ethyl acetate = 20:1). The title product was isolated as a colorless oil (0.34 g, 23%) from
the reaction of 2-naphthyl phenyl ketone (1.08 g, 4.65 mmol, 1.0 equiv) and EDA (1.12 mL, 9.30
mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.13 mL, 0.93 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 8.29 (s, 1H), 7.97-7.88 (m, 6H), 7.65-7.60 (m, 2H), 7.58-7.7.51

(m, 3H), 4.29-4.23 (m, 3H), 1.31 (t, J = 7.5 Hz, 3H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 196.7, 169.8, 137.9, 135.3, 134.8, 132.4, 132.3, 131.9, 130.1,

129.4, 128.4, 128.3, 127.8, 126.8, 125.8, 68.2, 61.1, 14.2.
HRMS (ESI/Q-TOF): Calculated (m/z) for C21H19O3 (M+H)+ : 319.1329, Found 319.1365.
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Ethyl 2-ethyl-3-oxopentanoate (35a). [184d] The compound was prepared according to the
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1).
The title product was isolated as a colorless oil (0.53 g, 52%) from the reaction of 3-pentanone
(0.51 g, 5.92 mmol, 1.0 equiv) and EDA (1.43 mL, 11.84 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.16 mL, 1.18 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.09 (q, J = 6.0 Hz, 2H), 3.28 (t, J = 7.5 Hz, 1H), 2.49-2.42 (m,

2H), 1.78 (t, J = 7.5 Hz, 2H), 1.17 (t, J = 6.0 Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H), 0.82 (t, J = 7.5 Hz,
3H).
Ethyl 3-oxo-2-propylhexanoate (35b). The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The
title product was isolated as a colorless oil (0.45 g, 50%) from the reaction of 4-heptanone (0.52
g, 4.53 mmol, 1.0 equiv) and EDA (1.43 mL, 9.06 mmol, 2.0 equiv) in the presence of HBF4∙OEt2
(0.13 mL, 0.91mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.15 (q, J = 7.5 Hz, 2H), 3.41 (t, J = 6.0 Hz, 1H), 2.52-2.43 (m,

2H), 1.82-1.78 (m, 2H), 1.59 (q, J = 7.5 Hz, 2H), 1.24 (t, J = 6.0 Hz, 5H), 0.91-0.86 (m, 6H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 205.3, 169.9, 61.1, 58.9, 43.6, 30.2, 20.7, 16.9, 14.0, 13.8,

13.5.
HRMS (ESI/Q-TOF): Calculated (m/z) for C11H21O3 (M+H)+ : 201.1485; Found 201.1478.
Ethyl 2-butyl-3-oxoheptanoate (35c). [184e] The compound was prepared according to the
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1).
The title product was isolated as a colorless oil (0.38 g, 47%) from the reaction of 5-nonanone

184

(0.51 g, 3.59 mmol, 1.0 equiv) and EDA (0.87 mL, 7.18 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.10 mL, 0.72 mmol, 0.2 equiv).
1

H NMR (CDCl3, 500 MHz): δ 4.14-4.11 (m, 2H), 3.36 (t, J = 7.5 Hz, 1H), 2.51-2.41 (m, 2H),

2.33 (t, J = 5.0 Hz, 1H), 1.78-1.75 (m, 2H), 1.51-1.47 (m, 2H), 1.27-1.24 (m, 3H), 1.22-1.18 (m,
3H), 0.85-0.81 (m, 6H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 205.3, 169.9, 61.0, 59.1, 42.4, 41.4, 29.5, 27.8, 25.9, 25.5,

22.3, 22.1, 14.0, 13.7.
Ethyl 2-acetylhexanoate (35d) and ethyl 2-methyl-3-oxoheptanoate (35d’). [184f] The compound
was prepared according to the general procedure and purified by silica gel column chromatography
(hexane/ethyl acetate = 50:1). The title product was isolated as a colorless oil (0.51 g, 55%) from
the reaction of 2-hexanone (0.50 g, 4.99 mmol, 1.0 equiv) and EDA (1.20 mL, 9.98 mmol, 2.0
equiv) in the presence of HBF4∙OEt2 (0.14 mL, 1.0 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.24-4.20 (m, 4H), 3.53 (q, J = 7.5 Hz, 1H), 3.41 (t, J = 7.5 Hz,

1H), 2.63-2.48 (m, 1H), 2.25 (s, 3H), 1.85-1.81 (m, 2H), 1.61-1.57 (m, 3H), 1.36-1.28 (m, 15H),
0.94-0.91 (m, 6H).
13

C{1H} NMR (CDCl3, 125 MHz): δ 206.0, 203.4, 170.6, 169.9, 61.2, 59.9, 41.0, 29.5, 28.7, 27.9,

25.6, 22.4, 22.2, 14.1, 14.0, 13.8.
Ethyl 2-acetyldecanoate 35e.[184g] The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The
title product was isolated as a colorless oil (0.36 g, 44%) from the reaction of 2-decanone (0.53 g,
3.39 mmol, 1.0 equiv) and EDA (0.89 mL, 6.78 mmol, 2.0 equiv) in the presence of HBF4∙OEt2
(0.09 mL, 0.68 mmol, 0.2 equiv).
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1

H NMR (CDCl3, 300 MHz): δ 4.21 (q, J = 7.5 Hz, 2H), 3.41 (t, J = 7.5 Hz, 1H), 2.23 (s, 3H),

1.85 (s, 2H), 1.31-1.27 (m, 15H), 0.89 (t, J = 6.0 Hz, 3H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 203.4, 170.0, 61.2, 60.0, 31.8, 29.3, 29.3, 29.2, 28.7, 28.2,

27.4, 22.6, 14.1, 14.1.
Ethyl 2-acetyldecanoate (35e’). The compound was prepared according to the general procedure
and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The title product
was isolated as a colorless oil (0.16 g, 20%) from the reaction of 2-decanone (0.53 g, 3.39 mmol,
1.0 equiv) and EDA (0.89 mL, 6.78 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.09 mL, 0.68
mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 5.32 (s, 1H), 4.32-4.13 (m, 2H), 3.52 (q, J = 7.5 Hz, 2H), 2.24 (s,

3H), 1.62 (s, 4H), 1.38-1.36 (m, 13H), 1.38 (t, J = 7.5 Hz, 3H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 203.3, 170.0, 61.2, 60.0, 32.0, 29.3, 29.2, 28.7, 28.2, 27.4,

22.6, 14.1.
HRMS (ESI/Q-TOF): Calculated (m/z) for C14H27O3 (M+H)+ : 243.1955; Found 243.1940.
Ethyl 5-methyl-3-oxohexanoate (35f). [184h] The compound was prepared according to the
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1).
The title product was isolated as a colorless oil (0.56 g, 55%) from the reaction of 3-methylbutanal
(0.51 g, 5.92 mmol, 1.0 equiv) and EDA (1.43 mL, 11.84 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.16 mL, 1.2 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.20-4.08 (m, 2H), 3.38 (s, 2H), 2.39 (d, J = 6.0 Hz, 2H), 2.18-

2.11 (m, 1H), 1.25 (t, J = 6.0 Hz, 3H), 0.92-0.88 (m, 6H).
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Ethyl 3-oxooctanoate (35g). [185f] The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The
title product was isolated as a colorless oil with hexane (0.60 g, 62%) from the reaction of hexanal
(0.52 g, 5.19 mmol, 1.0 equiv) and EDA (1.43 mL, 10.38 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.14 mL, 1.04 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.19 (q, J = 6.0 Hz, 2H), 3.42 (s, 2H), 2.53 (t, J = 7.5 Hz, 2H),

1.61-1.59 (m, 2H), 1.29-1.25 (m, 4H), 0.88-0.82 (m, 3H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 203.0, 167.3, 61.3, 49.3, 43.0, 31.9, 31.2, 29.7, 23.2, 22.7,

22.4, 14.1, 13.9.
Ethyl 3-oxodecanoate (35h). [184i] The compound was prepared according to the general
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The
title product was isolated as a colorless oil with hexane (0.70 g, 82%) from the reaction of octanal
(0.51 g, 3.98 mmol, 1.0 equiv) and EDA (0.96 mL, 7.96 mmol, 2.0 equiv) in the presence of
HBF4∙OEt2 (0.11 mL, 0.80 mmol, 0.2 equiv).
1

H NMR (CDCl3, 300 MHz): δ 4.91 (q, J = 7.5 Hz, 2H), 3.16 (s, 1H), 2.28 (t, J = 7.5 Hz, 1H),

1.32 (s, 2H), 1.03-0.98 (m, 15H), 0.62 (d, J = 6.0 Hz, 6H).
13

C{1H} NMR (CDCl3, 75 MHz): δ 201.7, 166.5, 88.2, 60.1, 48.3, 41.9, 31.0, 28.4, 28.3, 28.3,

22.7, 21.9, 13.2, 13.2.
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Part C: Exploring 18-Crown-6-ether complex as a Bronsted
Acid catalyst
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6.1 Introduction
Macrocyclic ether containing scaffolds have been used to estimate cationic recognition and
selective cation binding using different physical approaches such as filtration, absorption etc. [175177] which was used for the detection of cations such as Li+ , Na+ , K+ , and Rb+ as well as
perchlorates by the help of fluorescence spectroscopy. [178-179] Several crown ether complexes
have been synthesized so far because of its synthetic application in different fields such as trapping
metal ion in commercial waste container, as an additive in the asymmetric synthesis, to prepare
soluble ionic liquids etc.
A class of commercially available 18-crown-6 ether is shown in the Figure 14A. As part of our
ongoing research on the synthesis and reactivity of 18-crown-6 ether cationic complexes, we have
recently isolated the cis-syn-cis and cis-anti-cis isomers of dicyclohexano-18-crown-6 as their
hydronium cationic salts using Tf2NH super acids for the first time. However, this type of
complexes was separated before using K+ and NH4+ as a choice of cation. The uniqueness of this
isolation of such crown complexes with specific geometry of cyclohexyl group may distinctly
function for synthetic applications (Figure 14B).
There are data in the literature for the stability constants of the cis-syn-cis and cis-anti-cis isomers
of dicyclohexano-18-crown-6 with different alkali- and alkaline-earth metal cation salts in water
and in methanol, [185-188] and for potassium picrate in dichloromethane (picrate = 2,4,6trinitrophenolate). [189] However, explanation of the effect of the pendent hydronium ion as an
available proton source (which is related to the association constant) instead of alkali metal has
remained underdeveloped. In 1995 Bartsch et al introduced an excellent approach for more
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accessibility of one form of coordinated hydrogen compared to other. [190] It should be added that
host-guest association in organic media of low polarity imposes requirements different from those
found for the association in polar solvents.
To understand the influence of stereochemical availability of proton, we decided to screen our
complexes as a proton donor (Brønsted acid) catalyst in an organic reaction. In 2004, Hossain’s
group reported a coupling reaction of Ethyl diazoacetate (EDA) with aromatic aldehyde in
presence of tetrafluoroboric acid diethyl ether complex (HBF4.OEt2) as a Brønsted acid catalyst.
[132] We plan to study the same coupling reaction by replacing HBF4.OEt2 with our crown
complex A/B to determine the catalytic strength and scope of this reaction in organic synthesis. In
Figure 14 Commercially available predominant isomers of Dicyclohexyl-18-crown-6-ether
complexes

(A)
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B) Isolated protonated complex having specific geometrical structures

C) Geometry of the crown ether before protonation

this regard, we investigated the reaction of EDA with different aromatic aldehydes in the presence
of complex A and complex B (Scheme 88). We focused mainly on the accessibility of the
hydrogen ion of the complex instead of optimizing the percentage yield of the reaction. Therefore
different equivalent of complex A and B have been explored instead of choosing different solvent
systems or coupling partners.
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6.2 Results and Discussions
The results obtained from the screening of both complex A and complex B has summarized in
Table 14. At room temperature, in the presence of 0.12 equiv of complex A, benzaldehyde with 2
equiv of EDA provided a decent percentage of yield (52%) of hydroxy acrylate, 1a (Table 14,
Scheme 88 Preparation of 3-hydroxy-2-aryl acrylates from the reaction of aromatic
aldehydes and EDA catalyzed by complex A and complex B

Table 14 Optimization results of effectivity of Crown-ether complex A and B on exploring
coupling between EDA and Carbonyl compounds
Entrya

1
2
3
4
5

Carbonyl
compound

1a

6
7

1b

8b
9b

Complex

Temp
(℃)

A
A
Ad
Ae
Bf

rt
0
rt
rt
rt

A

rt

B

rt

A

rt

3-hydroxyacrylate

2a
2a

% yieldc

52
28
51
10
trace
71

2b
2b

17

N/R
2c

1c

B

rt

200

2c

N/R

a

1 equiv of substrate was reacted with 2 equiv of EDA (added dropwise over 20-30 mins) in the presence of 0.12 equiv

of catalyst complex and stirred for an additional 14h at that temperature unless otherwise stated. b the reaction was
allowed to stir for an additional 12h. c an unidentified compound was isolated about 5-10%. d 0.25 equiv of catalyst A
used. e 0.05 equiv of catalyst A used. f 0.05, 0.12 & 0.25 equiv of catalyst B used.

entry 1). Lowering the temperature reduced the yield of the product to 28% (Table 14, entry 2).
Increasing catalyst loading did not improve yield of the product (Table 14, entry 3 vs entry 1);
whereas, decreasing amount of the catalyst loading from 0.12 equiv to 0.05 equiv significantly
reduced the yield of the product (Table 14, entry 4 vs entry 1). Coupling reaction with
benzaldehyde and EDA in the presence of Complex B resulted trace amount of 1a (Table 14, entry
5). With complex A, electron rich para-methoxybenzaldehyde gave better yield (71%) of acrylate
2a (Table 14, entry 6). We believe that happen due to formation of stable carbocation during the
1,2-aryl migration. Very poor yield of 2a was obtained when the reaction was done with complex
B (Table 14, entry 7). Electron deficient ortho-nitrobenzaldehyde provided no product of 3a in
presence of complex A or complex B (Table 14, entries 8-9). Compounds having electron
withdrawing group might destabilized the carbocation during migration and resulted trace or no
product formation. It should be added that use of benzophenone with both the complex A and B at
-78-rt with the same reaction condition ended up with trace or no product.
Based on the mechanism proposed by Hossain et al, to start the reaction, protonation of carbonyl
oxygen of benzaldehyde is required followed by the nucleophilic attack of EDA. [132] It is very
likely that the carbonyl group of aromatic aldehydes could easily binds to the proton from the less
crowded face of the cis-syn-cis of complex A, [190] which initiated the reaction to form the
products. Whereas cis-anti-cis configuration of catalyst B may hinder the binding of the proton to
the incoming carbonyl compounds. As a result, there was little, or trace amount of product
formation was observed.
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There are few catalysts are known to give selective formation of 3-hydroxyacrylates from the
reaction of aromatic aldehydes and EDA. [149-150] In most of the cases, the acrylates form along
with β-keto esters4 or exclusively the latter compound. [191] Therefore, the use of crown ether
complex A as a catalyst, would be an additional finding for the selective synthesis of acrylates.
The possibility of preparing such prochiral molecules is pivotal for the synthesis of
pharmaceutically important scaffold as shown in Figure 15. [192, 88]

Figure 15 Application of acrylate for the preparation of pharmaceutically
important compounds
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6.3 General procedure for the synthesis of 3-hydroxy arylacrylates
For each experiment, carbonyl compounds (3.5-8.0 mmol, 1.0 equiv) was dissolved in 10-20 mL
of freshly distilled dichloromethane under nitrogen at -78 oC. A Brønsted acid, HBF4∙OEt2 catalyst
(0.18-2.0 mmol, 0.05-0.25 equiv) was added, and the reaction mixture was stirred for 1 hour at the
same temperature. Ethyl diazoacetate (EDA) (7.0-16.0 mmol, 2.0 equiv) was diluted in 5 mL of
freshly distilled dichloromethane and added to the solution over a period of 0.5-1 h. Then, the
reaction mixture was allowed to stir for 24-72 h at room temperature (depending on the substratearomatic aldehydes have ran for 24 h and the ketones have run until up to 3 days). After completion
of the reaction, it was quenched by adding THF and Na2SO4 had added to resolve the problem
associated with unreacted EDA. The reaction mixture was filtered through a silica plug using
dichloromethane as solvent and the solvent removed by rotary evaporation. Pure products were
isolated by silica gel column chromatography with 5-20% ethyl acetate in hexane.
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Chapter 2 Investigation of C2-alkylation of N-protected Gramine
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7.1 Introduction
An indole core with an alkyl substituent in the C2-position serve as precursors for a variety of
medicinally important alkaloids and their analogs.[193] Some of the representative examples are
Indomethacin 1 (non-steroidal anti-inflammatory drug commonly used for the treatment of
rheumatoid arthritis)[194], Tryprostatin A 2 (act as a breast cancer resistance protein
inhibitor)[195] and Tryprostatin B 3 (act as a microtubule inhibitor)[196], Neoechinulin A 4
(shows anti-nitration, antioxidant and cytoprotective activity against peroxynitrite from SIN-1 in
PC12 cells)[197], and Arbidol 5 (used the treatment of influenza infection)[198] (Figure 16). Due
to the weak reactivity of the C–H bond at the C2-position of an indole and the possibility of
metalation on the aromatic ring, C2–H alkylation of indoles are still challenging for chemists.[199]
Therefore, strong bases like nBuLi, secBuLi, tBuLi, LDA etc. was used as a deprotonation source
to obtain information concerning the position of attack by this organometallic compound either on
indole or some of its derivatives.
Figure 16 Important biologically active natural products containing C2-substituted indole
moiety
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7.1.1 Concepts on the C2-alkylation of Indole/ phenothiazine/N-carboxy
protected indole
Gilman and Sengupta introduce the lithiation chemistry in hetero-cyclic nuclei, explained the way
of metalation happen which is quite different from ordinary electrophilic substitution
processes.[200] Treatment of the indole with excess (up to 4 equiv) of n-BuLi could not introduce
anything next to the heteroatom nitrogen (at C2 position) which is in sharp contrast to the study
based on carbazole. The reason is the more acidic proton of -N-H comes out first and thus the
metalation are evident in that place. But Metalation of aromatic phenothiazine was successfully
resulted due the introduction of carboxy group to the N-H to induce a lithiation on that position.
As a result, they got an alkylation in C-1 position of the aromatic ring Scheme 89a. [201] Which
means the presence of sulfur/oxygen might enhanced the acidity of the C1 proton and thus get
alkylated. In case of less reactive indole, it is due to the stabilization of the anion shown in the
following Scheme 89b.
Scheme 89 Stabilization of the indole ring due to resonance

The early attempt of carbamate strategy shown by Akutagawa et al in 1986, was basically a one
pot method of preparing 2-substituted indole derivatives. [202] Indole was first converted to the
lithium carbamate by sequential treatment with n-BuLi in THF, followed by CO2. Then the
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lithiation of the lithium carbamate at the C2 position was achieved with 1.2 equivalent of t-BuLi
at -20 oC (Scheme 90). Addition of the electrophile at -70 oC and worming it up to room
temperature for several hours primarily formed the crude product mixture. An aqueous acid
treatment followed by gentle worming deprotected the product from CO2 and thus gave the desired
C2 substituted indoles 6 in good to excellent yield (52-86%)
Scheme 90 C2 alkylation of indole moiety after carboxy induce lithiation assistance
Electrophile,

nBuLi, CO2,
N
H

tBuLi

E

Li
N
LiO

N
H

H3O+, heat
O

6

The interesting things to notice about the carbamate directed lithiation method is its expansion
scope of alkylation to the β-aliphatic and β-aromatic carbons. Therefore, unlike other methods for
directing lithiation the carbamate anion route is not restricted to those patterns where the carbanion
present α to the nitrogen heteroatom and thus both the β-aliphatic and β-aromatic carbons have
been successfully lithiated. For an instance when 2-alkylindoles 7 protected by lithium carbamate
it can be lithiated on the α-carbon of the alkyl side chain which is β to the nitrogen to form product
9 as shown by exemplifying the following Scheme 91.
Scheme 91 C2 alkylation at the β-aliphatic position from the heteroatom (nitrogen)

Even though the carbanion can be delocalized in to the 3-position of the indole ring to give
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substitution at the C3 position, the only product observed at the aliphatic carbon. The addition of
a substituent at the 3-position disfavors this delocalization and lithiation fails to occur with 2,3dialkylindoles other than the exception of 2,3-dimethylindole. Because of the enhance acidity of
methyl groups compared to another alkyl permits deprotonation to occur.
Here the carbamate groups provide some assistance to lithiation by prior coordination to the
lithiated species, but their main mode of action appears to be by dipole stabilization of the lithiated
species once formed. The dipolar effect of the carbamate anions is not as strong as other systems
such as nitrosamines, formamidines and oxazolidines and cannot be used for the asymmetric
allylation as well. The advantage for the carbamates is their convenience (one pot procedure and
available reagents) and versatility (for protection, main nucleophilic attack/reaction and
deprotection) of accomplishing the completion of the reaction readily. The scope of the carbamate
reaction is the electron rich heterocyclic system that can form relatively stable carbamate
derivatives.
In brief a summary can be drawn from the above discussion that the formation of carbanion due to
the deprotonation over the assistance of heteroatoms can occur in at least four distinct
environments. One such example can be shown based on simple pyridine moiety.
a. A ring: CH which is α-to the heteroatom
b. An exocyclic CHXY linkage attached α or ϒ to a pyridine-link nitrogen
c. A CHXY directly attached to the pyrrole like link nitrogen atom
d. The Ortho position of the aromatic ring α-to the ring nitrogen.
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7.1.2 Precedence for C2-alkylation of BOC-protected gramine
A breakthrough came when the Hossain’s group developed an unprecedented incorporation of
prenyl group at the C-2 position of (3-(dimethylaminomethyl)indole) (commercially named as
gramine) in 2019 during the concise total synthesis of Tryprostatin B (Scheme 92). [203] The idea
was executed by using a BOC protection of the more acidic nitrogen of the indole ring and then
by conducting the lithiation using n-BuLi as a base to pull out the proton from the C2 position.
Scheme 92 Precedence of C2-prenylation of BOC-protected Gramine

This unusual procedure opens a new window to explore a variety of N-protected gramine’s to
synthesize C2 substituted gramine salts by subsequent reactions with electrophiles which might be
potentially effective for framing biologically and pharmaceutically important compounds. In our
present research, we have examined several protecting groups and electrophiles to investigate the
scope of this reaction and to probe the reaction mechanism.

7.2 Results and Discussions
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At first, we decided to screen various N-protecting groups, make sure the effect of the protecting
group on the C2-alkylation more precisely C-2 metalation. Our attempt of screening focused on
the direct protection of the indole nitrogen of the commercially available compound 24 (Scheme
93). We believe there might be a directing effect of certain protecting group for inducing alkyl
group exactly on the C2 position. One step protection using TIPS group resulted the desired
compound 25a with 84% yield but the product 25b and 25c obtained with very low yield. We
therefore tried to confirm the reason why we are not getting the tosyl protection with better

Scheme 93 Protection of heteroatom nitrogen of gramine

Entrya
1
2
3

PG
(1.1‐1.2 equiv)
TIPS(TIPS‐Cl)
Tosyl (TsCl)
Mesyl (MsCl)

Solvent

Base
(1.5‐2 equiv)
NaH
NaH
NaH

DCM
ACN
ACN

a

Yield (%)
84
18
21

All reactions have carried out from 4-8 mmol scale, NaH added at -78 oC and the protecting reagents have added
after 45-60 minutes and the reactions bought to the room temperature, each reactions have done several times
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conversion. We have observed that during preparing the N-tosyl gramine the reaction also forming
another compound N, N-dimethyl sulfonamide 25b’ 35% of isolated yield which means
compound 25b is not stable under strong basic condition. The base NaH might pull the electron
next to the tertiary amine nitrogen heteroatoms and forcing the pair of electrons throughout the
aromatic system to finally retouch the tosyl group to form such byproduct 25b’.
Therefore, we decided to explore a new route to protect the indole-3-carboxaldehyde compound
26 first and then to convert that to gramine by reductive amination reaction. It should be mentioned
that commercially there are very few gramine is available with different substituent on the aromatic
ring but if we can prepare gramine from Indole 3-carboxaldehyde it would be beneficial for
exploring lot of gramine analogues. Initially, we considered three protecting group -Ts, -Ms and Me (Scheme 94); out of that methyl gave a very good productivity of 80% isolated
yield (compound 27d). For the mesyl protection we obtained about 64% of desired product, 27c
but the tosyl protection was limited to 30% product 27a formation. We then thought to switch the
base from NaH to relatively mild organic base DIPEA for tosyl protection and successfully
isolated 80% of the product 27b. Surprisingly the reductive amination to form N-protected
gramine did not work good with the tosyl protection and obtained 25b with 27% isolated yield,
but the reaction went well with mesyl and methyl protections.
After getting couple of N-protected gramine compounds in hand we started studying the C2alkylation using prenyl bromide and benzyl bromide as electrophile in presence of n-BuLi as
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Scheme 94 Two-step alternative route to prepare N-protected gramine

a lithiating agent (Scheme 95). It is expected that the monoalkylated salt would form first due to
the lone pair electron of nitrogen on the amine and then the nucleophilic C2 carbon attacks the
electrophile to form C-C bond by the extrusion of the leaving group. Surprisingly, we have got
only monoalkylated salt (28a, 28c, 28d) for methyl and TIPS, mesityl protected gramine even we
have screened different equivalent of n-BuLi (from 2-4 equiv). It should be mentioned that Iwao et
al reported lithiation at C-2 position by using N-methyl tyramine in the presence of tBuLi in ether
at 0 oC. [204] The anomaly of the two findings may be because of the use of stronger base and
different type of electrophiles than us. However, tosyl protection gave a mixture of monoalkylated
product 28b and 28b’ which could not be separated successfully by column chromatography.
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Scheme 95 C2-alkylation of N-protected gramine

a

Entrya

PG

Electrophile

1

TIPS

2
3

Tosyl
Mesyl

4

Methyl

Prenyl bromide
Benzyl bromide
Prenyl bromide
Prenyl bromide
Benzyl bromide
Prenyl bromide
Benzyl bromide

cpd 28 : cpd 29
(Overall yield%)
100 : 0 (60%)
100 : 0 (56%)
65 : 35 (40%)
100 : 0 (44%)
100 : 0 (35%)
100 : 0 (64%)
100 : 0 (52%)

all reactions have carried out from 2-5 mmol quantity, n-BuLi was added at -78 oC and the protecting reacgent had

added after 60-90 minutes of lithiation, overnight

Then we decided to do a deuteration study to see whether the proton from C2 had pulled out by the
base or it remains intact even after introducing a strong base like n-BuLi. Running the study with
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N-Me gramine we have seen no deuteration even after 24 h waiting after quenched
with MeOD. Similar reaction was performed with the N-tosyl gramine and n-butyllithium in THF,
quenching with MeOD, location of the deuterium incorporation was calculated by analysis of the
mass spectrum and 1H NMR (Scheme 96 and SI). In 1H NMR, the singlet of the C-2 position for
H was diminished by the incorporation of D and the percentage of D incorporation was calculated
91% based on 1H NMR.
Scheme 96 Deuteration study of N-tosyl and N-Me protected gramine

In summary, we have so far got some idea about the assistance of the protecting group especially
the tosyl group which has similar nature like CO2 in indole protection. Therefore. the lone pair on
the oxygen present in the tosyl group might help initial lithiation then the electrophilic attack on
that specific position. Mesyl group on the other side should show the assistance but it is not
happening may be because of the less donating and non-resonating methyl group instead of the
aromatic participation of the phenyl group. The idea also justified when the methyl protection did
not work with the procedure. However, the bulkiness of the TIPS group could not direct the
lithiation rather stopped that completely.
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7.3 General methods and experimental
7.3.1 General procedure for the N-protection of gramine
20 ml of DCM was added to 1 gm (5-10 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,Ndimethylmethanamine and stirred for 5 minutes to dissolve. Then the bright yellow
solution bought to -78 oC using dry ice-acetone bath. By the time the solution reached
the desired temperature, we have washed the NaH (containing mineral oil) by hexane and weighed
0.275-0.30 g (11.46 mmol, 2.0-2.1 equiv). Added the NaH to the reaction flask and stirred for an
hour at -78 oC. Then we have added 6.876 mmol, 1.2 equiv protecting reagent all at once. The
reaction was monitored by TLC for completion and the desired product 25 was isolated by column
chromatography using 10-20% EtOAc in hexane as oily liquid.
Synthesis of N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanamine (25a)
20 ml of DCM was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,Ndimethylmethanamine and stirred for 5 minutes to dissolve. Then the bright yellow
solution bought to -78 oC using dry ice-acetone bath. By the time the solution reached
the desired temperature, we have washed the NaH (containing mineral oil) by hexane and weighed
0.275 g (11.46 mmol, 2.0 equiv). Added the NaH to the reaction flask and stirred for an hour at 78 oC. Then we have added 1.33 g (6.876 mmol, 1.2 equiv) triisopropropylsilyl chloride all at
once. The reaction was monitored by TLC for completion and 1.60 g of the desired
product 25a was isolated by column chromatography using 10-20% EtOAc in hexane as a light
beige oily liquid.
1

H NMR (CDCl3, 500 MHz): δ 7.70 (t, J = 7.5 Hz, 1H), 7.51 (t, J = 7.5 Hz, 1H), 7.18 (m, s, 1H),

7.16 (dd, J = 10 Hz, 5 Hz, 2H), 3.66 (s, 2H), 2.30 (s, 6H),1.78 – 1.71 (m, 3H), 1.67 (d, J = 10 Hz,
18H).
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13

C NMR (CDCl3, 75 MHz): δ 141.3, 131.4, 130.5, 121.4, 119.6, 119.2, 115.1, 113.9, 54.7, 18.2,

12.9.
N,N-dimethyl-1-(1-tosyl-1H-indol-3-yl)methanamine (25b)
20 ml of acetonitrile was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,Ndimethylmethanamine and stirred for 5 minutes to dissolve. Then the solution was bought to 78 oC using dryice-acetone bath. By the time the solution reached the desired temperature, we have
washed the NaH (containing mineral oil) by hexane and weighed 0.275 g (11.46 mmol, 2.0 equiv).
Added the NaH to the reaction flask and stirred for an hour at -78 oC. Then we have added 1.31 g
(6.876 mmol, 1.2 equiv) 4-toluenesulfonyl chloride all at once. The reaction was monitored by
TLC for completion and 0.34 g of the desired product 25b was isolated by column
chromatography using 20-30% EtOAc in hexane as a brown oily liquid.
1

H NMR (CDCl3, 300 MHz): δ 8.03 (d, J = 9.0 Hz, 1H), 7.76 (t, J = 9.0 Hz, 1H), 7.65 (d, J = 9.0

Hz, 1H), 7.54 (s, 1H), 7.32 (t, J = 7.5 Hz, 1H), 7.22 (t, J = 7.5 Hz, 1H), 7.11 (d, J = 6.0 Hz, 2H),
3.52 (s, 2H), 2.23 (s, 6H), 2.21 (s, 3H).
N,N-dimethyl-1-(1-methyl-1H-indol-3-yl)methanamine (25c)
20 ml of acetonitrile was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,Ndimethylmethanamine and stirred for 5 minutes to dissolve. Then the solution bought to 78 oC using dry ice-acetone bath. By the time the solution reached the desired temperature, we
have washed the NaH (containing mineral oil) by hexane and weighed 0.275 g (11.46 mmol, 2.0
equiv). Added the NaH to the reaction flask and stirred for an hour at -78 oC. Then we have
added 0.43 ml (6.876 mmol, 1.2 equiv) methyl iodide dropwise within 5 minutes. The reaction
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was monitored by TLC for completion and 0.23 g of the desired product 25a was isolated by
column chromatography using 5-15% EtOAc in hexane as colorless oil.
1

H NMR (CDCl3, 500 MHz): d 7.92 (d, J = 10.0 Hz, 1H), 7.76 (d, J = 10.0 Hz, 1H),7.41-7.32 (m,

3H), 3.69 (s, 2H), 3.10 (s, 3H), 2.31 (s, 6H).
13

C NMR (CDCl3, 75 MHz): δ 135.4, 130.9, 125.0, 124.4, 123.5, 120.6, 120.1, 113.1, 54.5, 50.5,

45.6, 44.6, 40.6.
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7.3.2 General procedure for preparing N-protected 1H-indole-3-carbaldehyde
26
To a 20 ml of DCM solvent, we have added 1g (6.84 -13.7 mmol, 1 equiv) of 1H-indole-3carbaldehyde 26. After dissolving the starting material completely, we put the solution in a dry ice
acetone bath to set up the temperature at -78 OC. Then 0.25-0.30 g (10.3-12.0 mmol, 1.5-1.8 equiv)
of NaH was added after washing it with hexane. We let the reaction run for an hour and half and
then started adding 0.47 -1.20 mL (7.52 -10.25 mmol, 1.1-1.5 equiv) of protecting reagent
dropwise. The reaction left overnight for completion and quenched with water. The crude was then
separated in 2 later. The organic layer was collected, and the aq. layer washed with DCM two more
time. All the organic fractional gathered and rotavap. The crude was clean enough to carry out the
next step.

Synthesis of 1-tosyl-1H-indole-3-carbaldehyde (27b)
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5-1.8 equiv) of NaH was added
after washing it with hexane. We let the reaction run for an hour and half and then started adding
1.20 ml (8.20 mmol, 1.2 equiv) of Tosyl chloride dropwise. The reaction left overnight for
completion and quenched with water. The crude was then separated in 2 later. The organic layer
was collected, and the aq. layer washed with DCM two more time. All the organic fractional
gathered and rotavap. The crude was clean enough to carry out the next step.
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1

H NMR (CDCl3, 300 MHz): δ 10.1 (s, 1H), 8.37 (d, J = 9.0 Hz, 2H), 7.97 (d, J = 9.0 Hz, 1H),

7.87 (d, J = 9.0 Hz, 1H) 7.45-7.31 (m, J = 4H), 2.37 (s, 3H).
Synthesis of 1-(methylsulfonyl)-1H-indole-3-carbaldehyde (27c)
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5-1.8 equiv) of NaH was added
after washing it with hexane. We let the reaction run for an hour and half and then started adding
0.64 ml (8.20 mmol, 1.2 equiv) of methyl iodide dropwise. The reaction left overnight for
completion and quenched with water. The crude was then separated in 2 later. The organic layer
was collected, and the aq. layer washed with DCM two more time. All the organic fractional
gathered and rotavap. The crude was clean enough to carry out the next step.
1

H NMR (CDCl3, 500 MHz): δ 10.1 (s, 1H), 8.37 (d, J = 10.0 Hz, 2H), 8.14 (s, 1H), 7.92 (d, J =

5.0 Hz, 1H) 7.53-7.46 (m, J = 2H), 3.31 (s, 3H).
13

C NMR (CDCl3, 75 MHz): δ 186.5, 186.0, 138.3, 137.8, 125.9, 124.7, 123.6, 122.2, 122.00,

121.0, 118.7, 112.8, 111.7, 40.3.
Synthesis of 1-methyl-1H-indole-3-carbaldehyde (27d)
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5 equiv) of NaH was added after
washing it with hexane. We let the reaction run for an hour and half and then started adding 0.47
ml (7.52 mmol, 1.1 equiv) of methyl iodide dropwise. The reaction left overnight for completion
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and quenched with water. The crude was then separated in 2 later. The organic layer was collected,
and the aq. layer washed with DCM two more time. All the organic fractional gathered
and rotavap. The crude was clean enough to carry out the next step.
1

H NMR (CDCl3, 500 MHz): δ 10.3 (s, 1H), 8.34 (d, J = 10.0 Hz, 2H), 7.71 (s, 1H), 7.40-7.28

(m, 3H), 3.90 (s, 3H).
13

C NMR (CDCl3, 75 MHz): δ 184.4, 139.1, 125.3, 124.0, 123.0, 122.1, 118.1, 108.9, 33.7.

7.3.3 General procedure for the reductive amination of N-protected 1H-indole3-carbaldehyde 27
500 mg – 1000 mg of compound 27 (b-d) was added in 15-20 ml of MeOH solvent and bought it
to 0 OC by using an ice bath. When dissolved, 3 equiv of dimethylamine (in 2M THF) solution
was added all at once. The reaction ran for 3 - 4 h and added monitored by TLC until the starting
material disappear. While done with the TLC monitoring 1.1 equiv. of NaBH4 was added slowly
in 3 portions within 5 minutes. The reduction then ran for 1 hour for completion. The reaction was
quenched with water, methanol was removed by rotary evaporation and the organic fraction had
separated by extracting with EtOAc. The crude obtained as an oily liquid then purified with
MeOH: DCM (1:50) solvent mixture.
NMR for the final product 25a, 25b and 25c has attached to appendix A.
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7.3.4 General procedure for C2 alkylation of Gramine
Synthesis of N,N,3-trimethyl-N-((2-(3-methylbut-2-en-1-yl)-1-tosyl-1H-indol-3-yl)methyl)but-2en-1-aminium (28b/28b’)
A

solution

of N,N-dimethyl-1-(1-(methylsulfonyl)-1H-indol-3-yl)methanamine 25 (0.50

–

1.0 mmol) in THF (15 mL) was taken in three necked round bottomed flask and nitrogen was
bubbled through the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium
(0.40–0.72 mL,1.0 – 2.0 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction
mixture maintaining a temperature -78 °C over a period of 1 h under nitrogen atmosphere. Then
the electrophile (2.25-6.0 mmol, 4.5-6.0 equiv) was added to the reaction dropwise through the
dropping funnel over a period of 30 min. The reaction mixture was allowed to warm to room
temperature and was stirred overnight. After consumption of the starting material, as judged by
TLC analysis, water (5 mL) was added to the reaction mixture and THF was removed under
reduced pressure. The mixture was then extracted with CH2Cl2 (3 x 15 mL), the combined organic
layers were washed with brine solution (1 x 10 mL) and dried over anhydrous Na2SO4 and
evaporated in vacuo to obtain crude product. The residue was purified with flash column
chromatography on silica gel (DCM/MeOH = 25/1) to afford mixture of either monoalkylated
product 28 or a mixture of mono/dialkylated products (28/29).
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Synthesis of N,N,3-trimethyl-N-((1-tosyl-1H-indol-3-yl)methyl)but-2-en-1-aminium bromide
28b/ N,N,3-trimethyl-N-((2-(3-methylbut-2-en-1-yl)-1-tosyl-1H-indol-3-yl)methyl)but-2-en1-aminium bromide 29b
A solution of N,N-dimethyl-1-(1-tosyl-1H-indol-3-yl)methanamine 25b (0.2 g, 0.61 mmol) in
THF (15 mL) was taken in three necked round bottomed flask and nitrogen was bubbled through
the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium (0.47 mL,
1.22 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture maintaining a
temperature -78 °C over a period of 1 h under nitrogen atmosphere. Prenyl bromide
(0.32 mL, 2.745 mmol) was added to the reaction dropwise through the dropping funnel over a
period of 30 min. The reaction mixture was allowed to warm to room temperature and was stirred
overnight. After consumption of the starting material, as judged by TLC analysis, water (5 mL)
was added to the reaction mixture and THF was removed under reduced pressure. The mixture
was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed with brine
solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to obtain crude
product. The residue was purified with flash column chromatography on silica gel (DCM/MeOH
= 25/1) to afford mixture of 28b/29b as a brown oily liquid (27 %).
1

H NMR (CDCl3, 300 MHz): δ 8.24 – 8.21 (m, 1H), 8.22 (d, J = 3.0 Hz, 1H), 8.10 (d, J = 3.0 Hz,

2H), 7.61 (d, J = 9.0 Hz, 2H), 7.38 – 7.34 (m, 2H), 7.22 (d, J = 9.0 Hz, 2H), 5.35 (t, J = 10.5 Hz,
1H), 5.17 (s, 2H), 5.10 (s, 1H), 4.49 (d, J = 9.0 Hz, 2H), 3.93 (s, 2H), 3.47 (s, 2H), 3.10 (s, 6H),
2.37 (s, 3H), 2.08 (d, J = 12 Hz, 3H), 1.87 (d, J = 6.0 Hz, 6H), 1.79 (s, 3H), 1.64 (s, 3H), 1.27 (S,
6H), 0.91(d, J = 9.0 Hz, 3H)
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Synthesis of N-benzyl-N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanaminium
bromide (28a’)
A

solution

N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanamine

25a

(0.2 g, 0.61 mmol) in THF (15 mL) was taken in three necked round bottomed flask and nitrogen
was bubbled through the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium
(0.47 mL, 1.22 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture
maintaining a temperature -78 °C over a period of 1 h under nitrogen atmosphere. Prenyl bromide
(0.32 mL, 2.745 mmol) was added to the reaction dropwise through the dropping funnel over a
period of 30 min. The reaction mixture was allowed to warm to room temperature and was stirred
overnight. After consumption of the starting material, as judged by TLC analysis, water (5 mL)
was added to the reaction mixture and THF was removed under reduced pressure. The mixture
was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed with brine
solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to obtain crude
product. The residue was purified with flash column chromatography on silica gel (DCM/MeOH
= 25/1) to afford mixture of 28b/29b as a brown oily liquid (56 %).
1

H NMR (CDCl3, 500 MHz): δ 7.93 (d, J = 10.0 Hz, 1H), 7.74 (s, 1H), 7.69 (d, J = 10.0 Hz, 2H),

7.54 (d, J = 10.0 Hz, 1H), 7.44 – 7.36 (m, 3H), 7.20 (t, J = 7.5 Hz, 2H), 5.31 (s, 2H), 5.24 (s, 2H),
3.17 (s, 6H), 1.78-1.69 (m, 3H), 1.14 (d, 18H)
13

C NMR (CDCl3, 75 MHz): δ 141.2, 137.1, 133.4, 129.1, 127.8, 122.6, 121.6, 119.3, 114.5,

104.6, 67.0, 60.8, 48.2, 18.1, 12.7.
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Synthesis

of

N,N,3-trimethyl-N-((1-methyl-1H-indol-3-yl)methyl)but-2-en-1-aminium

bromide (28d)
A solution N,N-dimethyl-1-(1-methyl-1H-indol-3-yl)methanamine 25d (0.2 g, 1.06 mmol) in
THF (15 mL) was taken in three necked round bottomed flask and nitrogen was bubbled through
the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium (0.82 mL,
2.12 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture maintaining a
temperature -78 °C over a period of 1 h under nitrogen atmosphere. Benzyl bromide
(0.57 mL, 4.77 mmol, 4.5 equiv) was added to the reaction dropwise through the dropping funnel
over a period of 30 min. The reaction mixture was allowed to warm to room temperature and was
stirred overnight. After consumption of the starting material, as judged by TLC analysis, water
(5 mL) was added to the reaction mixture and THF was removed under reduced pressure. The
mixture was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed
with brine solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to
obtain crude product. The residue was purified with flash column chromatography on silica gel
(DCM/MeOH = 25/1) to afford mixture of 28b/29b as a brown oily liquid (52.1 %).
1

H NMR (CDCl3, 500 MHz): δ 7.63 – 7.34 (m, 9H), 5.35 (s, 1H), 5.05 (s, 1H), 4.52 (s, 6H), 3.73

(s, 2H), 2.55 (s, 3H)
13

C NMR (CDCl3, 75 MHz): δ 137.8, 137.0, 134.6, 133.3, 122.5, 121.2, 119.4, 109.9, 100.6, 66.7,

61.4, 53.5, 47.9, 33.7.
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APPENDIX A
HPLC, NMR, HPLC DATA

229

HPLC data of compound 2 (Method A)
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm). tR major =
13.2 min, tR minor = 15.4 min, e.r. = 82.7 :17.3.

Racemic:

Chiral:

Retention Time

Area

% Area

Height

Int Type

Peak Type

1

Peak1

Name

13.167

9263994

82.69

332254

bV

Found

2

Peak2

15.403

1938723

17.31

63495

Vb

Found

11202717

100.00

395749

Total

230

After Single Crystallization:
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm), tR major =
13.2 min, tR minor = 15.4 min, e.r. = 93:7.
Racemic:

Chiral:
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HPLC data of compound 2 (Method B):
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm). tR major =
13.6 min, tR minor = 15.6 min, e.r. = 78.5:21.5.
Racemic:

Chiral:
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HPLC data of compound 2 (Method C):
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary phase
(AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm). tR major = 12.8 min, tR
minor = 14.9 min, e.r. = 76.8:23.2.

Racemic:

Chiral:
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